≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Traumatic subarachnoid haemorrhage

MESH Endpoint Browser

ST19_TRAUMAT_SUBAR_HAEMORRHAGE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — S06.6
  • Hospital discharge: ICD-9 — 852[0-1]
  • Cause of death: ICD-10 — S06.6
  • Cause of death: ICD-9 — 852[0-1]

2 out of 7 registries used, show all original rules.

1658

4. Check minimum number of events

None

1658

5. Include endpoints

None

1658

6. Filter based on genotype QC (FinnGen only)

1603

Control definitions (FinnGen only)

Control exclude
NEURODIS

Extra metadata

Level in the ICD hierarchy
4
Special
ST19_SAHTRAU
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S06
Name in latin
Haemorrhagia subarachnoidalis traumatica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1603 618 985
Unadjusted period prevalence (%) 0.36 0.22 0.45
Median age at first event (years) 68.30 70.21 67.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1658
Matched controls
16580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
139.6
307.7
197
16
NA1AD
NOMESCO Finland
Cervical spine CT examination
33.3
307.7
433
174
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
11.5
307.7
1173
2887
N03AX14
ATC
levetiracetam; systemic
107.2
307.7
173
18
S06.3
ICD-10 Finland
Focal brain injury
5862.0
307.7
447
*
W19
ICD-10 Finland
Unspecified fall
11.6
307.7
519
625
S06.0
ICD-10 Finland
Concussion
62.9
307.7
503
114
AA1AD
NOMESCO Finland
CT of head and brain
27.5
307.7
1229
1565
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
307.7
1636
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
12580.5
307.7
734
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
92.5
303.6
159
19
XA800
NOMESCO Finland
Neuropsychological investigation
38.2
285.4
178
52
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.4
274.5
619
1417
T90.5
ICD-10 Finland
Sequelae of intracranial injury
504.5
265.6
258
6
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
222.0
208
*
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
110.2
220.2
113
11
K90
ICPC
Stroke/cerebrovascular accident
99.1
213.7
111
12
S06.2
ICD-10 Finland
Diffuse brain injury
2134.4
211.0
200
*
G47.3
ICD-10 Finland
Sleep apnoea
10.2
210.9
255
289
S01.0
ICD-10 Finland
Open wound of scalp
7.4
202.7
333
544
X59
ICD-10 Finland
Exposure to unspecified factor
5.2
201.5
553
1462
W10
ICD-10 Finland
Fall on and from stairs and steps
9.3
196.4
257
322
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
39.4
185.4
114
31
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
181.0
554
1585
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.0
177.0
262
379
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.7
176.7
219
255
S02.11
ICD-10 Finland
Fracture of base of skull, open
889.1
166.8
161
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
13.6
163.7
158
127
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.8
163.2
468
1261
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
156.8
148
*
N80
ICPC
Head injury other
17.2
153.0
129
81
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.5
143.6
196
256
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
79.6
142.1
76
10
N03AF02
ATC
oxcarbazepine; oral
44.8
136.2
81
19
ZXD35
NOMESCO Finland
Usual procedure
10.6
131.1
149
153
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
126.7
120
*
R4120
NOMESCO Finland
Occupational therapy
7.9
120.5
175
245
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
14.5
118.6
109
80
N05AH04
ATC
quetiapine; oral
4.4
117.1
349
950
Z2445
NOMESCO Finland
Psychologist
14.5
114.3
105
77
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
22.1
112.8
84
40
PA6AD
NOMESCO Finland
CT of neck arteries
14.1
112.6
105
79
N03AG01
ATC
valproic acid; systemic, rectal
10.4
112.0
128
132
S22.4
ICD-10 Finland
Multiple fractures of ribs
11.9
109.9
114
102
W00
ICD-10 Finland
Fall on same level involving ice and snow
4.5
109.4
311
814
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
106.4
101
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
41.5
99.1
60
15
A28
ICPC
Limited function/disability NOS
3.4
97.4
446
1613
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.0
93.5
132
178
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
31.1
91.4
60
20
S02.70
ICD-10 Finland
Multiple fractures involving skull and facial bones, closed
49.7
91.2
53
11
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
13.3
89.4
86
68
G40.9
ICD-10 Finland
Epilepsy, unspecified
192.4
88.2
91
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.7
86.0
218
517
P20
ICPC
Memory disturbance
3.7
85.6
318
998
N06AX11
ATC
mirtazapine; oral
2.8
85.3
606
2788
G56.0
ICD-10 Finland
Carpal tunnel syndrome
7.7
83.8
122
170
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
15.5
83.2
73
49
S06.9
ICD-10 Finland
Intracranial injury, unspecified
827.5
81.2
79
*
N05AX08
ATC
risperidone; systemic
5.0
80.5
187
412
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
21.4
79.8
60
29
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
10.9
79.5
87
84
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
77.7
74
*
W17
ICD-10 Finland
Other fall from one level to another
6.2
77.7
139
241
S00.0
ICD-10 Finland
Superficial injury of scalp
9.1
76.9
96
111
G30.1
ICD-10 Finland
Alzheimer disease with late onset
7.9
76.6
108
145
P15
ICPC
Chronic alcohol abuse
8.5
71.8
95
118
N07BB01
ATC
disulfiram; oral
6.4
69.8
121
203
R51.80
ICD-10 Finland
Headache
3.9
69.4
230
663
ZXD05
NOMESCO Finland
Urgent procedure
2.6
68.4
582
2873
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
+∞
67.1
64
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
67.1
64
*
N18
ICPC
Paralysis/weakness
30.1
66.3
44
15
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
66.1
63
*
R55
ICD-10 Finland
Syncope and collapse
3.5
65.4
258
834
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
652.7
64.3
63
*
N06DX01
ATC
memantine; oral
5.4
64.3
132
260
L28
ICPC
Limited function/disability (L)
2.9
63.4
379
1559
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
330.4
62.8
63
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
116.3
62.3
67
6
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
28.0
60.3
41
15
N03AF01
ATC
carbamazepine; oral, rectal
7.1
59.4
92
137
PA2AD
NOMESCO Finland
CT angiography of brain
110.9
59.3
64
6
Z3226
NOMESCO Finland
Physiotherapist
2.8
58.4
351
1443
F10.09
ICD-10 Finland
Alcohol intoxication UNS
9.1
58.2
72
82
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
57.6
198
583
N06AB10
ATC
escitalopram; oral
3.0
56.6
302
1162
R5140
NOMESCO Finland
Monitoring the use of the aid
5.2
56.0
120
245
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
566.5
55.9
55
*
R53
ICD-10 Finland
Malaise and fatigue
2.6
55.7
420
1930
QAB00
NOMESCO Finland
Suture of skin of head or neck
10.7
55.5
61
59
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.0
55.5
86
128
AA3AD
NOMESCO Finland
CT of face
14.7
55.5
50
35
S22.3
ICD-10 Finland
Fracture of rib
3.8
55.1
185
535
R42
ICD-10 Finland
Dizziness and giddiness
2.6
55.1
406
1844
X58
ICD-10 Finland
Exposure to other specified factors
2.9
55.1
296
1143
F10.20
ICD-10 Finland
Alcohol dependence currently independent
9.3
54.9
67
75
R4110
NOMESCO Finland
Physiotherapy
2.4
54.6
536
2775
S06.8
ICD-10 Finland
Other intracranial injuries
+∞
53.4
51
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
534.4
52.8
52
*
N02BE01
ATC
paracetamol; systemic, rectal
3.3
52.1
1482
11935
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.8
51.5
60
63
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
6.4
51.4
87
142
S06.4
ICD-10 Finland
Epidural haemorrhage
+∞
51.3
49
*
S09.9
ICD-10 Finland
Unspecified injury of head
9.5
50.3
60
65
P16
ICPC
Acute alcohol abuse
9.5
50.3
60
65
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.6
50.3
176
523
ACC51
NOMESCO Finland
Release of median nerve
72.2
49.4
56
8
N06DA03
ATC
rivastigmine; oral, transdermal
7.5
49.0
71
98
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
48.9
185
578
R4130
NOMESCO Finland
Speech therapy
9.1
48.6
60
68
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
14.6
48.6
44
31
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
48.3
842
5428
S42.0
ICD-10 Finland
Fracture of clavicle
5.6
47.5
93
175
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
6.8
47.0
75
115
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.0
47.0
143
385
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
7.1
46.9
72
106
N06AB04
ATC
citalopram; systemic
2.6
46.8
311
1333
F10.24
ICD-10 Finland
Alcohol depence active use
10.7
46.6
51
49
WX723
NOMESCO Finland
CPAP therapy
470.5
46.5
46
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
5.6
46.5
91
171
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
8.2
46.2
62
78
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.5
46.2
168
511
WX872
NOMESCO Finland
Intensive care
3.9
46.0
143
391
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
8.3
45.9
61
76
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.9
45.8
53
55
K91
ICPC
Cerebrovascular disease
60.8
45.6
53
9
G30.8
ICD-10 Finland
Other Alzheimer disease
18.0
45.6
37
21
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.9
45.5
83
146
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.4
45.3
118
283
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
45.0
43
*
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
5.5
44.3
87
164
WX002
NOMESCO Finland
Sedation and analgesia
2.4
44.0
367
1747
G20
ICD-10 Finland
Parkinson disease
120.9
44.0
47
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
43.9
42
*
N06AX16
ATC
venlafaxine; oral
3.2
43.8
195
672
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
43.4
235
904
R41.0
ICD-10 Finland
Disorientation, unspecified
6.4
43.0
72
116
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
42.9
41
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
42.9
248
988
Z3231
NOMESCO Finland
Registered nurse
2.2
42.7
478
2572
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
6.9
42.7
67
101
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.2
42.6
185
628
N06DA02
ATC
donepezil; oral
4.8
42.2
99
218
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
42.1
266
1108
N29
ICPC
Neurological sympt/complt other
11.0
41.9
45
42
Y94.0
ICD-10 Finland
Accident at home
7.0
41.7
64
94
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
41.7
179
603
N05BA04
ATC
oxazepam; oral
2.3
41.7
402
2032
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
417.6
41.3
41
*
GBB00
NOMESCO Finland
Tracheostomy
9.7
40.8
48
51
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
9.0
40.3
50
57
Y94.8
ICD-10 Finland
Other leisure activity accident
5.6
40.0
78
146
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
39.7
38
*
F05.9
ICD-10 Finland
Delirium, unspecified
7.0
39.6
61
90
PA7BD
NOMESCO Finland
CT angiography of neck and brain
15.8
39.2
34
22
N03AX16
ATC
[U] pregabalin
2.4
39.0
323
1524
Z2446
NOMESCO Finland
Social worker
3.6
38.9
137
407
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.5
38.9
77
146
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.9
38.9
119
321
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
38.8
299
1366
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
14.3
38.3
35
25
V18.4
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident, driver injured in traffic accident
8.2
38.1
51
64
WX892
NOMESCO Finland
Monitored bed care
3.2
37.9
163
549
G72.8
ICD-10 Finland
Other specified myopathies
105.1
37.9
41
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
37.6
36
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
37.6
276
1232
SPAT1216
SPAT
Assessment of functional ability
2.5
37.6
275
1226
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
9.6
37.2
44
47
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
37.0
492
2805
N02AX02
ATC
tramadol; systemic, rectal
2.0
37.0
682
4363
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
13.2
36.6
35
27
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
11.8
36.1
37
32
N05CF01
ATC
zopiclone; oral
2.0
36.1
531
3135
N19
ICPC
Speech disorder
45.1
36.1
44
10
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.5
36.0
59
93
ZXE00
NOMESCO Finland
One hour or less
2.0
35.9
631
3960
Z72.1
ICD-10 Finland
Alcohol use
10.8
35.8
39
37
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
10.8
35.8
39
37
G56.2
ICD-10 Finland
Lesion of ulnar nerve
13.3
35.8
34
26
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
14.0
35.7
33
24
SPAT1229
SPAT
Assessment of need for aid
3.4
35.4
135
422
N03AX09
ATC
lamotrigine; oral
6.2
35.1
61
102
S18
ICPC
Laceration/cut
1.9
35.0
786
5337
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
12.8
35.0
34
27
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
10.0
34.8
40
41
J01DB01
ATC
cefalexin; oral
2.1
34.8
1303
10484
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
34.3
134
425
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.8
34.1
79
172
AAF00
NOMESCO Finland
Ventriculostomy
344.0
34.0
34
*
N05BA01
ATC
diazepam; systemic, rectal
2.6
33.9
212
874
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
178.7
33.8
35
*
N28
ICPC
Limited function/disability (N)
10.8
33.2
36
34
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
33.0
583
3643
L76
ICPC
Fracture: other
4.6
32.5
78
175
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.0
32.3
93
240
A04
ICPC
Weakness/tiredness general
2.4
32.3
257
1185
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
32.2
330
1692
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
6.5
32.2
53
84
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
31.9
153
548
P29
ICPC
Psychological sympt/compl other
3.6
31.8
107
308
N06AX21
ATC
duloxetine; oral
3.0
31.5
149
529
S27.0
ICD-10 Finland
Traumatic pneumothorax
8.7
31.5
40
47
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
31.4
654
4295
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
34.1
31.0
40
12
T74.1
ICD-10 Finland
Physical abuse
8.5
30.9
40
48
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
4.1
30.8
86
217
NB3AA
NOMESCO Finland
Clavicle X-ray examination
7.5
30.6
44
60
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
30.6
165
630
X57
ICD-10 Finland
Unspecified privation
5.2
30.6
63
124
W11
ICD-10 Finland
Fall on and from ladder
5.5
29.9
58
108
Y96.9
ICD-10 Finland
Unspecified type of accident
6.8
29.8
47
71
NC2AA
NOMESCO Finland
Forearm X-ray examination
7.0
29.4
45
66
TAB00
NOMESCO Finland
Lumbar puncture
6.4
29.2
49
79
ZXA05
NOMESCO Finland
Left side
2.0
29.2
418
2416
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
29.1
148
547
NB6AA
NOMESCO Finland
Humerus X-ray examination
5.2
29.1
61
122
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
6.2
29.0
50
83
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
152.7
28.7
30
*
N17
ICPC
Vertigo/dizziness
2.4
28.7
221
1002
G44.2
ICD-10 Finland
Tension-type headache
3.2
28.6
121
403
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
28.5
1070
8297
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
28.2
27
*
P06
ICPC
Sleep disturbance
2.8
28.2
156
603
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
28.2
112
359
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
27.9
368
2064
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
8.2
27.8
37
46
S42.1
ICD-10 Finland
Fracture of scapula
9.1
27.8
34
38
R4150
NOMESCO Finland
Neuropsychological rehabilitation
101.8
27.7
30
*
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
7.9
27.7
38
49
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
27.5
130
461
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.8
27.4
87
241
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
27.2
26
*
N06AX26
ATC
vortioxetine; oral
3.4
27.1
101
311
SPAT1254
SPAT
Administration of medicine
2.3
27.1
243
1175
N06AB06
ATC
sertraline; oral
2.7
27.1
150
580
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
27.1
215
987
P03
ICPC
Feeling depressed
3.1
27.0
118
400
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
27.0
56
111
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
26.8
409
2406
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
6.2
26.8
46
76
WX882
NOMESCO Finland
High dependency care
4.7
26.8
62
135
L17
ICPC
Foot/toe symptom/complaint
1.9
26.7
461
2825
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
26.6
244
1189
Z2221
NOMESCO Finland
Medical doctor
1.9
26.6
433
2602
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
26.6
411
2428
S01.9
ICD-10 Finland
Open wound of head, part unspecified
5.8
26.6
49
87
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.7
26.4
42
64
I95.1
ICD-10 Finland
Orthostatic hypotension
3.8
26.4
81
219
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
26.3
248
1223
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
9.6
26.2
31
33
N03AE01
ATC
clonazepam; systemic
4.2
26.2
71
175
C03CA01
ATC
furosemide; systemic
1.8
26.2
566
3712
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
26.1
25
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
26.1
25
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.2
25.9
69
168
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.5
25.7
42
66
WX730
NOMESCO Finland
Conventional respirator
6.1
25.7
45
76
A06AD11
ATC
lactulose; oral
2.2
25.6
251
1256
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
4.9
25.6
57
120
C07AB07
ATC
bisoprolol; oral
1.7
25.3
827
6079
Z02.7
ICD-10 Finland
Issue of medical certificate
2.8
25.2
129
478
S70.0
ICD-10 Finland
Contusion of hip
3.7
25.0
82
232
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.8
24.9
56
119
S01.8
ICD-10 Finland
Open wound of other parts of head
5.4
24.7
49
93
A02BC02
ATC
pantoprazole; systemic
1.7
24.5
1049
8268
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
24.4
307
1686
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.9
24.2
117
420
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
24.0
23
*
A01
ICPC
Pain general/multiple sites
2.5
23.9
156
654
S27.3
ICD-10 Finland
Other injuries of lung
68.5
23.9
27
*
SPAT1053
SPAT
Memory test
2.1
23.8
244
1240
B01AC04
ATC
clopidogrel; oral
2.1
23.8
261
1362
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
23.7
1017
7986
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
5.3
23.7
48
93
N05AA02
ATC
levomepromazine; systemic
3.8
23.6
74
203
SPAT1234
SPAT
Support of social functional capacity
3.2
23.2
95
310
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.5
23.2
30
36
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
23.2
110
391
XF600
NOMESCO Finland
Bloodpressure measurement
3.0
23.2
108
380
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.2
23.1
62
152
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
23.0
192
898
C10AA01
ATC
simvastatin; oral
1.7
23.0
702
5025
N03AX18
ATC
lacosamide; systemic
+∞
23.0
22
*
D21
ICPC
Swallowing problem
7.5
22.9
33
45
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
22.8
155
662
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
233.1
22.7
23
*
ZXA00
NOMESCO Finland
Right side
1.8
22.6
415
2571
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
23.3
22.6
32
14
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.8
22.5
51
109
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
22.4
92
301
M79.6
ICD-10 Finland
Pain in limb
1.7
22.2
595
4102
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
22.2
135
546
G51.0
ICD-10 Finland
Bell palsy
24.3
22.2
31
13
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
22.0
134
542
S02.01
ICD-10 Finland
Fracture of the upper part of the head open
+∞
21.9
21
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
21.9
21
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
21.9
21
*
B01AB05
ATC
enoxaparin; parenteral
1.7
21.8
483
3157
AA5PD
NOMESCO Finland
CT examination of brain pefusion
81.2
21.7
24
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
222.8
21.6
22
*
N01
ICPC
Headache
2.7
21.6
124
487
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
116.6
21.6
23
*
S00.8
ICD-10 Finland
Superficial injury of other parts of head
5.6
21.5
41
75
B01AA03
ATC
warfarin; systemic
1.9
21.4
354
2121
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
19.2
21.3
32
17
R41.3
ICD-10 Finland
Other amnesia
4.9
21.1
47
99
V18.0
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident, driver injured in nontraffic accident
8.6
21.0
27
32
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.9
21.0
62
163
N05CD07
ATC
temazepam; oral
2.2
20.9
195
953
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
60.8
20.9
24
*
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
+∞
20.9
20
*
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
+∞
20.9
20
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.6
20.9
50
112
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.9
20.8
32
47
Z29
ICPC
Social problem NOS
5.5
20.8
40
74
U04
ICPC
Incontinence urine
2.9
20.7
103
376
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.1
20.6
90
305
N06AA09
ATC
amitriptyline; systemic
2.7
20.6
116
452
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
20.5
238
1264
AA1ED
NOMESCO Finland
Trauma CT of head and neck
22.7
20.4
29
13
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
20.4
207
1046
SPAT1301
SPAT
No procedures
1.7
20.3
453
2958
S72.0
ICD-10 Finland
Fracture of neck of femur
3.1
20.2
88
298
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
20.0
102
377
SPAT1240
SPAT
Therapeutic discussion
2.6
19.9
115
454
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.8
19.8
101
373
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
+∞
19.8
19
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
19.8
19
*
N05AH03
ATC
olanzapine; systemic
3.0
19.8
92
323
A29
ICPC
General symptom/complaint other
2.1
19.8
217
1128
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.4
19.8
50
117
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
19.8
591
4165
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
202.3
19.6
20
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
19.5
404
2580
AA1DD
NOMESCO Finland
Head and neck CT
31.7
19.3
25
8
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
19.2
158
733
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
17.0
19.2
30
18
C09AA05
ATC
ramipril; oral
1.7
19.2
433
2830
N30.0
ICD-10 Finland
Acute cystitis
2.0
19.1
224
1192
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
19.0
571
4018
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.4
19.0
47
108
SPAT1310
SPAT
Counselling related to known health issue
1.7
18.9
447
2955
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.0
18.9
87
304
P01
ICPC
Feeling anxious/nervous/tense
2.5
18.9
126
533
P76
ICPC
Depressive disorder
3.2
18.8
76
246
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
18.8
18
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
18.8
18
*
S01.3
ICD-10 Finland
Open wound of ear
6.6
18.8
30
46
H53.2
ICD-10 Finland
Diplopia
4.2
18.7
50
122
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
18.7
93
339
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
5.5
18.6
36
67
L14
ICPC
Leg/thigh symptom/complaint
2.4
18.5
134
588
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.6
18.4
108
429
V14.9
ICD-10 Finland
Pedal cyclist injured in collision with heavy transport vehicle or bus, unspecified pedal cyclist injured in traffic accident
16.4
18.3
29
18
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.7
18.3
29
44
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.6
18.3
43
95
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.9
18.2
53
138
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
18.1
78
262
G43.9
ICD-10 Finland
Migraine, unspecified
5.5
18.1
35
65
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
17.9
212
1131
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
23.1
17.8
25
11
I63.8
ICD-10 Finland
Other cerebral infarction
+∞
17.7
17
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
17.7
17
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
17.7
243
1364
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
17.6
265
1533
WX402
NOMESCO Finland
General anaesthesia
1.8
17.5
326
2013
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
17.4
429
2859
S80.0
ICD-10 Finland
Contusion of knee
2.6
17.4
105
423
N03AX12
ATC
[U] gabapentin; oral
2.1
17.4
169
838
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.0
17.3
78
269
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
24.3
17.3
24
10
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
21.1
17.3
25
12
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
17.3
991
8057
N87
ICPC
Parkinsonism
42.5
17.3
21
5
S02.80
ICD-10 Finland
Fractures of other skull and facial bones, closed
42.5
17.3
21
5
G04BD12
ATC
mirabegron; oral
2.0
17.3
189
980
ZXD00
NOMESCO Finland
Emergency procedure
3.3
17.2
66
207
C08CA01
ATC
amlodipine; oral
1.6
17.1
619
4531
L08
ICPC
Shoulder symptom/complaint
1.8
17.1
324
2009
V03.1
ICD-10 Finland
Pedestrian injured in collision with car, pick-up truck or van, traffic accident
31.8
17.0
22
7
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.6
17.0
24
32
N03AB02
ATC
phenytoin; systemic
17.6
16.9
26
15
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
16.9
188
980
N02AA05
ATC
oxycodone; systemic
1.8
16.9
302
1839
S01
ICD-10 Finland
Open wound of head
6.1
16.9
29
48
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.0
16.8
76
263
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
16.7
16
*
RF220, ,
NOMESCO Finland
6.5
16.7
27
42
N06AX03
ATC
mianserin; oral
3.1
16.6
70
233
AAK80
NOMESCO Finland
Partial excision of skull cap
171.7
16.5
17
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
16.5
180
933
WYA20
NOMESCO Finland
Home visit
5.0
16.4
35
71
Z71.8
ICD-10 Finland
Other specified counselling
1.6
16.4
465
3204
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
5.4
16.4
32
60
N06DA04
ATC
galantamine; oral
4.7
16.4
38
83
S12.7
ICD-10 Finland
Multiple fractures of cervical spine
40.5
16.3
20
5
Y86
ICD-10 Finland
Sequelae of other accidents
15.5
16.2
26
17
R50.9
ICD-10 Finland
Fever, unspecified
1.9
16.2
224
1259
Y07
ICD-10 Finland
Other maltreatment
11.8
16.1
29
25
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
16.0
208
1144
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
16.0
415
2795
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
15.9
124
562
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
15.9
121
543
S20.2
ICD-10 Finland
Contusion of thorax
2.7
15.9
88
340
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.9
15.7
34
70
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.8
15.7
47
125
M54.5
ICD-10 Finland
Low back pain
1.6
15.7
458
3173
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
15.6
15
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
15.6
15
*
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
+∞
15.6
15
*
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.1
15.6
67
225
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.2
15.6
41
99
R47.0
ICD-10 Finland
Dysphasia and aphasia
26.6
15.6
21
8
AA1XD
NOMESCO Finland
Other special CT of head and brain
19.4
15.6
23
12
NH1AD
NOMESCO Finland
Ankle and foot CT
4.1
15.5
43
108
F03
ICD-10 Finland
Unspecified dementia
3.1
15.5
66
221
J01MA02
ATC
ciprofloxacin; systemic
1.6
15.4
585
4304
R13
ICD-10 Finland
Dysphagia
2.5
15.4
102
430
N05CF02
ATC
zolpidem; oral
1.9
15.3
224
1282
R06.5
ICD-10 Finland
Mouth breathing
2.6
15.3
87
341
R1260
NOMESCO Finland
Evaluation of communicative skills
5.7
15.1
28
50
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
15.1
200
1108
C07AA05
ATC
propranolol; systemic
1.8
15.0
229
1327
A46
ICD-10 Finland
Erysipelas
1.8
15.0
239
1404
WX722
NOMESCO Finland
PEEP
3.8
14.9
46
125
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
14.9
117
532
F05.8
ICD-10 Finland
Other delirium
6.8
14.9
23
34
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
14.9
457
3199
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
32.0
14.8
19
6
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
32.0
14.8
19
6
N05BE01
ATC
buspirone; oral
3.9
14.8
43
112
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
14.8
68
238
N02BF01
ATC
gabapentin; oral
2.3
14.7
109
483
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.3
14.7
29
55
XF404
NOMESCO Finland
Ambulatory ECG
2.2
14.7
134
648
N06AB03
ATC
fluoxetine; oral
2.1
14.6
145
724
N05BA09
ATC
clobazam; oral
+∞
14.6
14
*
F34.1
ICD-10 Finland
Dysthymia
3.7
14.6
46
127
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
14.6
183
995
N04BC05
ATC
pramipexole; oral
2.7
14.4
80
309
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.3
14.4
55
172
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
14.4
547
4010
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
14.4
73
269
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.4
14.4
98
418
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
14.3
150
764
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.4
14.3
36
84
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
14.3
360
2397
W18
ICD-10 Finland
Other fall on same level
17.1
14.3
22
13
J01FF01
ATC
clindamycin; systemic
1.6
14.3
369
2474
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
14.1
183
1005
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
14.1
365
2446
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
14.1
272
1688
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
6.7
14.0
22
33
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
14.0
96
411
R35
ICD-10 Finland
Polyuria
2.2
14.0
114
527
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
30.3
13.9
18
6
UKC02
NOMESCO Finland
Cystoscopy
1.7
13.9
266
1647
R5110, ,
SPAT
2.2
13.9
127
615
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
13.8
331
2174
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
4.5
13.8
33
74
S01.2
ICD-10 Finland
Open wound of nose
4.6
13.8
32
70
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
13.8
114
530
F06.7
ICD-10 Finland
Mild cognitive disorder
3.4
13.7
49
147
L03
ICPC
Low back symptom/complaint
1.6
13.7
359
2410
N05BA02
ATC
chlordiazepoxide; systemic
3.6
13.7
44
123
SPAT1263
SPAT
Sampling
1.5
13.7
559
4154
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
13.7
371
2513
SPAT1262
SPAT
Handing over of treatment supplies
1.8
13.6
247
1506
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.8
13.6
30
63
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.8
13.6
30
63
G40.89
ICD-10 Finland
Other epilepsy
+∞
13.6
13
*
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
13.6
13
*
N88
ICPC
Epilepsy
+∞
13.6
13
*
AAD12
NOMESCO Finland
Drainage of subdural fluid
+∞
13.6
13
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
13.6
13
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
13.5
84
344
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
13.5
94
406
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
13.4
233
1401
R25.1
ICD-10 Finland
Tremor, unspecified
4.0
13.4
37
93
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
13.4
736
5807
H53.4
ICD-10 Finland
Visual field defects
4.9
13.3
29
60
R1250
NOMESCO Finland
Evaluation of functional capability
4.5
13.3
32
72
ZXA10
NOMESCO Finland
Bilateral
1.7
13.3
281
1785
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.9
13.2
164
887
R33
ICD-10 Finland
Retention of urine
2.0
13.2
143
738
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
13.2
104
474
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
13.2
518
3813
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
13.2
494
3600
R02
ICPC
Shortness of breath/dyspnoea
1.8
13.2
195
1118
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.2
13.1
53
172
R07.3
ICD-10 Finland
Other chest pain
2.0
13.1
139
712
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.1
13.1
128
636
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.3
13.1
50
157
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
11.1
13.0
24
22
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.6
13.0
74
290
WX704
NOMESCO Finland
Intubation
2.2
13.0
116
556
JN4AE
NOMESCO Finland
Focused Assessment with Sonography for Trauma (FAST) of torso
16.9
13.0
20
12
S52.5
ICD-10 Finland
Fracture of lower end of radius
2.0
12.9
150
793
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
22.7
12.9
18
8
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.5
12.9
31
70
ZXY02
NOMESCO Finland
Neuropsychologist
50.4
12.8
15
*
C03DA01
ATC
spironolactone; oral
1.8
12.8
207
1218
P74
ICPC
Anxiety disorder/anxiety state
3.1
12.8
54
180
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
14.2
12.8
21
15
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
12.8
486
3549
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
12.7
390
2714
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.7
12.7
66
247
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.7
12.6
68
259
A10AE04
ATC
insulin glargine; parenteral
2.0
12.6
139
721
SPAT1094
SPAT
Continuous Positive Airway Pressure
70.4
12.6
14
*
N05BA12
ATC
alprazolam; oral
2.1
12.5
128
646
N06AB05
ATC
paroxetine; oral
2.6
12.5
70
272
G40
ICD-10 Finland
Epilepsy
+∞
12.5
12
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
12.5
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
12.4
136
704
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
12.4
78
321
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.7
12.2
38
104
E86
ICD-10 Finland
Volume depletion
3.4
12.2
43
128
S42.4
ICD-10 Finland
Fracture of lower end of humerus
5.0
12.2
26
53
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.1
12.2
49
159
G45.4
ICD-10 Finland
Transient global amnesia
16.0
12.1
19
12
NF3AA
NOMESCO Finland
Femur X-ray examination
3.4
12.1
42
124
A97
ICPC
No disease
1.6
12.1
292
1918
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
12.1
350
2402
EBA00
NOMESCO Finland
Extraction of tooth
1.5
12.0
498
3691
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
12.0
67
260
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.2
12.0
48
155
M03BX01
ATC
baclofen; systemic
10.1
12.0
23
23
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
12.0
497
3685
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
12.0
206
1234
JN4BD
NOMESCO Finland
Extensive body CT
1.8
12.0
189
1104
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
13.5
11.9
20
15
S97
ICPC
Chronic ulcer skin
2.2
11.9
103
488
L12
ICPC
Hand/finger symptom/complaint
1.8
11.9
209
1260
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
11.9
343
2350
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
11.9
250
1584
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.5
11.8
40
116
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.0
11.7
52
179
S02.90
ICD-10 Finland
Fracture of skull and facial bones, part unspecified, closed
30.2
11.6
15
5
J01DA01
ATC
[U] cefalexin
1.4
11.6
847
6982
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
65.4
11.6
13
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.6
685
5435
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
11.5
42
128
W06
ICD-10 Finland
Fall involving bed
9.3
11.5
23
25
J01CF05
ATC
flucloxacillin; systemic
2.2
11.5
102
488
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
11.5
11
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
+∞
11.5
11
*
S06.1
ICD-10 Finland
Traumatic cerebral oedema
+∞
11.5
11
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
+∞
11.5
11
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
11.5
11
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
120.8
11.4
12
*
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.7
11.4
36
100
S70.1
ICD-10 Finland
Contusion of thigh
4.2
11.3
30
73
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
8.4
11.3
24
29
S02.47
ICD-10 Finland
Multiple fracture of the upper jaw bone
35.3
11.3
14
*
S02.71
ICD-10 Finland
Multiple fractures involving skull and facial bones, open
35.3
11.3
14
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
11.2
179
1048
A99
ICPC
Disease/condition unspecnature/site
1.9
11.2
149
824
S21
ICPC
Skin texture symptom/complaint
1.7
11.2
219
1359
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.6
11.2
21
38
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
4.1
11.2
30
74
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.2
770
6269
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
11.1
239
1522
NCJ62
NOMESCO Finland
Internal fixation of fracture of forearm using plate
3.7
11.1
35
97
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
11.0
228
1436
SPAT1252
SPAT
Overall medication plan or its review
2.1
11.0
99
476
L86
ICPC
Back syndrome with radiating pain
2.4
11.0
76
327
Y96.8
ICD-10 Finland
Other type of accident
9.3
11.0
22
24
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
11.0
166
956
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
14.0
11.0
18
13
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.7
11.0
25
54
-1, ,
NOMESCO Finland
1.5
10.9
409
2963
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.9
10.9
31
80
E0000UV, ,
ATC
1.5
10.8
549
4219
S51.0
ICD-10 Finland
Open wound of elbow
4.0
10.8
30
76
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.9
10.8
22
25
N06AA12
ATC
doxepin; systemic
2.5
10.8
69
287
R01AD09
ATC
mometasone; nasal
1.5
10.7
519
3950
R47.1
ICD-10 Finland
Dysarthria and anarthria
17.9
10.7
16
9
SPAT1377
SPAT
Polysomnography
4.1
10.7
29
72
K59.0
ICD-10 Finland
Constipation
2.4
10.7
76
332
G30.0
ICD-10 Finland
Alzheimer disease with early onset
60.4
10.6
12
*
N02BF02
ATC
pregabalin; oral
2.4
10.6
74
320
A02BC03
ATC
lansoprazole; oral
1.5
10.6
369
2628
JN4AD
NOMESCO Finland
Body CT examination
1.7
10.6
193
1174
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.9
10.6
48
167
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.3
10.6
27
64
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.5
10.5
25
56
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
10.5
187
1132
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
110.7
10.4
11
*
I60
ICD-10 Finland
Subarachnoid haemorrhage
+∞
10.4
10
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
10.4
10
*
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
10.4
10
*
2161
FHL
Neck ligation, big brain
+∞
10.4
10
*
Y87.1
ICD-10 Finland
Sequelae of assault
+∞
10.4
10
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
10.4
10
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
10.4
10
*
R4110, ,
SPAT
1.8
10.4
161
935
D07AC01
ATC
betamethasone; topical
1.5
10.4
497
3772
SPAT1153
SPAT
Removal of sutures
1.5
10.4
436
3227
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.3
10.3
26
61
SPAT1251
SPAT
Organisation of medication
2.7
10.3
56
215
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
10.3
57
221
J01EA01
ATC
trimethoprim; systemic
1.6
10.3
313
2164
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
2.7
10.2
54
204
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
10.2
86
403
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
10.2
104
525
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
10.2
94
457
N05AX12
ATC
aripiprazole; systemic
3.1
10.1
42
139
P70
ICPC
Dementia
3.8
10.1
30
80
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
11.4
10.1
18
16
H02AB06
ATC
prednisolone; systemic
1.4
10.0
649
5193
N99
ICPC
Neurological disease other
10.1
10.0
19
19
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
10.0
390
2840
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
3.7
10.0
31
85
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
10.0
145
826
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
10.0
294
2018
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
9.9
253
1678
G04CA02
ATC
tamsulosin; oral
1.5
9.9
412
3039
N05AF03
ATC
chlorprothixene; systemic
3.3
9.9
36
110
Z72.2
ICD-10 Finland
Drug use
16.8
9.9
15
9
V03AA01, ,
ATC
3.9
9.9
28
72
R11
ICD-10 Finland
Nausea and vomiting
2.0
9.9
113
595
S43.0
ICD-10 Finland
Dislocation of shoulder joint
2.5
9.8
60
244
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
9.8
120
646
A02BC01
ATC
omeprazole; systemic
1.5
9.8
354
2536
N04BD01
ATC
selegiline; oral
26.2
9.8
13
5
S82.1
ICD-10 Finland
Fracture of upper end of tibia
3.6
9.8
32
91
AN1
HP
Coronary angiography
1.7
9.8
180
1098
U02
ICPC
Urinary frequency/urgency
1.7
9.8
192
1192
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
9.8
182
1114
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.2
9.8
37
116
B01AC07
ATC
dipyridamole; systemic
2.7
9.7
53
204
SPAT1211
SPAT
Application of soft bandage
1.9
9.7
116
620
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.9
9.7
28
73
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
4.2
9.6
25
60
XKC03
NOMESCO Finland
Water cystometry
3.2
9.6
38
122
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
9.6
76
347
C10AA05
ATC
atorvastatin; oral
1.4
9.6
607
4827
P01AB01
ATC
metronidazole; oral, rectal
1.4
9.6
485
3710
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
9.5
375
2733
V48.9
ICD-10 Finland
Car occupant injured in noncollision transport accident, unspecified car occupant injured in traffic accident
10.1
9.5
18
18
R06.0
ICD-10 Finland
Dyspnoea
1.5
9.5
362
2620
L29
ICPC
Musculoskeletal sympt/complt other
1.9
9.5
116
624
M48.0
ICD-10 Finland
Spinal stenosis
1.8
9.5
144
830
R06AE07
ATC
cetirizine; oral
1.4
9.5
525
4077
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.2
9.5
37
118
C07AB02
ATC
metoprolol; systemic
1.5
9.5
297
2065
N05AD01
ATC
haloperidol; systemic
2.7
9.4
49
184
G45.3
ICD-10 Finland
Amaurosis fugax
30.2
9.4
12
*
N79
ICPC
Concussion
17.6
9.4
14
8
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
9.4
570
4498
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
9.4
572
4517
IHZ05, ,
SPAT
3.1
9.4
38
124
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
9.4
9
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
9.4
9
*
I61
ICD-10 Finland
Intracerebral haemorrhage
+∞
9.4
9
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
9.4
9
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
9.4
9
*
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
+∞
9.4
9
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
9.4
9
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
9.4
9
*
SFA30
NOMESCO Finland
Three-surface restoration
1.4
9.4
558
4390
A98
ICPC
Health maint/preventive medicine
1.7
9.4
1490
13932
S12.0
ICD-10 Finland
Fracture of first cervical vertebra
21.8
9.4
13
6
M19.9
ICD-10 Finland
Arthrosis, unspecified
2.5
9.3
57
232
S52.0
ICD-10 Finland
Fracture of upper end of ulna
3.5
9.3
32
94
R52.2
ICD-10 Finland
Other chronic pain
3.0
9.3
39
130
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
9.3
156
927
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.7
9.3
29
80
S09.8
ICD-10 Finland
Other specified injuries of head
9.6
9.3
18
19
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.5
9.3
55
221
WX212
NOMESCO Finland
Femoral plexus blockade
2.9
9.3
43
152
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
9.3
103
537
N06AG02
ATC
moclobemide; oral
2.6
9.2
51
198
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.3
9.2
34
105
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.3
9.2
34
105
S01.51
ICD-10 Finland
Open wound on lip
3.3
9.2
33
100
H01
ICPC
Ear pain/earache
1.8
9.2
134
764
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
9.2
43
153
G04BD08
ATC
solifenacin; oral
2.1
9.1
89
442
A02BC05
ATC
esomeprazole; systemic
1.4
9.1
507
3935
SPAT1265
SPAT
Breathalyser
7.8
9.1
20
26
D10
ICPC
Vomiting
2.4
9.1
60
253
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
9.1
95
484
XCK00
NOMESCO Finland
Perimetry
2.1
9.1
87
429
P17
ICPC
Tobacco abuse
5.0
9.1
19
38
S32.4
ICD-10 Finland
Fracture of acetabulum
5.0
9.1
19
38
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
9.1
543
4268
M03BX02
ATC
tizanidine; oral
1.4
9.1
760
6317
P19
ICPC
Drug abuse
8.3
9.1
19
23
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.5
9.1
31
91
T90
ICPC
Diabetes non-insulin dependent
1.5
9.0
343
2479
N06AX12
ATC
bupropion; oral
2.4
9.0
58
242
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
36.9
9.0
11
*
S29
ICPC
Skin symptom/complaint other
1.5
9.0
280
1941
N06AB08
ATC
fluvoxamine; oral
3.1
9.0
37
122
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
9.0
81
391
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
8.9
70
319
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
18.7
8.9
13
7
WX320
NOMESCO Finland
Spinalanesthesy
1.5
8.9
341
2467
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
24.1
8.9
12
5
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
8.9
152
908
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.9
8.9
40
139
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
8.9
135
780
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
8.8
271
1873
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
8.7
131
753
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.7
8.7
47
180
K92.1
ICD-10 Finland
Melaena
2.0
8.7
90
457
V49
ICD-10 Finland
Car occupant injured in other and unspecified transport accidents
14.1
8.7
14
10
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
14.1
8.7
14
10
Z91.5
ICD-10 Finland
Personal history of self-harm
50.3
8.7
10
*
R52.9
ICD-10 Finland
Pain, unspecified
1.8
8.7
123
695
Z04.3
ICD-10 Finland
Examination and observation following other accident
3.2
8.7
33
104
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.4
8.6
30
89
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.4
8.6
21
48
L11
ICPC
Wrist symptom/complaint
2.0
8.6
97
508
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
8.3
8.6
18
22
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
3.1
8.6
35
115
S12.1
ICD-10 Finland
Fracture of second cervical vertebra
11.6
8.6
15
13
K89
ICPC
Transient cerebral ischaemia
11.6
8.6
15
13
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
8.6
95
495
S22.2
ICD-10 Finland
Fracture of sternum
7.0
8.5
20
29
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
2.2
8.5
67
306
L16
ICPC
Ankle symptom/complaint
1.7
8.5
144
858
SPAT1260
SPAT
Consultation of another employee
1.6
8.5
217
1438
N07
ICPC
Convulsion/seizure
27.7
8.5
11
*
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
27.7
8.5
11
*
T91.1
ICD-10 Finland
Sequelae of fracture of spine
27.7
8.5
11
*
NAJ22
NOMESCO Finland
Posterior reduction of fractrue of thoracic spine
27.7
8.5
11
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
8.5
42
154
U07
ICPC
Urine symptom/complaint other
1.8
8.5
122
693
N06AX22
ATC
agomelatine; oral
4.2
8.5
22
53
E87.6
ICD-10 Finland
Hypokalaemia
2.4
8.5
54
225
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
8.4
153
929
G30
ICD-10 Finland
Alzheimer disease
7.4
8.4
19
26
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.4
291
2060
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.9
8.4
112
620
S15.0
ICD-10 Finland
Injury of carotid artery
90.5
8.4
9
*
S09.7
ICD-10 Finland
Multiple injuries of head
90.5
8.4
9
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
90.5
8.4
9
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
90.5
8.4
9
*
205
Kela drug reimbursment
Chronic hypertension
1.4
8.4
406
3070
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
8.3
8
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
8.3
8
*
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
8.3
8
*
G41.8
ICD-10 Finland
Other status epilepticus
+∞
8.3
8
*
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
8.3
8
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
8.3
8
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
8.3
8
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
8.3
8
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
8.3
8
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
8.3
8
*
S22
ICPC
Nail symptom/complaint
2.0
8.3
90
465
R51
ICD-10 Finland
Headache
2.6
8.3
46
179
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
8.3
326
2369
J01MA12
ATC
levofloxacin; systemic
1.5
8.3
260
1804
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
9.5
8.3
16
17
SPAT1307
SPAT
Psychosocial counselling and guidance
2.6
8.3
48
191
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
8.3
141
842
Z00.0
ICD-10 Finland
General medical examination
1.5
8.2
248
1706
RS221, ,
NOMESCO Finland
4.2
8.2
21
50
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.0
8.2
83
419
A10AB05
ATC
insulin aspart; parenteral
1.9
8.2
99
532
R60.9
ICD-10 Finland
Oedema, unspecified
2.1
8.2
74
358
L09
ICPC
Arm symptom/complaint
2.3
8.2
59
260
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.9
8.2
23
59
P99
ICPC
Psychological disorders other
3.1
8.1
32
103
S82.3
ICD-10 Finland
Fracture of lower end of tibia
3.1
8.1
32
103
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.2
8.1
31
98
R25.2
ICD-10 Finland
Cramp and spasm
3.3
8.1
30
93
G50.0
ICD-10 Finland
Trigeminal neuralgia
8.2
8.1
17
21
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
33.5
8.1
10
*
S16
ICPC
Bruise/contusion
2.7
8.1
43
164
S27.1
ICD-10 Finland
Traumatic haemothorax
6.9
8.1
19
28
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.9
8.0
36
125
V89
ICD-10 Finland
Motor- or nonmotor-vehicle accident, type of vehicle unspecified
22.1
8.0
11
5
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
8.0
63
288
K04.0
ICD-10 Finland
Pulpitis
1.9
8.0
104
572
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.9
8.0
23
60
A07DA03
ATC
loperamide; oral
2.4
8.0
52
219
OAB50, ,
SPAT
1.9
8.0
99
537
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
7.9
155
961
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.2
7.9
62
283
D07AA02
ATC
hydrocortisone; topical
1.6
7.9
167
1056
S52.6
ICD-10 Finland
Fracture of lower end of both ulna and radius
3.0
7.9
33
110
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
7.9
114
648
ND1AD
NOMESCO Finland
Wrist CT examination
4.5
7.9
19
43
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.3
7.9
56
245
L84
ICPC
Back syndrome without radiat pain
2.2
7.9
65
303
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
13.1
7.9
13
10
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.7
7.9
40
149
B01AB10
ATC
tinzaparin; parenteral
1.7
7.9
151
932
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
7.8
252
1757
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.8
7.8
107
599
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
10.8
7.8
14
13
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
7.8
223
1516
A10BA02
ATC
metformin; oral
1.4
7.8
401
3059
SFA10
NOMESCO Finland
One-surface restoration
1.3
7.8
697
5810
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
7.8
162
1021
S17
ICPC
Abrasion/scratch/blister
3.1
7.8
32
106
V29.9
ICD-10 Finland
Motorcycle rider [any] injured in unspecified traffic accident
4.2
7.7
20
48
SPAT1281
SPAT
Other administrative function
1.9
7.7
98
535
V80
ICD-10 Finland
Animal-rider or occupant of animal-drawn vehicle injured in transport accident
45.2
7.7
9
*
S01.7
ICD-10 Finland
Multiple open wounds of head
6.4
7.7
19
30
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
7.7
355
2656
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
7.7
335
2480
-50
ICPC
Medication/prescr/renewal
2.3
7.7
58
261
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
7.6
286
2056
J01CA04
ATC
amoxicillin; systemic
1.4
7.6
1146
10302
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
7.6
56
249
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.5
7.6
45
181
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
7.6
456
3567
R4130, ,
SPAT
18.4
7.6
11
6
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
7.6
55
243
R5599
NOMESCO Finland
Other rehabilitation service
2.8
7.6
37
135
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.0
7.6
33
113
K78
ICPC
Atrial fibrillation/flutter
1.8
7.6
123
725
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.4
7.5
26
77
G25.0
ICD-10 Finland
Essential tremor
3.8
7.5
22
58
UDC00
NOMESCO Finland
Ear microscopy
1.9
7.5
99
547
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.5
221
1511
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
7.5
285
2054
R03AC02
ATC
salbutamol; inhalant
1.3
7.5
676
5631
KMAK, ,
NOMESCO Finland
1.3
7.5
622
5118
K92.0
ICD-10 Finland
Haematemesis
2.6
7.5
42
165
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
7.5
43
171
UDM02
NOMESCO Finland
Sinoscopy
3.1
7.4
30
98
L72
ICPC
Fracture: radius/ulna
3.1
7.4
30
98
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
80.4
7.4
8
*
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
80.4
7.4
8
*
S37.0
ICD-10 Finland
Injury of kidney
13.4
7.4
12
9
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.4
374
2842
H03AA01
ATC
levothyroxine sodium; systemic
1.5
7.4
267
1907
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
7.4
65
312
RF210, ,
NOMESCO Finland
2.8
7.3
35
126
K08.3
ICD-10 Finland
Retained dental root
1.8
7.3
110
633
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
7.3
89
479
D11
ICPC
Diarrhoea
1.7
7.3
130
785
R31
ICD-10 Finland
Unspecified haematuria
1.6
7.3
158
1005
J01CA08
ATC
pivmecillinam; oral
1.4
7.3
412
3187
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
7.3
477
3779
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.6
7.3
23
64
S02.21
ICD-10 Finland
Fracture of nasal bones, open
10.9
7.3
13
12
Y09
ICD-10 Finland
Assault by unspecified means
10.9
7.3
13
12
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
7.3
7
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
7.3
7
*
35399
ICD-8 Finland
Sciatica
+∞
7.3
7
*
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
7.3
7
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
7.3
7
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
7.3
7
*
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
+∞
7.3
7
*
8500B
ICD-9 Finland
Concussion, With no loss of consciousness[COMMOTIO CEREBRI,EI TAJUTTOMUUTTA]
+∞
7.3
7
*
AA9CW, ,
NOMESCO Finland
+∞
7.3
7
*
J01FA06
ATC
roxithromycin; oral
1.4
7.3
495
3946
S82.4
ICD-10 Finland
Fracture of fibula alone
3.4
7.3
25
74
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.7
7.2
123
734
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.3
7.2
18
29
F32
ICD-10 Finland
Depressive episode
2.4
7.2
48
204
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.3
7.2
18
42
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.3
7.2
16
22
4471
FHL
Pharyngoplasty
30.1
7.1
9
*
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
30.1
7.1
9
*
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
30.1
7.1
9
*
G44.0
ICD-10 Finland
Cluster headache syndrome
20.1
7.1
10
5
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.2
7.1
27
85
M54.2
ICD-10 Finland
Cervicalgia
1.9
7.1
84
448
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.1
840
7254
EEC35
NOMESCO Finland
Reduction and osteosynthesis of zygomaticomaxillary fracture
12.1
7.1
12
10
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
2.4
7.1
45
188
S19
ICPC
Skin injury other
2.2
7.0
58
271
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.0
352
2668
R51.81
ICD-10 Finland
Facial pain NOS
3.5
7.0
23
66
L01
ICPC
Neck symptom/complaint
1.6
7.0
172
1130
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
7.0
174
1147
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.7
6.9
21
57
R4120, ,
SPAT
5.9
6.9
18
31
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
6.9
136
845
L13
ICPC
Hip symptom/complaint
1.5
6.9
241
1707
Z08
ICPC
Social welfare problem
4.0
6.9
19
48
RS222, ,
NOMESCO Finland
4.0
6.9
19
48
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
13.8
6.9
11
8
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.9
250
1785
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
6.9
1300
11993
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.8
6.9
32
114
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
6.9
221
1540
NB1AD
NOMESCO Finland
Shoulder CT examination
3.2
6.9
26
82
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.8
221
1542
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
11.0
6.8
12
11
S02.62
ICD-10 Finland
Fracture of the condyle of the lower jaw
11.0
6.8
12
11
S36.0
ICD-10 Finland
Injury of spleen
11.0
6.8
12
11
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.3
6.8
47
204
J01AA02
ATC
doxycycline; systemic
1.3
6.8
1086
9757
OAB43, ,
SPAT
0.6
6.8
148
2239
ZY010
NOMESCO Finland
Hospital outpatient
2.2
6.8
54
249
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
6.8
88
485
S52.2
ICD-10 Finland
Fracture of shaft of ulna
4.3
6.8
17
40
R60.0
ICD-10 Finland
Localized oedema
1.6
6.7
161
1050
SPAT1050
SPAT
Extensive neurological examination
3.2
6.7
25
78
207
Kela drug reimbursment
Chronic arrhythmias
1.5
6.7
252
1811
EFB20
NOMESCO Finland
Reduction and/or immobilisation of multiple fractures of facial bones
22.6
6.7
9
*
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
22.6
6.7
9
*
5CM18, ,
NOMESCO Finland
22.6
6.7
9
*
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
22.6
6.7
9
*
OAA67, ,
SPAT
0.5
6.7
66
1235
F33
ICD-10 Finland
Recurrent depressive disorder
3.7
6.6
20
54
SFA20
NOMESCO Finland
Two-surface restoration
1.3
6.6
728
6202
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
6.6
914
8030
AA1AA
NOMESCO Finland
Head X-ray examination
5.9
6.6
17
29
Z50.5
ICD-10 Finland
Speech therapy
5.9
6.6
17
29
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.1
6.6
63
312
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
6.6
26
84
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.6
6.6
21
59
S62.6
ICD-10 Finland
Fracture of other finger
2.1
6.6
59
285
RF310, ,
NOMESCO Finland
12.3
6.6
11
9
S27.2
ICD-10 Finland
Traumatic haemopneumothorax
12.3
6.6
11
9
S02.61
ICD-10 Finland
Fracture of mandible, open
12.3
6.6
11
9
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
3.3
6.6
24
74
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.2
6.6
17
41
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
8.7
6.6
13
15
G44.8
ICD-10 Finland
Other specified headache syndromes
10.1
6.5
12
12
A10BH05
ATC
linagliptin; oral
1.9
6.5
75
397
L81
ICPC
Injury musculoskeletal NOS
2.7
6.5
33
123
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.5
297
2211
Z01.2
ICD-10 Finland
Dental examination
1.3
6.5
550
4515
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
6.5
267
1950
R04.2
ICD-10 Finland
Haemoptysis
2.2
6.5
55
260
A08
ICPC
Swelling
1.9
6.5
77
412
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
6.5
64
321
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.4
6.5
42
177
SPAT1325
SPAT
Vaccination
1.3
6.5
459
3672
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
6.5
204
1415
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
6.2
6.5
16
26
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.3
6.5
18
34
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.1
6.5
57
274
-34
ICPC
Blood test
2.5
6.5
38
153
U01
ICPC
Dysuria/painful urination
1.8
6.5
86
478
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
6.4
25
80
A06
ICPC
Fainting/syncope
3.2
6.4
25
80
K05.18
ICD-10 Finland
Chronic gingivitis
1.8
6.4
85
471
F32.0
ICD-10 Finland
Mild depressive episode
2.9
6.4
28
96
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
3.2
6.4
24
75
2212
FHL
Hematoma removal, subdural
70.1
6.4
7
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
70.1
6.4
7
*
S36.4
ICD-10 Finland
Injury of small intestine
70.1
6.4
7
*
S23.4
ICD-10 Finland
Sprain and strain of ribs and sternum
3.3
6.4
23
70
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
14.4
6.4
10
7
S14
ICPC
Burn/scald
2.3
6.4
45
197
H81.3
ICD-10 Finland
Other peripheral vertigo
2.6
6.4
36
142
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.4
369
2860
L02
ICPC
Back symptom/complaint
1.7
6.4
109
653
SPAT1227
SPAT
Substance abuse rehabilitation
8.2
6.3
13
16
QCB00
NOMESCO Finland
Suture of skin of upper limb
3.1
6.3
25
81
L75
ICPC
Fracture: femur
3.1
6.3
25
81
AA1AD, ,
SPAT
5.2
6.3
18
35
D12
ICPC
Constipation
2.2
6.3
53
250
A41.8
ICD-10 Finland
Other specified sepsis
2.6
6.3
35
137
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
6.0
6.3
16
27
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
11.1
6.3
11
10
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
6.3
38
155
SPAT1247
SPAT
Outpatient detoxication and monitoring
9.3
6.3
12
13
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.3
6.3
23
71
I95.9
ICD-10 Finland
Hypotension, unspecified
3.3
6.3
23
71
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
18.1
6.3
9
5
V87
ICD-10 Finland
Traffic accident of specified type but victim's mode of transport unknown
18.1
6.3
9
5
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
+∞
6.3
6
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
6.3
6
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
6.3
6
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
6.3
6
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
6.3
6
*
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
+∞
6.3
6
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
+∞
6.3
6
*
SPAT1360
SPAT
Extensive global examination
1.9
6.2
79
432
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.2
6.2
51
238
WX290
NOMESCO Finland
Other blockage of nerve
1.3
6.2
546
4500
NEJ50
NOMESCO Finland
Operation of fracture of pelvic ring
26.8
6.2
8
*
V03.9
ICD-10 Finland
Pedestrian injured in collision with car, pick-up truck or van, unspecified whether traffic or nontraffic accident
26.8
6.2
8
*
T07
ICD-10 Finland
Unspecified multiple injuries
26.8
6.2
8
*
EBA00, ,
SPAT
2.5
6.2
37
150
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.0
6.2
61
306
C03AA03
ATC
hydrochlorothiazide; oral
1.7
6.2
119
736
NDJ40
NOMESCO Finland
Closed reduction of fracture of wrist or hand
3.5
6.2
20
57
NC1AD
NOMESCO Finland
Elbow CT
6.3
6.2
15
24
Z73.6
ICD-10 Finland
Limitation of activities due to disability
5.4
6.2
17
32
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.3
6.1
22
67
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
6.1
39
163
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
2.5
6.1
37
151
D07AB08
ATC
desonide; topical
1.6
6.1
129
816
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
7.7
6.1
13
17
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
7.7
6.1
13
17
U05
ICPC
Urination problems other
1.9
6.1
74
399
UJF32
NOMESCO Finland
Coloscopy
1.4
6.1
340
2620
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
2.9
6.1
27
94
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
8.6
6.1
12
14
WYA30, ,
SPAT
8.6
6.1
12
14
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
6.0
70
372
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
6.0
68
358
H47.2
ICD-10 Finland
Optic atrophy
10.1
6.0
11
11
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.5
6.0
20
58
A11
ICPC
Chest pain NOS
1.7
6.0
111
679

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurology
13 [38004458]
2.3e+00
3.0e+00
4.3e+00
—
6.0e+00
4.8e+00
3.1e+00
cases:20.40%
controls:2.47%
cases:13.36%
controls:0.74%
cases:5.34%
controls:0.07%
—
—
cases:24.22%
controls:0.08%
cases:47.48%
controls:0.73%
cases:34.15%
controls:2.38%
336
406
1311
16050
220
121
1427
16335
88
12
1559
16444
—
371
13
1161
16388
659
114
729
15580
336
282
648
11564
Neurosurgery
14 [38004459]
1.6e+00
2.6e+00
4.2e+00
1.0e+50
6.2e+00
4.3e+00
2.3e+00
cases:5.53%
controls:1.12%
cases:4.55%
controls:0.36%
cases:4.25%
controls:0.07%
cases:33.82%
controls:0.00%
cases:14.95%
controls:0.04%
cases:22.48%
controls:0.40%
cases:8.43%
controls:0.93%
91
184
1556
16272
75
60
1572
16396
70
11
1577
16445
557
0
1090
16456
229
6
1303
16395
312
63
1076
15631
83
110
901
11736
Unspecified fall
W19 [45756257]
1.7e+00
2.5e+00
4.2e+00
1.0e+50
5.5e+00
3.3e+00
2.1e+00
cases:3.95%
controls:0.75%
cases:3.16%
controls:0.26%
cases:2.37%
controls:0.04%
cases:10.38%
controls:0.00%
cases:6.79%
controls:0.03%
cases:8.29%
controls:0.33%
cases:8.33%
controls:1.14%
65
124
1582
16332
52
42
1595
16414
39
6
1608
16450
171
0
1476
16456
104
5
1428
16396
115
52
1273
15642
82
135
902
11711
Inpatient Hospital
21 [8717]
7.2e-01
1.1e+00
2.1e+00
7.7e+00
3.7e+00
1.4e+00
9.1e-01
cases:41.65%
controls:25.87%
cases:19.13%
controls:7.52%
cases:8.86%
controls:1.12%
cases:41.04%
controls:0.03%
cases:31.07%
controls:1.09%
cases:22.48%
controls:6.50%
cases:32.01%
controls:15.95%
686
4257
961
12199
315
1237
1332
15219
146
185
1501
16271
676
5
971
16451
476
178
1056
16223
312
1020
1076
14674
315
1890
669
9956
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.4e+00
2.0e+00
4.1e+00
—
5.0e+00
3.1e+00
1.6e+00
cases:13.48%
controls:3.62%
cases:10.56%
controls:1.51%
cases:10.38%
controls:0.20%
—
—
cases:26.96%
controls:0.24%
cases:27.02%
controls:1.59%
cases:22.46%
controls:5.59%
222
595
1425
15861
174
249
1473
16207
171
33
1476
16423
—
413
40
1119
16361
375
250
1013
15444
221
662
763
11184
Emergency Medicine
93 [38004510]
6.6e-01
1.2e+00
2.8e+00
7.2e+00
2.4e+00
1.2e+00
7.9e-01
cases:26.78%
controls:15.88%
cases:22.40%
controls:8.03%
cases:13.24%
controls:0.92%
cases:36.85%
controls:0.04%
cases:10.57%
controls:1.08%
cases:22.98%
controls:8.62%
cases:41.77%
controls:24.52%
441
2614
1206
13842
369
1322
1278
15134
218
151
1429
16305
607
7
1040
16449
162
177
1370
16224
319
1353
1069
14341
411
2905
573
8941
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.7e-01
1.1e+00
2.4e+00
6.1e+00
3.6e+00
1.4e+00
9.6e-01
cases:12.81%
controls:6.37%
cases:7.95%
controls:2.92%
cases:4.25%
controls:0.40%
cases:11.54%
controls:0.03%
cases:11.42%
controls:0.35%
cases:9.65%
controls:2.70%
cases:16.36%
controls:6.99%
211
1049
1436
15407
131
480
1516
15976
70
66
1577
16390
190
5
1457
16451
175
58
1357
16343
134
423
1254
15271
161
828
823
11018
Concussion
S06.0 [45582805]
3.2e+00
4.3e+00
—
1.0e+50
1.0e+50
4.3e+00
3.8e+00
cases:4.07%
controls:0.17%
cases:4.01%
controls:0.05%
—
—
cases:7.53%
controls:0.00%
cases:3.59%
controls:0.00%
cases:4.68%
controls:0.06%
cases:6.20%
controls:0.14%
67
28
1580
16428
66
9
1581
16447
—
124
0
1523
16456
55
0
1477
16401
65
10
1323
15684
61
17
923
11829
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
2.0e+00
2.4e+00
3.0e+00
—
2.0e+00
2.8e+00
2.7e+00
cases:2.37%
controls:0.32%
cases:2.06%
controls:0.20%
cases:1.09%
controls:0.05%
—
—
cases:0.78%
controls:0.10%
cases:3.53%
controls:0.22%
cases:4.78%
controls:0.32%
39
53
1608
16403
34
33
1613
16423
18
9
1629
16447
—
12
17
1520
16384
49
34
1339
15660
47
38
937
11808
Exposure to unspecified factor
X59 [45756412]
1.3e+00
1.7e+00
3.1e+00
1.0e+50
4.4e+00
2.9e+00
1.6e+00
cases:6.50%
controls:1.88%
cases:2.85%
controls:0.54%
cases:1.94%
controls:0.09%
cases:7.71%
controls:0.00%
cases:5.42%
controls:0.07%
cases:9.22%
controls:0.57%
cases:9.55%
controls:2.16%
107
309
1540
16147
47
89
1600
16367
32
14
1615
16442
127
0
1520
16456
83
12
1449
16389
128
90
1260
15604
94
256
890
11590
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
5.5e-01
8.4e-01
2.2e+00
6.8e+00
2.8e+00
1.1e+00
6.5e-01
cases:23.92%
controls:15.41%
cases:15.06%
controls:7.08%
cases:7.89%
controls:0.91%
cases:23.98%
controls:0.04%
cases:13.38%
controls:0.96%
cases:17.87%
controls:6.73%
cases:30.79%
controls:18.86%
394
2536
1253
13920
248
1165
1399
15291
130
150
1517
16306
395
6
1252
16450
205
158
1327
16243
248
1056
1140
14638
303
2234
681
9612
Orthopedic Surgery
20 [38004465]
6.2e-01
7.8e-01
2.0e+00
6.6e+00
2.7e+00
1.4e+00
7.6e-01
cases:23.62%
controls:14.20%
cases:10.93%
controls:5.34%
cases:6.38%
controls:0.91%
cases:20.89%
controls:0.04%
cases:11.49%
controls:0.89%
cases:18.01%
controls:5.21%
cases:25.81%
controls:13.99%
389
2337
1258
14119
180
879
1467
15577
105
150
1542
16306
344
6
1303
16450
176
146
1356
16255
250
817
1138
14877
254
1657
730
10189
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
2.1e+00
2.9e+00
3.7e+00
—
—
3.4e+00
2.5e+00
cases:4.43%
controls:0.58%
cases:2.79%
controls:0.15%
cases:1.28%
controls:0.03%
—
—
—
—
cases:4.90%
controls:0.18%
cases:7.11%
controls:0.60%
73
95
1574
16361
46
25
1601
16431
21
5
1626
16451
—
—
68
28
1320
15666
70
71
914
11775
Chronic alcohol abuse
P15 [2002000811]
2.0e+00
2.3e+00
2.2e+00
—
2.4e+00
2.9e+00
2.6e+00
cases:1.82%
controls:0.24%
cases:1.03%
controls:0.11%
cases:0.43%
controls:0.05%
—
—
cases:0.39%
controls:0.04%
cases:1.80%
controls:0.10%
cases:3.46%
controls:0.26%
30
40
1617
16416
17
18
1630
16438
7
8
1640
16448
—
6
6
1526
16395
25
16
1363
15678
34
31
950
11815
Supine thorax X-ray examination
GD1QA [2001303648]
1.4e+00
1.5e+00
3.9e+00
1.0e+50
3.8e+00
2.1e+00
1.4e+00
cases:7.10%
controls:1.82%
cases:3.70%
controls:0.83%
cases:3.34%
controls:0.07%
cases:9.96%
controls:0.00%
cases:4.24%
controls:0.10%
cases:7.13%
controls:0.97%
cases:10.98%
controls:3.09%
117
299
1530
16157
61
137
1586
16319
55
11
1592
16445
164
0
1483
16456
65
16
1467
16385
99
152
1289
15542
108
366
876
11480
Other and unspecified convulsions
R56.8 [45602033]
2.8e+00
3.1e+00
1.0e+50
—
—
4.2e+00
3.7e+00
cases:2.31%
controls:0.14%
cases:1.03%
controls:0.05%
cases:0.67%
controls:0.00%
—
—
—
—
cases:3.24%
controls:0.05%
cases:3.46%
controls:0.08%
38
23
1609
16433
17
8
1630
16448
11
0
1636
16456
—
—
45
8
1343
15686
34
10
950
11836
Sleep apnoea
G47.3 [45562094]
3.5e+00
3.7e+00
—
1.0e+50
—
3.7e+00
3.0e+00
cases:6.50%
controls:0.22%
cases:4.98%
controls:0.13%
—
—
cases:1.28%
controls:0.00%
—
—
cases:4.68%
controls:0.13%
cases:8.43%
controls:0.44%
107
36
1540
16420
82
22
1565
16434
—
21
0
1626
16456
—
65
20
1323
15674
83
52
901
11794
Fall on same level involving ice and snow
W00 [45756242]
9.6e-01
1.8e+00
3.1e+00
—
4.4e+00
2.7e+00
9.2e-01
cases:2.73%
controls:1.06%
cases:1.94%
controls:0.32%
cases:1.15%
controls:0.05%
—
—
cases:3.72%
controls:0.05%
cases:4.32%
controls:0.31%
cases:3.05%
controls:1.24%
45
175
1602
16281
32
52
1615
16404
19
9
1628
16447
—
57
8
1475
16393
60
49
1328
15645
30
147
954
11699
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
6.2e-01
1.2e+00
2.1e+00
4.9e+00
3.3e+00
1.1e+00
6.0e-01
cases:4.80%
controls:2.64%
cases:4.07%
controls:1.31%
cases:1.70%
controls:0.21%
cases:3.76%
controls:0.03%
cases:5.55%
controls:0.22%
cases:3.82%
controls:1.29%
cases:7.83%
controls:4.47%
79
435
1568
16021
67
216
1580
16240
28
35
1619
16421
62
5
1585
16451
85
36
1447
16365
53
203
1335
15491
77
529
907
11317
Headache
R51.80 [2000503603]
1.4e+00
1.4e+00
3.0e+00
1.0e+50
3.2e+00
2.4e+00
1.7e+00
cases:2.85%
controls:0.70%
cases:0.91%
controls:0.24%
cases:0.73%
controls:0.04%
cases:0.49%
controls:0.00%
cases:0.91%
controls:0.04%
cases:2.59%
controls:0.23%
cases:3.56%
controls:0.70%
47
116
1600
16340
15
39
1632
16417
12
6
1635
16450
8
0
1639
16456
14
6
1518
16395
36
36
1352
15658
35
83
949
11763
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.1e-01
8.7e-01
1.3e+00
5.6e+00
2.5e+00
1.2e+00
7.8e-01
cases:20.52%
controls:11.25%
cases:13.24%
controls:6.00%
cases:3.76%
controls:1.08%
cases:7.83%
controls:0.03%
cases:10.51%
controls:0.98%
cases:16.79%
controls:5.88%
cases:27.03%
controls:14.56%
338
1851
1309
14605
218
987
1429
15469
62
177
1585
16279
129
5
1518
16451
161
160
1371
16241
233
923
1155
14771
266
1725
718
10121
carbamazepine; oral, rectal
N03AF01 [21604417]
2.6e+00
3.7e+00
—
—
—
3.4e+00
3.0e+00
cases:1.52%
controls:0.12%
cases:1.28%
controls:0.03%
—
—
—
—
—
—
cases:1.95%
controls:0.06%
cases:2.03%
controls:0.10%
25
19
1622
16437
21
5
1626
16451
—
—
—
27
10
1361
15684
20
12
964
11834
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
8.0e-01
1.2e+00
3.4e+00
1.0e+50
4.3e+00
1.7e+00
1.3e+00
cases:5.22%
controls:2.41%
cases:2.85%
controls:0.84%
cases:1.88%
controls:0.07%
cases:12.08%
controls:0.00%
cases:3.72%
controls:0.05%
cases:3.96%
controls:0.71%
cases:8.03%
controls:2.23%
86
397
1561
16059
47
139
1600
16317
31
11
1616
16445
199
0
1448
16456
57
9
1475
16392
55
112
1333
15582
79
264
905
11582
Alzheimer disease with late onset
G30.1 [45552521]
2.2e+00
2.4e+00
3.0e+00
1.0e+50
—
2.7e+00
2.4e+00
cases:1.82%
controls:0.20%
cases:1.52%
controls:0.15%
cases:0.61%
controls:0.03%
cases:0.67%
controls:0.00%
—
—
cases:1.80%
controls:0.13%
cases:3.66%
controls:0.35%
30
33
1617
16423
25
24
1622
16432
10
5
1637
16451
11
0
1636
16456
—
25
20
1363
15674
36
41
948
11805
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
6.5e-01
8.4e-01
1.2e+00
5.7e+00
2.3e+00
1.1e+00
6.7e-01
cases:22.10%
controls:12.85%
cases:15.12%
controls:7.11%
cases:4.25%
controls:1.26%
cases:8.62%
controls:0.03%
cases:11.42%
controls:1.23%
cases:18.30%
controls:7.00%
cases:29.27%
controls:17.47%
364
2115
1283
14341
249
1170
1398
15286
70
208
1577
16248
142
5
1505
16451
175
202
1357
16199
254
1099
1134
14595
288
2070
696
9776
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.2e-01
7.6e-01
1.6e+00
5.5e+00
2.9e+00
8.5e-01
5.0e-01
cases:46.45%
controls:36.32%
cases:36.98%
controls:21.59%
cases:19.00%
controls:4.34%
cases:40.62%
controls:0.29%
cases:45.82%
controls:4.40%
cases:40.56%
controls:22.56%
cases:58.94%
controls:46.50%
765
5977
882
10479
609
3553
1038
12903
313
714
1334
15742
669
47
978
16409
702
721
830
15680
563
3541
825
12153
580
5508
404
6338
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.1e+00
1.6e+00
2.9e+00
1.0e+50
3.8e+00
1.9e+00
1.1e+00
cases:13.60%
controls:4.96%
cases:8.32%
controls:1.77%
cases:3.46%
controls:0.21%
cases:14.69%
controls:0.00%
cases:7.96%
controls:0.19%
cases:10.73%
controls:1.74%
cases:17.38%
controls:6.30%
224
816
1423
15640
137
292
1510
16164
57
34
1590
16422
242
0
1405
16456
122
31
1410
16370
149
273
1239
15421
171
746
813
11100
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
9.3e-01
1.5e+00
2.8e+00
1.0e+50
4.2e+00
1.7e+00
1.1e+00
cases:2.43%
controls:0.97%
cases:2.00%
controls:0.47%
cases:0.91%
controls:0.05%
cases:3.46%
controls:0.00%
cases:2.68%
controls:0.04%
cases:2.74%
controls:0.51%
cases:5.18%
controls:1.73%
40
160
1607
16296
33
78
1614
16378
15
9
1632
16447
57
0
1590
16456
41
7
1491
16394
38
80
1350
15614
51
205
933
11641
Respiratory and circulatory monitoring
WX700 [2001310817]
9.3e-01
1.4e+00
3.1e+00
1.0e+50
3.8e+00
1.6e+00
1.3e+00
cases:5.34%
controls:2.18%
cases:2.55%
controls:0.61%
cases:1.58%
controls:0.07%
cases:10.26%
controls:0.00%
cases:2.61%
controls:0.06%
cases:3.10%
controls:0.62%
cases:6.20%
controls:1.83%
88
359
1559
16097
42
101
1605
16355
26
12
1621
16444
169
0
1478
16456
40
10
1492
16391
43
98
1345
15596
61
217
923
11629
Exposure to other specified factors
X58 [45756411]
9.6e-01
1.5e+00
2.8e+00
—
3.7e+00
1.9e+00
1.3e+00
cases:3.40%
controls:1.33%
cases:1.58%
controls:0.35%
cases:0.85%
controls:0.05%
—
—
cases:1.24%
controls:0.03%
cases:3.10%
controls:0.47%
cases:5.28%
controls:1.56%
56
219
1591
16237
26
57
1621
16399
14
9
1633
16447
—
19
5
1513
16396
43
74
1345
15620
52
185
932
11661
Other fall from one level to another
W17 [45756255]
1.1e+00
1.6e+00
3.2e+00
1.0e+50
—
3.5e+00
2.4e+00
cases:0.85%
controls:0.30%
cases:0.49%
controls:0.10%
cases:0.73%
controls:0.03%
cases:3.89%
controls:0.00%
—
—
cases:3.24%
controls:0.10%
cases:3.15%
controls:0.29%
14
49
1633
16407
8
16
1639
16440
12
5
1635
16451
64
0
1583
16456
—
45
16
1343
15678
31
34
953
11812
INR in Blood by Coagulation assay
34714-6 [3032080]
7.1e-01
9.7e-01
1.3e+00
5.3e+00
1.7e+00
1.0e+00
7.9e-01
cases:25.26%
controls:14.24%
cases:18.15%
controls:7.78%
cases:9.90%
controls:2.88%
cases:22.59%
controls:0.15%
cases:14.10%
controls:2.90%
cases:18.01%
controls:7.51%
cases:29.78%
controls:16.08%
416
2344
1231
14112
299
1281
1348
15175
163
474
1484
15982
372
25
1275
16431
216
476
1316
15925
250
1178
1138
14516
293
1905
691
9941
Cervical spine CT examination
NA1AD [2001306982]
2.4e+00
3.2e+00
1.0e+50
1.0e+50
—
3.3e+00
2.7e+00
cases:2.43%
controls:0.22%
cases:2.25%
controls:0.09%
cases:2.73%
controls:0.00%
cases:15.00%
controls:0.00%
—
—
cases:1.95%
controls:0.07%
cases:3.86%
controls:0.26%
40
37
1607
16419
37
15
1610
16441
45
0
1602
16456
247
0
1400
16456
—
27
11
1361
15683
38
31
946
11815
Open wound of scalp
S01.0 [45592468]
1.8e+00
2.4e+00
—
1.0e+50
3.3e+00
2.4e+00
1.7e+00
cases:4.01%
controls:0.66%
cases:2.19%
controls:0.19%
—
—
cases:4.61%
controls:0.00%
cases:1.50%
controls:0.05%
cases:2.45%
controls:0.23%
cases:5.18%
controls:1.00%
66
109
1581
16347
36
32
1611
16424
—
76
0
1571
16456
23
9
1509
16392
34
36
1354
15658
51
118
933
11728
Alcohol dependence continuous use
F10.25 [2000501682]
2.2e+00
2.7e+00
—
—
—
3.4e+00
3.3e+00
cases:0.85%
controls:0.09%
cases:0.55%
controls:0.04%
—
—
—
—
—
—
cases:0.94%
controls:0.03%
cases:2.54%
controls:0.09%
14
15
1633
16441
9
6
1638
16450
—
—
—
13
5
1375
15689
25
11
959
11835
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.7e-01
6.6e-01
1.5e+00
4.9e+00
2.5e+00
9.9e-01
6.1e-01
cases:27.38%
controls:19.06%
cases:16.64%
controls:9.32%
cases:6.01%
controls:1.39%
cases:5.53%
controls:0.04%
cases:15.14%
controls:1.45%
cases:21.90%
controls:9.44%
cases:35.77%
controls:23.20%
451
3137
1196
13319
274
1534
1373
14922
99
229
1548
16227
91
7
1556
16449
232
237
1300
16164
304
1482
1084
14212
352
2748
632
9098
Internal Medicine
11 [38004456]
6.8e-01
8.6e-01
1.5e+00
4.9e+00
2.1e+00
8.9e-01
7.3e-01
cases:33.09%
controls:20.10%
cases:16.03%
controls:7.49%
cases:5.28%
controls:1.20%
cases:6.25%
controls:0.05%
cases:8.55%
controls:1.18%
cases:16.35%
controls:7.45%
cases:30.08%
controls:17.20%
545
3307
1102
13149
264
1232
1383
15224
87
198
1560
16258
103
8
1544
16448
131
193
1401
16208
227
1169
1161
14525
296
2038
688
9808
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.2e-01
1.3e+00
2.7e+00
—
4.7e+00
1.3e+00
9.4e-01
cases:3.52%
controls:1.75%
cases:2.67%
controls:0.75%
cases:1.03%
controls:0.07%
—
—
cases:4.44%
controls:0.04%
cases:2.74%
controls:0.73%
cases:6.61%
controls:2.68%
58
288
1589
16168
44
123
1603
16333
17
12
1630
16444
—
68
7
1464
16394
38
115
1350
15579
65
317
919
11529
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
7.2e-01
1.4e+00
2.8e+00
1.0e+50
4.4e+00
1.4e+00
8.4e-01
cases:2.25%
controls:1.11%
cases:1.88%
controls:0.47%
cases:0.73%
controls:0.04%
cases:2.25%
controls:0.00%
cases:2.81%
controls:0.04%
cases:2.02%
controls:0.52%
cases:4.27%
controls:1.89%
37
182
1610
16274
31
78
1616
16378
12
7
1635
16449
37
0
1610
16456
43
6
1489
16395
28
81
1360
15613
42
224
942
11622
Geriatric Medicine
38 [38004478]
1.4e+00
1.8e+00
2.2e+00
1.0e+50
3.4e+00
1.6e+00
1.0e+00
cases:2.49%
controls:0.65%
cases:1.64%
controls:0.28%
cases:0.55%
controls:0.06%
cases:0.55%
controls:0.00%
cases:1.70%
controls:0.05%
cases:1.95%
controls:0.40%
cases:3.05%
controls:1.11%
41
107
1606
16349
27
46
1620
16410
9
10
1638
16446
9
0
1638
16456
26
9
1506
16392
27
62
1361
15632
30
132
954
11714
Head injury other
N80 [2002000783]
1.8e+00
2.3e+00
1.0e+50
—
1.0e+50
4.4e+00
2.9e+00
cases:0.73%
controls:0.12%
cases:0.55%
controls:0.05%
cases:0.36%
controls:0.00%
—
—
cases:1.83%
controls:0.00%
cases:3.46%
controls:0.04%
cases:2.34%
controls:0.13%
12
20
1635
16436
9
9
1638
16447
6
0
1641
16456
—
28
0
1504
16401
48
7
1340
15687
23
15
961
11831
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
6.5e-01
1.1e+00
2.6e+00
—
4.7e+00
1.5e+00
9.0e-01
cases:4.25%
controls:2.26%
cases:2.91%
controls:0.98%
cases:1.09%
controls:0.09%
—
—
cases:4.90%
controls:0.05%
cases:3.82%
controls:0.91%
cases:7.32%
controls:3.12%
70
372
1577
16084
48
161
1599
16295
18
14
1629
16442
—
75
8
1457
16393
53
143
1335
15551
72
370
912
11476
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
6.5e-01
1.1e+00
2.6e+00
—
4.7e+00
1.5e+00
9.0e-01
cases:4.25%
controls:2.26%
cases:2.91%
controls:0.98%
cases:1.09%
controls:0.09%
—
—
cases:4.90%
controls:0.05%
cases:3.82%
controls:0.92%
cases:7.32%
controls:3.12%
70
372
1577
16084
48
161
1599
16295
18
14
1629
16442
—
75
8
1457
16393
53
144
1335
15550
72
370
912
11476
pH of Arterial blood
2744-1 [3019977]
6.5e-01
1.1e+00
2.5e+00
—
4.7e+00
1.5e+00
8.9e-01
cases:4.25%
controls:2.25%
cases:2.91%
controls:0.98%
cases:1.09%
controls:0.09%
—
—
cases:4.96%
controls:0.05%
cases:3.82%
controls:0.90%
cases:7.42%
controls:3.17%
70
371
1577
16085
48
161
1599
16295
18
15
1629
16441
—
76
8
1456
16393
53
141
1335
15553
73
376
911
11470
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.1e-01
7.6e-01
1.3e+00
4.8e+00
2.4e+00
9.8e-01
5.5e-01
cases:12.81%
controls:8.12%
cases:8.86%
controls:4.36%
cases:2.73%
controls:0.74%
cases:3.52%
controls:0.03%
cases:7.31%
controls:0.72%
cases:11.02%
controls:4.43%
cases:19.41%
controls:12.19%
211
1336
1436
15120
146
717
1501
15739
45
122
1602
16334
58
5
1589
16451
112
118
1420
16283
153
696
1235
14998
191
1444
793
10402
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
1.5e+00
2.4e+00
1.0e+50
3.7e+00
1.6e+00
9.6e-01
cases:8.01%
controls:2.76%
cases:4.07%
controls:0.92%
cases:1.15%
controls:0.11%
cases:6.50%
controls:0.00%
cases:3.52%
controls:0.09%
cases:4.18%
controls:0.85%
cases:7.32%
controls:2.95%
132
455
1515
16001
67
152
1580
16304
19
18
1628
16438
107
0
1540
16456
54
15
1478
16386
58
133
1330
15561
72
349
912
11497
Base excess in Arterial blood by calculation
1925-7 [3003396]
6.6e-01
1.1e+00
2.5e+00
—
4.7e+00
1.5e+00
9.0e-01
cases:4.25%
controls:2.25%
cases:2.85%
controls:0.99%
cases:1.09%
controls:0.09%
—
—
cases:4.96%
controls:0.05%
cases:3.75%
controls:0.90%
cases:7.32%
controls:3.11%
70
370
1577
16086
47
163
1600
16293
18
15
1629
16441
—
76
8
1456
16393
52
141
1336
15553
72
368
912
11478
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.0e-01
5.6e-01
1.3e+00
5.4e+00
2.6e+00
6.6e-01
2.8e-01
cases:51.49%
controls:44.11%
cases:46.99%
controls:33.51%
cases:20.52%
controls:6.31%
cases:43.17%
controls:0.33%
cases:48.04%
controls:6.18%
cases:50.58%
controls:34.52%
cases:65.45%
controls:58.79%
848
7258
799
9198
774
5514
873
10942
338
1039
1309
15417
711
55
936
16401
736
1014
796
15387
702
5418
686
10276
644
6964
340
4882
rivastigmine; oral, transdermal
N06DA03 [21604796]
2.6e+00
2.4e+00
2.3e+00
—
—
2.0e+00
1.9e+00
cases:1.58%
controls:0.12%
cases:1.70%
controls:0.16%
cases:0.61%
controls:0.06%
—
—
—
—
cases:1.66%
controls:0.22%
cases:2.44%
controls:0.37%
26
20
1621
16436
28
27
1619
16429
10
10
1637
16446
—
—
23
35
1365
15659
24
44
960
11802
Physiotherapist
Z3226 [2001311560]
9.3e-01
1.5e+00
2.1e+00
1.0e+50
3.3e+00
1.9e+00
1.5e+00
cases:4.92%
controls:2.00%
cases:1.88%
controls:0.44%
cases:0.67%
controls:0.08%
cases:2.85%
controls:0.00%
cases:2.02%
controls:0.08%
cases:2.52%
controls:0.40%
cases:4.07%
controls:0.96%
81
329
1566
16127
31
72
1616
16384
11
13
1636
16443
47
0
1600
16456
31
13
1501
16388
35
62
1353
15632
40
114
944
11732
Oxygen saturation in Arterial blood
2708-6 [3016502]
6.8e-01
1.1e+00
2.7e+00
1.0e+50
4.6e+00
1.2e+00
8.6e-01
cases:3.70%
controls:1.92%
cases:2.55%
controls:0.83%
cases:1.03%
controls:0.07%
cases:4.19%
controls:0.00%
cases:4.44%
controls:0.05%
cases:2.67%
controls:0.80%
cases:6.50%
controls:2.85%
61
316
1586
16140
42
136
1605
16320
17
12
1630
16444
69
0
1578
16456
68
8
1464
16393
37
125
1351
15569
64
338
920
11508
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.9e-01
5.6e-01
1.3e+00
5.4e+00
2.6e+00
6.4e-01
2.6e-01
cases:51.67%
controls:44.43%
cases:47.36%
controls:33.91%
cases:20.52%
controls:6.45%
cases:42.74%
controls:0.33%
cases:48.04%
controls:6.37%
cases:50.50%
controls:34.99%
cases:65.24%
controls:59.13%
851
7311
796
9145
780
5580
867
10876
338
1061
1309
15395
704
55
943
16401
736
1044
796
15357
701
5491
687
10203
642
7004
342
4842
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
7.4e-01
1.3e+00
2.5e+00
1.0e+50
4.4e+00
1.3e+00
7.8e-01
cases:2.25%
controls:1.09%
cases:1.70%
controls:0.46%
cases:0.73%
controls:0.06%
cases:2.37%
controls:0.00%
cases:2.81%
controls:0.04%
cases:1.95%
controls:0.52%
cases:4.07%
controls:1.90%
37
179
1610
16277
28
75
1619
16381
12
10
1635
16446
39
0
1608
16456
43
6
1489
16395
27
81
1361
15613
40
225
944
11621
Oral Surgery
19 [38004464]
1.5e+00
1.2e+00
1.8e+00
1.0e+50
3.2e+00
2.0e+00
1.3e+00
cases:2.67%
controls:0.63%
cases:0.91%
controls:0.27%
cases:0.43%
controls:0.07%
cases:0.36%
controls:0.00%
cases:1.37%
controls:0.05%
cases:2.38%
controls:0.32%
cases:2.24%
controls:0.62%
44
103
1603
16353
15
44
1632
16412
7
12
1640
16444
6
0
1641
16456
21
9
1511
16392
33
50
1355
15644
22
73
962
11773
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
2.8e+00
2.8e+00
—
—
—
2.8e+00
2.6e+00
cases:2.19%
controls:0.14%
cases:1.46%
controls:0.09%
—
—
—
—
—
—
cases:1.30%
controls:0.08%
cases:1.63%
controls:0.12%
36
23
1611
16433
24
15
1623
16441
—
—
—
18
13
1370
15681
16
14
968
11832
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
2.8e+00
2.8e+00
—
—
—
2.8e+00
2.6e+00
cases:2.19%
controls:0.14%
cases:1.46%
controls:0.09%
—
—
—
—
—
—
cases:1.30%
controls:0.08%
cases:1.63%
controls:0.12%
36
23
1611
16433
24
15
1623
16441
—
—
—
18
13
1370
15681
16
14
968
11832
General Practice
1 [38004446]
9.8e-01
1.2e+00
2.4e+00
—
3.8e+00
1.6e+00
9.7e-01
cases:28.84%
controls:13.17%
cases:16.64%
controls:5.43%
cases:7.95%
controls:0.81%
—
—
cases:27.22%
controls:0.81%
cases:23.20%
controls:6.02%
cases:33.03%
controls:15.79%
475
2168
1172
14288
274
893
1373
15563
131
134
1516
16322
—
417
133
1115
16268
322
945
1066
14749
325
1870
659
9976
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
7.1e-01
1.4e+00
2.5e+00
1.0e+50
4.2e+00
1.3e+00
7.9e-01
cases:2.19%
controls:1.09%
cases:1.76%
controls:0.46%
cases:0.73%
controls:0.06%
cases:2.37%
controls:0.00%
cases:2.87%
controls:0.04%
cases:1.95%
controls:0.52%
cases:4.27%
controls:1.99%
36
179
1611
16277
29
76
1618
16380
12
10
1635
16446
39
0
1608
16456
44
7
1488
16394
27
82
1361
15612
42
236
942
11610
Leukocytes [#/volume] in Urine
30405-5 [3018095]
4.7e-01
6.6e-01
1.3e+00
4.5e+00
2.3e+00
9.6e-01
5.7e-01
cases:13.66%
controls:9.00%
cases:9.35%
controls:5.05%
cases:2.91%
controls:0.83%
cases:3.52%
controls:0.04%
cases:7.70%
controls:0.87%
cases:12.46%
controls:5.19%
cases:22.26%
controls:13.97%
225
1481
1422
14975
154
831
1493
15625
48
137
1599
16319
58
7
1589
16449
118
142
1414
16259
173
814
1215
14880
219
1655
765
10191
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.9e+00
2.8e+00
—
1.0e+50
—
3.6e+00
2.4e+00
cases:2.37%
controls:0.38%
cases:1.34%
controls:0.09%
—
—
cases:2.55%
controls:0.00%
—
—
cases:2.31%
controls:0.06%
cases:2.95%
controls:0.29%
39
62
1608
16394
22
14
1625
16442
—
42
0
1605
16456
—
32
10
1356
15684
29
34
955
11812
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.1e+00
1.6e+00
—
—
3.1e+00
2.9e+00
1.8e+00
cases:1.58%
controls:0.53%
cases:0.91%
controls:0.19%
—
—
—
—
cases:0.65%
controls:0.03%
cases:2.95%
controls:0.17%
cases:3.35%
controls:0.55%
26
88
1621
16368
15
32
1632
16424
—
—
10
5
1522
16396
41
26
1347
15668
33
65
951
11781
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.1e+00
1.5e+00
2.1e+00
—
2.9e+00
1.7e+00
1.1e+00
cases:5.53%
controls:1.97%
cases:2.61%
controls:0.60%
cases:0.55%
controls:0.07%
—
—
cases:1.37%
controls:0.07%
cases:3.31%
controls:0.61%
cases:6.71%
controls:2.36%
91
325
1556
16131
43
98
1604
16358
9
11
1638
16445
—
21
12
1511
16389
46
95
1342
15599
66
280
918
11566
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
8.2e-01
1.2e+00
2.8e+00
—
3.4e+00
1.4e+00
7.6e-01
cases:3.34%
controls:1.49%
cases:2.61%
controls:0.83%
cases:1.52%
controls:0.09%
—
—
cases:3.07%
controls:0.11%
cases:3.24%
controls:0.82%
cases:5.69%
controls:2.74%
55
246
1592
16210
43
137
1604
16319
25
15
1622
16441
—
47
18
1485
16383
45
129
1343
15565
56
324
928
11522
Emergency Room Visit
ER [9203]
9.6e-01
1.3e+00
2.9e+00
—
2.7e+00
1.4e+00
1.1e+00
cases:52.22%
controls:29.46%
cases:26.59%
controls:9.21%
cases:16.21%
controls:1.09%
—
—
cases:16.32%
controls:1.25%
cases:29.25%
controls:9.05%
cases:48.37%
controls:24.64%
860
4848
787
11608
438
1516
1209
14940
267
180
1380
16276
—
250
205
1282
16196
406
1420
982
14274
476
2919
508
8927
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.9e+00
2.9e+00
—
—
1.0e+50
3.3e+00
2.1e+00
cases:1.34%
controls:0.20%
cases:0.97%
controls:0.05%
—
—
—
—
cases:0.33%
controls:0.00%
cases:1.59%
controls:0.06%
cases:2.34%
controls:0.28%
22
33
1625
16423
16
9
1631
16447
—
—
5
0
1527
16401
22
9
1366
15685
23
33
961
11813
Emergency Room and Inpatient Visit
ERIP [262]
8.4e-01
1.3e+00
2.6e+00
—
3.7e+00
1.1e+00
6.7e-01
cases:13.24%
controls:6.17%
cases:11.05%
controls:3.43%
cases:6.25%
controls:0.48%
—
—
cases:13.25%
controls:0.36%
cases:11.31%
controls:3.99%
cases:21.24%
controls:12.17%
218
1016
1429
15440
182
565
1465
15891
103
79
1544
16377
—
203
59
1329
16342
157
626
1231
15068
209
1442
775
10404
Otolaryngology
4 [38004449]
5.3e-01
6.4e-01
1.0e+00
3.7e+00
2.4e+00
1.3e+00
6.1e-01
cases:16.88%
controls:10.72%
cases:7.29%
controls:3.98%
cases:1.70%
controls:0.61%
cases:1.46%
controls:0.04%
cases:6.20%
controls:0.57%
cases:13.26%
controls:4.11%
cases:17.89%
controls:10.59%
278
1764
1369
14692
120
655
1527
15801
28
101
1619
16355
24
6
1623
16450
95
94
1437
16307
184
645
1204
15049
176
1255
808
10591
Office Visit
OMOP4822458 [581477]
6.5e-01
9.8e-01
1.7e+00
—
3.6e+00
2.1e+00
1.2e+00
cases:11.35%
controls:6.30%
cases:4.43%
controls:1.71%
cases:1.15%
controls:0.22%
—
—
cases:7.31%
controls:0.22%
cases:9.44%
controls:1.31%
cases:11.89%
controls:4.09%
187
1036
1460
15420
73
282
1574
16174
19
36
1628
16420
—
112
36
1420
16365
131
206
1257
15488
117
484
867
11362
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.3e-01
4.8e-01
1.1e+00
5.2e+00
2.4e+00
5.6e-01
1.6e-01
cases:53.37%
controls:47.62%
cases:50.39%
controls:38.50%
cases:21.86%
controls:8.28%
cases:42.99%
controls:0.43%
cases:48.04%
controls:7.96%
cases:53.89%
controls:39.94%
cases:67.38%
controls:63.68%
879
7837
768
8619
830
6335
817
10121
360
1362
1287
15094
708
70
939
16386
736
1305
796
15096
748
6268
640
9426
663
7543
321
4303
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.1e-01
6.9e-01
1.2e+00
4.0e+00
1.9e+00
8.3e-01
6.3e-01
cases:21.86%
controls:13.21%
cases:13.60%
controls:7.29%
cases:5.04%
controls:1.56%
cases:3.28%
controls:0.06%
cases:9.33%
controls:1.49%
cases:14.99%
controls:7.13%
cases:28.05%
controls:17.13%
360
2174
1287
14282
224
1199
1423
15257
83
256
1564
16200
54
10
1593
16446
143
245
1389
16156
208
1119
1180
14575
276
2029
708
9817
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.9e-01
4.7e-01
1.2e+00
5.0e+00
2.2e+00
5.3e-01
2.6e-01
cases:38.25%
controls:31.73%
cases:35.28%
controls:25.46%
cases:16.09%
controls:5.66%
cases:31.15%
controls:0.30%
cases:35.05%
controls:5.60%
cases:37.82%
controls:26.37%
cases:51.12%
controls:44.71%
630
5221
1017
11235
581
4189
1066
12267
265
931
1382
15525
513
50
1134
16406
537
919
995
15482
525
4138
863
11556
503
5296
481
6550
Physiotherapy
R4110 [2001310233]
7.0e-01
1.0e+00
2.0e+00
—
3.5e+00
1.6e+00
1.0e+00
cases:10.38%
controls:5.44%
cases:4.43%
controls:1.68%
cases:1.64%
controls:0.22%
—
—
cases:6.92%
controls:0.23%
cases:7.49%
controls:1.55%
cases:10.98%
controls:4.31%
171
896
1476
15560
73
277
1574
16179
27
37
1620
16419
—
106
37
1426
16364
104
243
1284
15451
108
510
876
11336
CBC panel - Blood by Automated count
58410-2 [40761511]
2.3e-01
4.2e-01
1.2e+00
5.1e+00
2.4e+00
5.0e-01
2.0e-01
cases:47.42%
controls:41.70%
cases:35.52%
controls:26.52%
cases:14.09%
controls:4.82%
cases:31.15%
controls:0.27%
cases:35.38%
controls:4.75%
cases:37.25%
controls:26.46%
cases:54.98%
controls:50.11%
781
6862
866
9594
585
4364
1062
12092
232
793
1415
15663
513
45
1134
16411
542
779
990
15622
517
4153
871
11541
541
5936
443
5910
Psychologist
Z2445 [2001311558]
1.8e+00
—
—
—
1.0e+50
4.6e+00
3.3e+00
cases:0.73%
controls:0.12%
—
—
—
—
—
—
cases:0.85%
controls:0.00%
cases:3.17%
controls:0.03%
cases:1.42%
controls:0.05%
12
19
1635
16437
—
—
—
13
0
1519
16401
44
5
1344
15689
14
6
970
11840
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.7e-01
7.9e-01
1.1e+00
3.2e+00
2.4e+00
1.1e+00
6.8e-01
cases:18.15%
controls:11.14%
cases:12.14%
controls:5.91%
cases:3.04%
controls:1.04%
cases:1.03%
controls:0.04%
cases:9.46%
controls:0.96%
cases:15.92%
controls:5.89%
cases:25.61%
controls:14.79%
299
1833
1348
14623
200
973
1447
15483
50
171
1597
16285
17
7
1630
16449
145
158
1387
16243
221
924
1167
14770
252
1752
732
10094
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.7e-01
4.7e-01
1.0e+00
4.5e+00
2.2e+00
7.3e-01
4.9e-01
cases:27.20%
controls:20.52%
cases:15.30%
controls:10.17%
cases:4.49%
controls:1.63%
cases:4.13%
controls:0.05%
cases:12.66%
controls:1.55%
cases:19.02%
controls:10.18%
cases:34.86%
controls:24.62%
448
3377
1199
13079
252
1673
1395
14783
74
268
1573
16188
68
8
1579
16448
194
255
1338
16146
264
1597
1124
14097
343
2917
641
8929
Essential (primary) hypertension
I10 [45591453]
4.2e-01
5.8e-01
1.0e+00
5.2e+00
1.6e+00
6.5e-01
2.7e-01
cases:31.75%
controls:23.42%
cases:19.73%
controls:12.09%
cases:5.40%
controls:1.99%
cases:11.90%
controls:0.07%
cases:10.05%
controls:2.15%
cases:21.54%
controls:12.57%
cases:34.45%
controls:28.64%
523
3854
1124
12602
325
1990
1322
14466
89
327
1558
16129
196
12
1451
16444
154
353
1378
16048
299
1972
1089
13722
339
3393
645
8453
memantine; oral
N06DX01 [21604799]
1.4e+00
1.8e+00
1.8e+00
-1.0e+50
1.4e+00
1.7e+00
1.6e+00
cases:1.94%
controls:0.47%
cases:2.98%
controls:0.53%
cases:1.76%
controls:0.29%
cases:0.00%
controls:0.04%
cases:1.31%
controls:0.31%
cases:3.39%
controls:0.66%
cases:4.88%
controls:1.00%
32
78
1615
16378
49
87
1598
16369
29
47
1618
16409
0
6
1647
16450
20
51
1512
16350
47
103
1341
15591
48
118
936
11728
Fracture of thoracic vertebra
S22.0 [45592654]
2.0e+00
2.5e+00
—
1.0e+50
—
3.7e+00
1.6e+00
cases:0.73%
controls:0.10%
cases:0.43%
controls:0.04%
—
—
cases:1.34%
controls:0.00%
—
—
cases:1.22%
controls:0.03%
cases:0.91%
controls:0.19%
12
16
1635
16440
7
6
1640
16450
—
22
0
1625
16456
—
17
5
1371
15689
9
22
975
11824
Psychiatry
26 [38004469]
1.3e+00
1.4e+00
1.5e+00
—
1.8e+00
2.1e+00
1.7e+00
cases:9.11%
controls:2.61%
cases:4.55%
controls:1.22%
cases:1.82%
controls:0.43%
—
—
cases:2.42%
controls:0.39%
cases:7.78%
controls:1.04%
cases:12.30%
controls:2.53%
150
430
1497
16026
75
200
1572
16256
30
71
1617
16385
—
37
64
1495
16337
108
163
1280
15531
121
300
863
11546
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.5e-01
9.7e-01
1.9e+00
—
3.4e+00
1.5e+00
1.3e+00
cases:5.46%
controls:2.66%
cases:2.85%
controls:1.10%
cases:0.97%
controls:0.15%
—
—
cases:4.24%
controls:0.15%
cases:4.25%
controls:0.96%
cases:8.33%
controls:2.52%
90
438
1557
16018
47
181
1600
16275
16
25
1631
16431
—
65
25
1467
16376
59
150
1329
15544
82
298
902
11548
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.9e-01
4.6e-01
1.1e+00
5.1e+00
2.4e+00
5.2e-01
1.4e-01
cases:54.58%
controls:49.95%
cases:51.73%
controls:40.42%
cases:23.07%
controls:8.93%
cases:44.44%
controls:0.50%
cases:50.33%
controls:8.80%
cases:54.68%
controls:41.85%
cases:69.72%
controls:66.70%
899
8219
748
8237
852
6651
795
9805
380
1469
1267
14987
732
83
915
16373
771
1443
761
14958
759
6568
629
9126
686
7901
298
3945
Platelets [#/volume] in Blood
26515-7 [3007461]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.4e+00
5.2e-01
1.4e-01
cases:54.40%
controls:49.79%
cases:51.73%
controls:40.30%
cases:23.01%
controls:8.91%
cases:44.44%
controls:0.51%
cases:50.39%
controls:8.79%
cases:54.61%
controls:41.75%
cases:69.61%
controls:66.57%
896
8194
751
8262
852
6632
795
9824
379
1466
1268
14990
732
84
915
16372
772
1442
760
14959
758
6553
630
9141
685
7886
299
3960
MCH [Entitic mass]
28539-5 [3035941]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.4e+00
5.2e-01
1.4e-01
cases:54.46%
controls:49.85%
cases:51.73%
controls:40.31%
cases:23.01%
controls:8.91%
cases:44.38%
controls:0.51%
cases:50.39%
controls:8.77%
cases:54.61%
controls:41.80%
cases:69.61%
controls:66.60%
897
8204
750
8252
852
6634
795
9822
379
1467
1268
14989
731
84
916
16372
772
1439
760
14962
758
6560
630
9134
685
7889
299
3957
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.4e+00
5.2e-01
1.4e-01
cases:54.46%
controls:49.92%
cases:51.73%
controls:40.39%
cases:23.07%
controls:8.92%
cases:44.44%
controls:0.51%
cases:50.39%
controls:8.80%
cases:54.68%
controls:41.82%
cases:69.61%
controls:66.65%
897
8215
750
8241
852
6647
795
9809
380
1468
1267
14988
732
84
915
16372
772
1444
760
14957
759
6563
629
9131
685
7895
299
3951
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.4e+00
5.2e-01
1.4e-01
cases:54.46%
controls:49.93%
cases:51.79%
controls:40.39%
cases:23.01%
controls:8.91%
cases:44.38%
controls:0.51%
cases:50.39%
controls:8.80%
cases:54.68%
controls:41.82%
cases:69.61%
controls:66.66%
897
8216
750
8240
853
6647
794
9809
379
1467
1268
14989
731
84
916
16372
772
1443
760
14958
759
6564
629
9130
685
7897
299
3949
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.4e+00
5.1e-01
1.4e-01
cases:54.46%
controls:49.91%
cases:51.79%
controls:40.42%
cases:23.01%
controls:8.93%
cases:44.44%
controls:0.51%
cases:50.39%
controls:8.82%
cases:54.61%
controls:41.86%
cases:69.61%
controls:66.68%
897
8214
750
8242
853
6652
794
9804
379
1469
1268
14987
732
84
915
16372
772
1446
760
14955
758
6569
630
9125
685
7899
299
3947
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.8e-01
4.6e-01
1.1e+00
5.0e+00
2.3e+00
5.1e-01
1.4e-01
cases:54.46%
controls:49.96%
cases:51.79%
controls:40.49%
cases:23.01%
controls:8.97%
cases:44.44%
controls:0.51%
cases:50.39%
controls:8.83%
cases:54.68%
controls:41.90%
cases:69.72%
controls:66.74%
897
8222
750
8234
853
6663
794
9793
379
1476
1268
14980
732
84
915
16372
772
1449
760
14952
759
6576
629
9118
686
7906
298
3940
Poisoning by systemic antibiotics
T36 [45756588]
2.3e+00
2.8e+00
—
—
—
2.0e+00
2.5e+00
cases:1.09%
controls:0.11%
cases:0.61%
controls:0.04%
—
—
—
—
—
—
cases:0.43%
controls:0.06%
cases:1.73%
controls:0.14%
18
18
1629
16438
10
6
1637
16450
—
—
—
6
9
1382
15685
17
17
967
11829
CT of neck arteries
PA6AD [2001308692]
2.7e+00
2.9e+00
1.0e+50
1.0e+50
—
2.2e+00
1.7e+00
cases:0.55%
controls:0.04%
cases:0.91%
controls:0.05%
cases:0.61%
controls:0.00%
cases:2.43%
controls:0.00%
—
—
cases:0.50%
controls:0.06%
cases:0.81%
controls:0.14%
9
6
1638
16450
15
8
1632
16448
10
0
1637
16456
40
0
1607
16456
—
7
9
1381
15685
8
17
976
11829
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.5e-01
4.2e-01
1.1e+00
5.0e+00
2.2e+00
5.8e-01
2.2e-01
cases:39.77%
controls:34.05%
cases:37.83%
controls:28.52%
cases:15.97%
controls:6.08%
cases:31.15%
controls:0.30%
cases:36.55%
controls:5.84%
cases:42.44%
controls:29.25%
cases:54.47%
controls:49.05%
655
5604
992
10852
623
4693
1024
11763
263
1001
1384
15455
513
50
1134
16406
560
958
972
15443
589
4591
799
11103
536
5810
448
6036
Urgent procedure
ZXD05 [2001311386]
7.6e-01
1.2e+00
2.1e+00
1.0e+50
3.3e+00
1.6e+00
6.2e-01
cases:8.08%
controls:3.96%
cases:2.61%
controls:0.84%
cases:0.91%
controls:0.12%
cases:5.95%
controls:0.00%
cases:2.74%
controls:0.10%
cases:3.96%
controls:0.80%
cases:5.08%
controls:2.79%
133
652
1514
15804
43
138
1604
16318
15
19
1632
16437
98
0
1549
16456
42
17
1490
16384
55
125
1333
15569
50
331
934
11515
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.4e-01
1.1e+00
1.2e+00
1.0e+50
4.0e+00
1.5e+00
1.1e+00
cases:6.56%
controls:3.25%
cases:4.07%
controls:1.45%
cases:0.85%
controls:0.26%
cases:1.70%
controls:0.00%
cases:8.81%
controls:0.18%
cases:5.84%
controls:1.40%
cases:10.57%
controls:3.81%
108
535
1539
15921
67
239
1580
16217
14
42
1633
16414
28
0
1619
16456
135
30
1397
16371
81
219
1307
15475
104
451
880
11395
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.3e-01
1.1e+00
2.5e+00
—
3.2e+00
1.0e+00
7.7e-01
cases:5.22%
controls:2.59%
cases:4.25%
controls:1.39%
cases:1.52%
controls:0.12%
—
—
cases:3.20%
controls:0.13%
cases:3.96%
controls:1.45%
cases:9.96%
controls:4.88%
86
426
1561
16030
70
229
1577
16227
25
20
1622
16436
—
49
21
1483
16380
55
228
1333
15466
98
578
886
11268
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.6e+00
3.1e+00
—
1.0e+50
—
3.1e+00
1.7e+00
cases:1.70%
controls:0.35%
cases:1.03%
controls:0.05%
—
—
cases:1.82%
controls:0.00%
—
—
cases:2.45%
controls:0.11%
cases:1.73%
controls:0.32%
28
57
1619
16399
17
8
1630
16448
—
30
0
1617
16456
—
34
18
1354
15676
17
38
967
11808
Superficial injury of scalp
S00.0 [45548998]
1.4e+00
2.8e+00
—
1.0e+50
—
2.3e+00
2.8e+00
cases:0.73%
controls:0.18%
cases:0.73%
controls:0.04%
—
—
cases:0.73%
controls:0.00%
—
—
cases:0.79%
controls:0.08%
cases:1.93%
controls:0.12%
12
29
1635
16427
12
7
1635
16449
—
12
0
1635
16456
—
11
12
1377
15682
19
14
965
11832
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
2.2e+00
2.0e+00
—
—
—
2.8e+00
2.5e+00
cases:1.21%
controls:0.13%
cases:0.79%
controls:0.11%
—
—
—
—
—
—
cases:1.59%
controls:0.10%
cases:2.34%
controls:0.20%
20
22
1627
16434
13
18
1634
16438
—
—
—
22
16
1366
15678
23
24
961
11822
Gas panel - Venous blood
24339-4 [3000991]
8.6e-01
1.2e+00
2.1e+00
1.0e+50
3.1e+00
1.2e+00
9.0e-01
cases:3.46%
controls:1.50%
cases:2.73%
controls:0.86%
cases:1.28%
controls:0.16%
cases:2.37%
controls:0.00%
cases:2.94%
controls:0.14%
cases:3.24%
controls:0.98%
cases:6.50%
controls:2.75%
57
247
1590
16209
45
142
1602
16314
21
26
1626
16430
39
0
1608
16456
45
23
1487
16378
45
154
1343
15540
64
326
920
11520
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
7.9e-01
1.2e+00
2.3e+00
—
3.3e+00
1.0e+00
6.8e-01
cases:3.76%
controls:1.74%
cases:3.04%
controls:0.98%
cases:0.97%
controls:0.10%
—
—
cases:2.15%
controls:0.08%
cases:2.88%
controls:1.06%
cases:7.01%
controls:3.67%
62
286
1585
16170
50
161
1597
16295
16
16
1631
16440
—
33
13
1499
16388
40
166
1348
15528
69
435
915
11411
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
1.5e+00
2.1e+00
—
—
—
3.5e+00
2.1e+00
cases:1.09%
controls:0.24%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:1.30%
controls:0.04%
cases:1.63%
controls:0.19%
18
39
1629
16417
7
9
1640
16447
—
—
—
18
6
1370
15688
16
23
968
11823
Syncope and collapse
R55 [45568141]
1.3e+00
1.4e+00
3.1e+00
—
—
2.1e+00
1.4e+00
cases:3.89%
controls:1.07%
cases:1.46%
controls:0.35%
cases:1.03%
controls:0.05%
—
—
—
—
cases:2.95%
controls:0.38%
cases:5.08%
controls:1.33%
64
176
1583
16280
24
58
1623
16398
17
8
1630
16448
—
—
41
60
1347
15634
50
158
934
11688
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
3.8e-01
5.5e-01
1.4e+00
4.5e+00
1.9e+00
5.4e-01
2.0e-01
cases:9.11%
controls:6.42%
cases:5.65%
controls:3.35%
cases:2.13%
controls:0.55%
cases:3.28%
controls:0.04%
cases:4.11%
controls:0.63%
cases:5.76%
controls:3.45%
cases:9.96%
controls:8.31%
150
1057
1497
15399
93
551
1554
15905
35
91
1612
16365
54
6
1593
16450
63
104
1469
16297
80
542
1308
15152
98
984
886
10862
Depressive episode, unspecified
F32.9 [45571760]
1.4e+00
1.7e+00
—
1.0e+50
2.6e+00
1.9e+00
1.7e+00
cases:3.22%
controls:0.78%
cases:1.52%
controls:0.29%
—
—
cases:0.49%
controls:0.00%
cases:0.72%
controls:0.05%
cases:2.02%
controls:0.31%
cases:4.57%
controls:0.89%
53
129
1594
16327
25
48
1622
16408
—
8
0
1639
16456
11
9
1521
16392
28
48
1360
15646
45
106
939
11740
Supplier / Service Provider
OMOP5117446 [33004]
-1.9e-01
2.6e-02
3.1e-01
—
3.4e+00
2.6e+00
3.2e+00
cases:21.01%
controls:24.40%
cases:7.35%
controls:7.17%
cases:0.97%
controls:0.71%
—
—
cases:1.04%
controls:0.04%
cases:6.34%
controls:0.48%
cases:20.12%
controls:1.00%
346
4015
1301
12441
121
1180
1526
15276
16
117
1631
16339
—
16
6
1516
16395
88
76
1300
15618
198
118
786
11728
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.0e-01
4.7e-01
1.2e+00
4.2e+00
2.1e+00
6.2e-01
3.3e-01
cases:15.85%
controls:12.28%
cases:10.75%
controls:7.02%
cases:3.52%
controls:1.10%
cases:2.49%
controls:0.04%
cases:7.64%
controls:1.04%
cases:13.40%
controls:7.71%
cases:26.73%
controls:20.77%
261
2021
1386
14435
177
1155
1470
15301
58
181
1589
16275
41
6
1606
16450
117
170
1415
16231
186
1210
1202
14484
263
2461
721
9385
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.2e-01
1.1e+00
2.3e+00
—
3.3e+00
1.0e+00
6.4e-01
cases:3.83%
controls:1.71%
cases:3.04%
controls:1.04%
cases:1.03%
controls:0.10%
—
—
cases:2.28%
controls:0.09%
cases:3.03%
controls:1.10%
cases:7.22%
controls:3.93%
63
282
1584
16174
50
171
1597
16285
17
17
1630
16439
—
35
14
1497
16387
42
173
1346
15521
71
466
913
11380
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.2e-01
4.9e-01
9.5e-01
4.6e+00
1.9e+00
4.8e-01
4.3e-01
cases:17.12%
controls:11.93%
cases:14.45%
controls:9.42%
cases:5.53%
controls:2.22%
cases:9.29%
controls:0.10%
cases:12.73%
controls:2.24%
cases:15.27%
controls:10.05%
cases:26.02%
controls:18.67%
282
1963
1365
14493
238
1550
1409
14906
91
365
1556
16091
153
17
1494
16439
195
367
1337
16034
212
1578
1176
14116
256
2212
728
9634
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
9.2e-01
2.2e+00
1.0e+50
1.0e+50
—
4.2e+00
2.8e+00
cases:0.49%
controls:0.19%
cases:0.43%
controls:0.05%
cases:0.49%
controls:0.00%
cases:2.43%
controls:0.00%
—
—
cases:2.38%
controls:0.04%
cases:2.44%
controls:0.15%
8
32
1639
16424
7
8
1640
16448
8
0
1639
16456
40
0
1607
16456
—
33
6
1355
15688
24
18
960
11828
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.9e-01
4.6e-01
1.2e+00
4.2e+00
2.0e+00
6.1e-01
3.1e-01
cases:16.33%
controls:12.70%
cases:10.93%
controls:7.21%
cases:3.52%
controls:1.12%
cases:2.49%
controls:0.04%
cases:7.51%
controls:1.08%
cases:13.47%
controls:7.81%
cases:26.83%
controls:21.13%
269
2090
1378
14366
180
1186
1467
15270
58
184
1589
16272
41
6
1606
16450
115
177
1417
16224
187
1225
1201
14469
264
2503
720
9343
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.0e-01
4.5e-01
1.2e+00
4.2e+00
2.0e+00
6.1e-01
3.2e-01
cases:16.15%
controls:12.46%
cases:10.81%
controls:7.17%
cases:3.46%
controls:1.11%
cases:2.43%
controls:0.04%
cases:7.57%
controls:1.07%
cases:13.54%
controls:7.82%
cases:26.93%
controls:21.10%
266
2050
1381
14406
178
1180
1469
15276
57
183
1590
16273
40
6
1607
16450
116
176
1416
16225
188
1227
1200
14467
265
2500
719
9346
lamotrigine; oral
N03AX09 [21604431]
2.0e+00
2.6e+00
—
—
—
2.5e+00
2.0e+00
cases:0.73%
controls:0.10%
cases:0.49%
controls:0.04%
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:0.71%
controls:0.10%
12
17
1635
16439
8
6
1639
16450
—
—
—
9
8
1379
15686
7
12
977
11834
Outpatient Hospital
22 [8756]
5.5e-01
9.7e-01
1.9e+00
—
3.2e+00
1.4e+00
9.3e-01
cases:31.75%
controls:21.19%
cases:12.51%
controls:5.14%
cases:4.92%
controls:0.75%
—
—
cases:15.47%
controls:0.72%
cases:16.28%
controls:4.61%
cases:25.51%
controls:11.94%
523
3487
1124
12969
206
846
1441
15610
81
124
1566
16332
—
237
118
1295
16283
226
723
1162
14971
251
1414
733
10432
Sequelae of cerebral infarction
I69.3 [45533476]
4.5e+00
—
1.0e+50
1.0e+50
1.0e+50
—
4.5e+00
cases:3.10%
controls:0.04%
—
—
cases:0.61%
controls:0.00%
cases:1.21%
controls:0.00%
cases:1.17%
controls:0.00%
—
—
cases:4.27%
controls:0.05%
51
6
1596
16450
—
10
0
1637
16456
20
0
1627
16456
18
0
1514
16401
—
42
6
942
11840
Atrial fibrillation and flutter
I48 [45596206]
5.6e-01
7.1e-01
1.0e+00
4.1e+00
1.8e+00
6.7e-01
1.9e-01
cases:14.94%
controls:9.15%
cases:8.80%
controls:4.54%
cases:2.55%
controls:0.93%
cases:2.98%
controls:0.05%
cases:5.35%
controls:0.88%
cases:8.36%
controls:4.48%
cases:11.18%
controls:9.46%
246
1505
1401
14951
145
747
1502
15709
42
153
1605
16303
49
8
1598
16448
82
145
1450
16256
116
703
1272
14991
110
1121
874
10725
Fall on and from stairs and steps
W10 [45756250]
1.3e+00
1.6e+00
—
1.0e+50
—
3.8e+00
2.2e+00
cases:1.40%
controls:0.38%
cases:0.67%
controls:0.13%
—
—
cases:8.26%
controls:0.00%
—
—
cases:5.62%
controls:0.13%
cases:3.86%
controls:0.43%
23
63
1624
16393
11
22
1636
16434
—
136
0
1511
16456
—
78
21
1310
15673
38
51
946
11795
Social problem NOS
Z29 [2002001483]
1.7e+00
2.5e+00
—
—
—
3.0e+00
1.7e+00
cases:0.55%
controls:0.10%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.65%
controls:0.03%
cases:0.71%
controls:0.13%
9
16
1638
16440
7
6
1640
16450
—
—
—
9
5
1379
15689
7
15
977
11831
disulfiram; oral
N07BB01 [21604821]
1.9e+00
2.1e+00
—
—
—
2.4e+00
2.4e+00
cases:2.37%
controls:0.37%
cases:1.03%
controls:0.12%
—
—
—
—
—
—
cases:1.01%
controls:0.09%
cases:2.85%
controls:0.26%
39
61
1608
16395
17
20
1630
16436
—
—
—
14
14
1374
15680
28
31
956
11815
Malaise and fatigue
R53 [45553741]
1.1e+00
1.3e+00
2.3e+00
—
1.9e+00
1.4e+00
8.7e-01
cases:6.56%
controls:2.38%
cases:3.46%
controls:0.93%
cases:0.79%
controls:0.08%
—
—
cases:0.72%
controls:0.11%
cases:4.61%
controls:1.22%
cases:9.65%
controls:4.28%
108
391
1539
16065
57
153
1590
16303
13
13
1634
16443
—
11
18
1521
16383
64
192
1324
15502
95
507
889
11339
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.8e-01
9.1e-01
2.6e+00
1.0e+50
2.9e+00
1.1e+00
6.4e-01
cases:9.29%
controls:5.42%
cases:5.04%
controls:2.10%
cases:2.98%
controls:0.24%
cases:9.84%
controls:0.00%
cases:5.03%
controls:0.28%
cases:5.04%
controls:1.80%
cases:10.67%
controls:5.93%
153
892
1494
15564
83
345
1564
16111
49
39
1598
16417
162
0
1485
16456
77
46
1455
16355
70
283
1318
15411
105
703
879
11143
Atherosclerotic heart disease
I25.1 [45596196]
3.1e-01
5.3e-01
9.2e-01
4.6e+00
1.8e+00
4.1e-01
2.8e-02
cases:9.11%
controls:6.85%
cases:6.07%
controls:3.66%
cases:1.64%
controls:0.66%
cases:3.04%
controls:0.03%
cases:3.46%
controls:0.56%
cases:5.98%
controls:4.06%
cases:8.43%
controls:8.22%
150
1127
1497
15329
100
602
1547
15854
27
109
1620
16347
50
5
1597
16451
53
92
1479
16309
83
637
1305
15057
83
974
901
10872
quetiapine; oral
N05AH04 [21604544]
1.4e+00
1.5e+00
1.2e+00
—
1.4e+00
1.6e+00
1.6e+00
cases:7.59%
controls:1.90%
cases:6.38%
controls:1.54%
cases:1.88%
controls:0.60%
—
—
cases:2.02%
controls:0.52%
cases:8.29%
controls:1.75%
cases:11.18%
controls:2.57%
125
313
1522
16143
105
253
1542
16203
31
99
1616
16357
—
31
85
1501
16316
115
274
1273
15420
110
304
874
11542
sertraline; oral
N06AB06 [21604714]
1.3e+00
1.4e+00
1.7e+00
—
1.5e+00
1.3e+00
1.5e+00
cases:2.43%
controls:0.68%
cases:1.76%
controls:0.44%
cases:0.67%
controls:0.13%
—
—
cases:0.65%
controls:0.15%
cases:1.73%
controls:0.48%
cases:3.05%
controls:0.71%
40
112
1607
16344
29
72
1618
16384
11
21
1636
16435
—
10
24
1522
16377
24
76
1364
15618
30
84
954
11762
Fracture of rib
S22.3 [45573285]
1.3e+00
1.9e+00
2.6e+00
1.0e+50
—
1.9e+00
8.7e-01
cases:2.31%
controls:0.66%
cases:1.34%
controls:0.21%
cases:0.43%
controls:0.03%
cases:1.40%
controls:0.00%
—
—
cases:1.66%
controls:0.25%
cases:2.44%
controls:1.04%
38
108
1609
16348
22
34
1625
16422
7
5
1640
16451
23
0
1624
16456
—
23
40
1365
15654
24
123
960
11723
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
6.5e-01
9.6e-01
1.7e+00
—
2.6e+00
1.6e+00
1.1e+00
cases:3.64%
controls:1.93%
cases:2.49%
controls:0.97%
cases:0.49%
controls:0.09%
—
—
cases:1.96%
controls:0.15%
cases:3.39%
controls:0.72%
cases:6.71%
controls:2.30%
60
318
1587
16138
41
160
1606
16296
8
15
1639
16441
—
30
25
1502
16376
47
113
1341
15581
66
273
918
11573
Bacteria identified in Blood by Culture
600-7 [3023368]
6.4e-01
8.0e-01
1.9e+00
—
3.2e+00
1.2e+00
7.7e-01
cases:10.81%
controls:6.03%
cases:5.95%
controls:2.78%
cases:2.79%
controls:0.41%
—
—
cases:9.01%
controls:0.39%
cases:8.57%
controls:2.85%
cases:16.46%
controls:8.37%
178
992
1469
15464
98
457
1549
15999
46
67
1601
16389
—
138
64
1394
16337
119
447
1269
15247
162
991
822
10855
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
9.3e-02
3.1e-01
1.0e+00
4.7e+00
2.1e+00
3.8e-01
-1.1e-01
cases:38.62%
controls:36.42%
cases:33.76%
controls:27.30%
cases:15.12%
controls:5.89%
cases:27.08%
controls:0.33%
cases:33.03%
controls:5.79%
cases:36.17%
controls:27.91%
cases:45.83%
controls:48.56%
636
5994
1011
10462
556
4493
1091
11963
249
970
1398
15486
446
54
1201
16402
506
950
1026
15451
502
4380
886
11314
451
5753
533
6093
Gas panel - Central venous blood
97535-9 [1616796]
1.1e+00
1.5e+00
—
—
3.1e+00
1.5e+00
1.3e+00
cases:1.15%
controls:0.38%
cases:0.79%
controls:0.18%
—
—
—
—
cases:0.65%
controls:0.03%
cases:0.79%
controls:0.18%
cases:1.83%
controls:0.48%
19
62
1628
16394
13
30
1634
16426
—
—
10
5
1522
16396
11
28
1377
15666
18
57
966
11789
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.2e+00
1.3e+00
2.5e+00
1.0e+50
—
1.9e+00
1.6e+00
cases:1.64%
controls:0.50%
cases:0.79%
controls:0.21%
cases:0.43%
controls:0.04%
cases:1.82%
controls:0.00%
—
—
cases:1.15%
controls:0.17%
cases:3.56%
controls:0.73%
27
82
1620
16374
13
35
1634
16421
7
6
1640
16450
30
0
1617
16456
—
16
27
1372
15667
35
86
949
11760
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.1e+00
1.3e+00
1.9e+00
—
2.2e+00
1.1e+00
9.9e-01
cases:2.67%
controls:0.94%
cases:2.06%
controls:0.58%
cases:0.85%
controls:0.13%
—
—
cases:0.98%
controls:0.11%
cases:1.80%
controls:0.61%
cases:4.37%
controls:1.67%
44
154
1603
16302
34
96
1613
16360
14
22
1633
16434
—
15
18
1517
16383
25
96
1363
15598
43
198
941
11648
Shoulder X-ray examination without contrast
NB1AA [2001307225]
1.3e+00
1.3e+00
1.0e+50
1.0e+50
2.6e+00
2.2e+00
1.1e+00
cases:2.19%
controls:0.62%
cases:0.85%
controls:0.24%
cases:0.43%
controls:0.00%
cases:1.82%
controls:0.00%
cases:0.39%
controls:0.03%
cases:1.30%
controls:0.14%
cases:2.74%
controls:0.89%
36
102
1611
16354
14
40
1633
16416
7
0
1640
16456
30
0
1617
16456
6
5
1526
16396
18
22
1370
15672
27
106
957
11740
duloxetine; oral
N06AX21 [21604749]
1.1e+00
1.5e+00
1.7e+00
—
1.6e+00
1.3e+00
1.3e+00
cases:2.49%
controls:0.81%
cases:1.82%
controls:0.42%
cases:0.73%
controls:0.14%
—
—
cases:0.72%
controls:0.15%
cases:2.09%
controls:0.57%
cases:3.15%
controls:0.92%
41
133
1606
16323
30
69
1617
16387
12
23
1635
16433
—
11
24
1521
16377
29
89
1359
15605
31
109
953
11737
Accident at home
Y94.0 [2000503726]
1.6e+00
2.5e+00
—
1.0e+50
—
2.6e+00
1.8e+00
cases:0.67%
controls:0.14%
cases:0.36%
controls:0.03%
—
—
cases:0.73%
controls:0.00%
—
—
cases:0.50%
controls:0.04%
cases:1.02%
controls:0.17%
11
23
1636
16433
6
5
1641
16451
—
12
0
1635
16456
—
7
6
1381
15688
10
20
974
11826
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
5.9e-01
8.2e-01
2.4e+00
1.0e+50
2.9e+00
1.2e+00
5.6e-01
cases:12.93%
controls:7.63%
cases:6.31%
controls:2.89%
cases:3.58%
controls:0.35%
cases:15.06%
controls:0.00%
cases:6.46%
controls:0.37%
cases:7.42%
controls:2.47%
cases:13.01%
controls:7.88%
213
1256
1434
15200
104
476
1543
15980
59
57
1588
16399
248
0
1399
16456
99
60
1433
16341
103
387
1285
15307
128
933
856
10913
Alcohol depence active use
F10.24 [2000501681]
2.3e+00
—
—
—
—
2.9e+00
3.2e+00
cases:0.61%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.03%
cases:2.13%
controls:0.09%
10
10
1637
16446
—
—
—
—
8
5
1380
15689
21
11
963
11835
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.1e-01
4.3e-01
1.1e+00
4.2e+00
2.0e+00
6.1e-01
2.6e-01
cases:12.63%
controls:10.49%
cases:8.14%
controls:5.43%
cases:2.37%
controls:0.78%
cases:1.94%
controls:0.03%
cases:5.03%
controls:0.73%
cases:10.01%
controls:5.73%
cases:18.90%
controls:15.29%
208
1727
1439
14729
134
893
1513
15563
39
129
1608
16327
32
5
1615
16451
77
120
1455
16281
139
899
1249
14795
186
1811
798
10035
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
2.1e+00
1.9e+00
—
—
—
2.4e+00
1.9e+00
cases:1.58%
controls:0.19%
cases:0.67%
controls:0.10%
—
—
—
—
—
—
cases:1.44%
controls:0.13%
cases:2.54%
controls:0.41%
26
32
1621
16424
11
17
1636
16439
—
—
—
20
20
1368
15674
25
48
959
11798
donepezil; oral
N06DA02 [21604795]
1.8e+00
1.5e+00
1.6e+00
—
1.2e+00
1.7e+00
1.7e+00
cases:2.13%
controls:0.35%
cases:1.94%
controls:0.42%
cases:1.03%
controls:0.22%
—
—
cases:0.65%
controls:0.19%
cases:2.16%
controls:0.42%
cases:3.35%
controls:0.64%
35
58
1612
16398
32
69
1615
16387
17
36
1630
16420
—
10
31
1522
16370
30
66
1358
15628
33
76
951
11770
Other specified special examinations
Z01.8 [45581003]
6.4e-01
8.3e-01
1.7e+00
—
2.3e+00
1.6e+00
1.2e+00
cases:4.80%
controls:2.59%
cases:1.64%
controls:0.72%
cases:0.55%
controls:0.10%
—
—
cases:0.78%
controls:0.08%
cases:3.17%
controls:0.64%
cases:6.50%
controls:2.09%
79
427
1568
16029
27
119
1620
16337
9
17
1638
16439
—
12
13
1520
16388
44
100
1344
15594
64
247
920
11599
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
8.3e-01
8.6e-01
1.3e+00
1.0e+50
3.2e+00
1.2e+00
8.2e-01
cases:6.74%
controls:3.04%
cases:4.07%
controls:1.76%
cases:1.34%
controls:0.37%
cases:1.34%
controls:0.00%
cases:7.77%
controls:0.34%
cases:5.48%
controls:1.72%
cases:8.23%
controls:3.79%
111
501
1536
15955
67
289
1580
16167
22
61
1625
16395
22
0
1625
16456
119
56
1413
16345
76
270
1312
15424
81
449
903
11397
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
6.3e-01
1.0e+00
2.2e+00
—
2.9e+00
8.5e-01
5.5e-01
cases:8.74%
controls:4.86%
cases:5.83%
controls:2.15%
cases:2.19%
controls:0.25%
—
—
cases:4.77%
controls:0.26%
cases:5.12%
controls:2.24%
cases:10.26%
controls:6.19%
144
800
1503
15656
96
353
1551
16103
36
41
1611
16415
—
73
43
1459
16358
71
352
1317
15342
101
733
883
11113
Fracture of lumbar vertebra
S32.0 [45583057]
1.9e+00
2.2e+00
—
1.0e+50
—
2.6e+00
1.5e+00
cases:1.40%
controls:0.21%
cases:0.73%
controls:0.09%
—
—
cases:1.15%
controls:0.00%
—
—
cases:1.30%
controls:0.10%
cases:1.52%
controls:0.34%
23
35
1624
16421
12
14
1635
16442
—
19
0
1628
16456
—
18
15
1370
15679
15
40
969
11806
Alcohol intoxication UNS
F10.09 [2000501676]
2.6e+00
—
—
1.0e+50
—
2.7e+00
2.9e+00
cases:1.28%
controls:0.10%
—
—
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.72%
controls:0.05%
cases:2.34%
controls:0.14%
21
16
1626
16440
—
—
11
0
1636
16456
—
10
8
1378
15686
23
16
961
11830
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
5.8e-01
9.6e-01
2.1e+00
—
4.2e+00
8.9e-01
8.5e-01
cases:2.19%
controls:1.24%
cases:1.40%
controls:0.54%
cases:0.43%
controls:0.05%
—
—
cases:2.48%
controls:0.04%
cases:1.15%
controls:0.48%
cases:3.66%
controls:1.60%
36
204
1611
16252
23
89
1624
16367
7
9
1640
16447
—
38
6
1494
16395
16
75
1372
15619
36
189
948
11657
Carpal tunnel syndrome
G56.0 [45566891]
2.1e+00
2.6e+00
—
—
—
2.0e+00
1.4e+00
cases:1.52%
controls:0.19%
cases:0.73%
controls:0.05%
—
—
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.22%
controls:0.31%
25
31
1622
16425
12
9
1635
16447
—
—
—
8
12
1380
15682
12
37
972
11809
Laboratory Visit
OMOP4822461 [32036]
1.2e-01
3.3e-01
8.9e-01
4.6e+00
1.9e+00
4.2e-01
8.1e-02
cases:57.62%
controls:54.73%
cases:57.92%
controls:49.76%
cases:30.72%
controls:15.43%
cases:47.48%
controls:0.91%
cases:53.59%
controls:15.30%
cases:61.67%
controls:51.30%
cases:73.48%
controls:71.86%
949
9006
698
7450
954
8189
693
8267
506
2539
1141
13917
782
149
865
16307
821
2509
711
13892
856
8051
532
7643
723
8513
261
3333
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
9.0e-01
1.0e+00
2.0e+00
—
2.1e+00
1.1e+00
9.1e-01
cases:4.68%
controls:1.96%
cases:2.25%
controls:0.83%
cases:0.61%
controls:0.08%
—
—
cases:0.72%
controls:0.09%
cases:2.67%
controls:0.87%
cases:6.20%
controls:2.59%
77
323
1570
16133
37
137
1610
16319
10
13
1637
16443
—
11
15
1521
16386
37
136
1351
15558
61
307
923
11539
Oxygen saturation in Venous blood
2711-0 [3024928]
1.1e+00
1.6e+00
2.8e+00
1.0e+50
—
1.4e+00
1.1e+00
cases:1.09%
controls:0.36%
cases:0.97%
controls:0.19%
cases:0.49%
controls:0.03%
cases:0.55%
controls:0.00%
—
—
cases:0.86%
controls:0.21%
cases:2.24%
controls:0.73%
18
59
1629
16397
16
32
1631
16424
8
5
1639
16451
9
0
1638
16456
—
12
33
1376
15661
22
87
962
11759
Addiction caused by alcohol UNS
F10.29 [2000501684]
2.3e+00
—
—
—
—
2.9e+00
2.8e+00
cases:0.91%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.04%
cases:1.93%
controls:0.12%
15
15
1632
16441
—
—
—
—
10
6
1378
15688
19
14
965
11832
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
2.3e+00
2.3e+00
—
—
—
2.9e+00
2.9e+00
cases:0.73%
controls:0.07%
cases:0.30%
controls:0.03%
—
—
—
—
—
—
cases:0.58%
controls:0.03%
cases:1.02%
controls:0.06%
12
12
1635
16444
5
5
1642
16451
—
—
—
8
5
1380
15689
10
7
974
11839
Infiltration anesthesia
WX110 [2001310767]
3.9e-01
2.7e-01
8.8e-01
4.2e+00
1.3e+00
7.3e-01
5.8e-01
cases:26.65%
controls:19.74%
cases:9.47%
controls:7.43%
cases:2.06%
controls:0.86%
cases:3.40%
controls:0.05%
cases:2.87%
controls:0.80%
cases:13.54%
controls:7.01%
cases:32.01%
controls:20.82%
439
3248
1208
13208
156
1222
1491
15234
34
142
1613
16314
56
9
1591
16447
44
131
1488
16270
188
1100
1200
14594
315
2466
669
9380
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.6e-01
5.9e-01
8.6e-01
3.3e+00
1.6e+00
6.7e-01
5.2e-01
cases:34.18%
controls:24.74%
cases:23.74%
controls:14.66%
cases:6.74%
controls:2.95%
cases:2.73%
controls:0.10%
cases:12.73%
controls:2.74%
cases:25.00%
controls:14.57%
cases:42.58%
controls:30.63%
563
4071
1084
12385
391
2413
1256
14043
111
486
1536
15970
45
17
1602
16439
195
449
1337
15952
347
2286
1041
13408
419
3628
565
8218
pH of Urine
2756-5 [3015736]
2.5e-01
3.8e-01
1.3e+00
3.8e+00
2.0e+00
5.6e-01
2.1e-01
cases:12.08%
controls:9.66%
cases:7.23%
controls:5.04%
cases:2.73%
controls:0.78%
cases:1.64%
controls:0.04%
cases:5.03%
controls:0.72%
cases:9.29%
controls:5.52%
cases:18.70%
controls:15.70%
199
1590
1448
14866
119
830
1528
15626
45
129
1602
16327
27
6
1620
16450
77
118
1455
16283
129
867
1259
14827
184
1860
800
9986
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
6.5e-01
8.7e-01
1.4e+00
1.0e+50
3.3e+00
9.9e-01
7.6e-01
cases:4.25%
controls:2.26%
cases:2.85%
controls:1.22%
cases:1.09%
controls:0.26%
cases:1.46%
controls:0.00%
cases:5.87%
controls:0.23%
cases:3.31%
controls:1.26%
cases:5.79%
controls:2.79%
70
372
1577
16084
47
201
1600
16255
18
43
1629
16413
24
0
1623
16456
90
38
1442
16363
46
198
1342
15496
57
330
927
11516
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
6.0e-01
1.1e+00
1.7e+00
—
2.3e+00
1.3e+00
1.1e+00
cases:3.89%
controls:2.18%
cases:2.06%
controls:0.71%
cases:0.49%
controls:0.09%
—
—
cases:0.72%
controls:0.07%
cases:2.09%
controls:0.59%
cases:5.08%
controls:1.81%
64
358
1583
16098
34
117
1613
16339
8
15
1639
16441
—
11
12
1521
16389
29
92
1359
15602
50
215
934
11631
Alcoholic cirrhosis of liver
K70.3 [45596343]
1.9e+00
1.7e+00
1.0e+50
1.0e+50
—
2.2e+00
2.2e+00
cases:0.79%
controls:0.12%
cases:0.49%
controls:0.09%
cases:0.30%
controls:0.00%
cases:0.30%
controls:0.00%
—
—
cases:0.94%
controls:0.10%
cases:1.42%
controls:0.16%
13
20
1634
16436
8
15
1639
16441
5
0
1642
16456
5
0
1642
16456
—
13
16
1375
15678
14
19
970
11827
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
7.6e-01
1.4e+00
2.5e+00
—
3.2e+00
8.9e-01
5.8e-01
cases:1.40%
controls:0.66%
cases:1.82%
controls:0.46%
cases:0.61%
controls:0.05%
—
—
cases:1.44%
controls:0.06%
cases:1.44%
controls:0.60%
cases:3.76%
controls:2.14%
23
108
1624
16348
30
76
1617
16380
10
8
1637
16448
—
22
10
1510
16391
20
94
1368
15600
37
254
947
11592
Occupational therapy
R4120 [2001310234]
1.8e+00
1.4e+00
—
1.0e+50
—
2.8e+00
2.0e+00
cases:2.00%
controls:0.35%
cases:0.67%
controls:0.16%
—
—
cases:1.70%
controls:0.00%
—
—
cases:1.66%
controls:0.10%
cases:1.93%
controls:0.28%
33
57
1614
16399
11
26
1636
16430
—
28
0
1619
16456
—
23
16
1365
15678
19
33
965
11813
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
7.5e-01
1.2e+00
3.2e+00
1.0e+50
—
1.8e+00
9.8e-01
cases:2.06%
controls:0.98%
cases:1.46%
controls:0.45%
cases:0.91%
controls:0.04%
cases:3.10%
controls:0.00%
—
—
cases:2.59%
controls:0.44%
cases:4.37%
controls:1.68%
34
162
1613
16294
24
74
1623
16382
15
6
1632
16450
51
0
1596
16456
—
36
69
1352
15625
43
199
941
11647
Memory disturbance
P20 [2002000816]
1.2e+00
1.3e+00
1.6e+00
—
1.3e+00
1.4e+00
1.1e+00
cases:6.01%
controls:1.93%
cases:3.89%
controls:1.08%
cases:1.09%
controls:0.22%
—
—
cases:0.72%
controls:0.20%
cases:4.18%
controls:1.06%
cases:8.33%
controls:2.91%
99
318
1548
16138
64
178
1583
16278
18
36
1629
16420
—
11
33
1521
16368
58
166
1330
15528
82
345
902
11501
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
6.7e-01
1.2e+00
2.0e+00
—
3.5e+00
1.1e+00
6.7e-01
cases:1.46%
controls:0.75%
cases:1.34%
controls:0.39%
cases:0.36%
controls:0.05%
—
—
cases:1.83%
controls:0.05%
cases:1.08%
controls:0.36%
cases:2.74%
controls:1.43%
24
124
1623
16332
22
65
1625
16391
6
8
1641
16448
—
28
9
1504
16392
15
57
1373
15637
27
169
957
11677
12 lead EKG panel
34534-8 [3044889]
3.4e-01
4.6e-01
6.9e-01
4.0e+00
1.6e+00
5.3e-01
2.3e-01
cases:31.82%
controls:24.98%
cases:18.52%
controls:12.59%
cases:2.98%
controls:1.51%
cases:2.31%
controls:0.04%
cases:7.18%
controls:1.55%
cases:18.44%
controls:11.74%
cases:35.37%
controls:30.25%
524
4111
1123
12345
305
2072
1342
14384
49
249
1598
16207
38
7
1609
16449
110
255
1422
16146
256
1842
1132
13852
348
3584
636
8262
Inpatient Visit
IP [9201]
5.2e-01
7.7e-01
1.4e+00
—
3.2e+00
1.3e+00
6.6e-01
cases:12.14%
controls:7.57%
cases:7.10%
controls:3.42%
cases:1.76%
controls:0.44%
—
—
cases:10.84%
controls:0.51%
cases:10.16%
controls:2.94%
cases:17.89%
controls:10.09%
200
1245
1447
15211
117
562
1530
15894
29
73
1618
16383
—
166
83
1366
16318
141
462
1247
15232
176
1195
808
10651
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6.9e-01
9.1e-01
2.2e+00
—
2.7e+00
8.8e-01
5.1e-01
cases:16.45%
controls:9.00%
cases:9.53%
controls:4.06%
cases:4.43%
controls:0.53%
—
—
cases:6.98%
controls:0.51%
cases:9.65%
controls:4.26%
cases:19.72%
controls:12.84%
271
1481
1376
14975
157
668
1490
15788
73
88
1574
16368
—
107
84
1425
16317
134
668
1254
15026
194
1521
790
10325
Striking against or struck by other object(s)
W22 [45756260]
4.4e-01
2.0e+00
—
1.0e+50
2.5e+00
2.0e+00
1.3e+00
cases:0.79%
controls:0.51%
cases:0.85%
controls:0.12%
—
—
cases:0.79%
controls:0.00%
cases:0.46%
controls:0.04%
cases:0.79%
controls:0.11%
cases:2.13%
controls:0.60%
13
84
1634
16372
14
19
1633
16437
—
13
0
1634
16456
7
6
1525
16395
11
17
1377
15677
21
71
963
11775
Home Visit
OMOP4822459 [581476]
9.6e-01
1.0e+00
1.1e+00
8.6e-01
1.7e+00
1.5e+00
7.5e-01
cases:15.12%
controls:6.37%
cases:11.60%
controls:4.50%
cases:4.92%
controls:1.71%
cases:1.52%
controls:0.65%
cases:8.88%
controls:1.81%
cases:17.29%
controls:4.66%
cases:20.33%
controls:10.74%
249
1049
1398
15407
191
740
1456
15716
81
282
1566
16174
25
107
1622
16349
136
297
1396
16104
240
732
1148
14962
200
1272
784
10574
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.2e+00
1.5e+00
—
1.0e+50
3.0e+00
1.1e+00
9.7e-01
cases:3.28%
controls:0.99%
cases:1.58%
controls:0.35%
—
—
cases:1.40%
controls:0.00%
cases:0.85%
controls:0.04%
cases:1.51%
controls:0.52%
cases:4.67%
controls:1.82%
54
163
1593
16293
26
57
1621
16399
—
23
0
1624
16456
13
7
1519
16394
21
82
1367
15612
46
216
938
11630
Open wound of eyelid and periocular area
S01.1 [45602056]
1.3e+00
2.8e+00
1.0e+50
1.0e+50
—
2.8e+00
2.3e+00
cases:0.61%
controls:0.17%
cases:0.49%
controls:0.03%
cases:0.49%
controls:0.00%
cases:0.85%
controls:0.00%
—
—
cases:0.79%
controls:0.05%
cases:1.83%
controls:0.19%
10
28
1637
16428
8
5
1639
16451
8
0
1639
16456
14
0
1633
16456
—
11
8
1377
15686
18
23
966
11823
Alcohol dependence currently independent
F10.20 [2000501677]
2.6e+00
—
—
—
—
2.6e+00
2.6e+00
cases:1.15%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.04%
cases:1.63%
controls:0.13%
19
14
1628
16442
—
—
—
—
7
6
1381
15688
16
15
968
11831
clopidogrel; oral
B01AC04 [21600989]
9.6e-01
1.7e+00
1.1e+00
—
1.4e+00
1.5e+00
1.1e+00
cases:6.80%
controls:2.71%
cases:5.53%
controls:1.10%
cases:0.97%
controls:0.32%
—
—
cases:1.24%
controls:0.31%
cases:4.83%
controls:1.10%
cases:6.10%
controls:2.07%
112
446
1535
16010
91
181
1556
16275
16
53
1631
16403
—
19
51
1513
16350
67
173
1321
15521
60
245
924
11601
Pedal cyclist injured in other and unspecified transport accidents
V19 [45756225]
1.8e+00
2.6e+00
—
1.0e+50
1.0e+50
3.2e+00
—
cases:0.61%
controls:0.10%
cases:0.43%
controls:0.03%
—
—
cases:1.94%
controls:0.00%
cases:1.70%
controls:0.00%
cases:1.44%
controls:0.06%
—
—
10
16
1637
16440
7
5
1640
16451
—
32
0
1615
16456
26
0
1506
16401
20
9
1368
15685
—
CT angiography of head and neck vasculature
PA7AD [2001300233]
2.5e+00
2.4e+00
1.0e+50
1.0e+50
—
—
2.8e+00
cases:1.03%
controls:0.09%
cases:0.61%
controls:0.05%
cases:0.36%
controls:0.00%
cases:2.37%
controls:0.00%
—
—
—
—
cases:2.13%
controls:0.14%
17
14
1630
16442
10
9
1637
16447
6
0
1641
16456
39
0
1608
16456
—
—
21
16
963
11830
Social worker
Z2446 [2001311559]
1.5e+00
1.6e+00
—
1.0e+50
—
2.7e+00
1.9e+00
cases:1.82%
controls:0.43%
cases:0.67%
controls:0.14%
—
—
cases:0.85%
controls:0.00%
—
—
cases:1.08%
controls:0.07%
cases:1.52%
controls:0.23%
30
70
1617
16386
11
23
1636
16433
—
14
0
1633
16456
—
15
11
1373
15683
15
27
969
11819
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.1e+00
1.4e+00
—
—
2.6e+00
1.3e+00
1.4e+00
cases:2.98%
controls:1.03%
cases:0.91%
controls:0.23%
—
—
—
—
cases:0.39%
controls:0.03%
cases:0.94%
controls:0.27%
cases:3.46%
controls:0.86%
49
169
1598
16287
15
38
1632
16418
—
—
6
5
1526
16396
13
42
1375
15652
34
102
950
11744
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.6e-01
9.8e-01
2.0e+00
—
3.1e+00
1.0e+00
4.6e-01
cases:4.37%
controls:2.31%
cases:1.94%
controls:0.74%
cases:0.61%
controls:0.09%
—
—
cases:2.55%
controls:0.12%
cases:2.38%
controls:0.88%
cases:4.88%
controls:3.13%
72
380
1575
16076
32
122
1615
16334
10
14
1637
16442
—
39
20
1493
16381
33
138
1355
15556
48
371
936
11475
Bacterial infection, unspecified
A49.9 [45590816]
8.2e-01
-2.4e-01
2.6e+00
—
2.0e+00
1.5e+00
7.4e-01
cases:2.61%
controls:1.17%
cases:0.36%
controls:0.46%
cases:0.49%
controls:0.04%
—
—
cases:0.46%
controls:0.06%
cases:2.09%
controls:0.50%
cases:3.35%
controls:1.63%
43
192
1604
16264
6
76
1641
16380
8
6
1639
16450
—
7
10
1525
16391
29
78
1359
15616
33
193
951
11653
Monitoring the use of the aid
R5140 [2001310249]
2.0e+00
2.1e+00
—
—
—
1.4e+00
2.1e+00
cases:2.67%
controls:0.36%
cases:1.21%
controls:0.15%
—
—
—
—
—
—
cases:0.79%
controls:0.20%
cases:2.95%
controls:0.37%
44
59
1603
16397
20
24
1627
16432
—
—
—
11
32
1377
15662
29
44
955
11802
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
4.8e-01
7.4e-01
1.3e+00
—
2.5e+00
1.6e+00
1.1e+00
cases:8.93%
controls:5.73%
cases:3.52%
controls:1.71%
cases:0.97%
controls:0.27%
—
—
cases:3.66%
controls:0.32%
cases:6.84%
controls:1.51%
cases:11.48%
controls:4.34%
147
943
1500
15513
58
281
1589
16175
16
44
1631
16412
—
56
52
1476
16349
95
237
1293
15457
113
514
871
11332
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.7e-01
8.4e-01
1.5e+00
1.0e+50
2.8e+00
1.0e+00
7.3e-01
cases:4.49%
controls:2.35%
cases:2.25%
controls:0.98%
cases:0.67%
controls:0.15%
cases:0.36%
controls:0.00%
cases:2.28%
controls:0.14%
cases:2.67%
controls:0.99%
cases:5.49%
controls:2.72%
74
386
1573
16070
37
162
1610
16294
11
24
1636
16432
6
0
1641
16456
35
23
1497
16378
37
155
1351
15539
54
322
930
11524
magnesium hydroxide; oral
G04BX01 [21602658]
1.5e+00
1.4e+00
1.5e+00
—
1.7e+00
1.7e+00
1.2e+00
cases:2.00%
controls:0.45%
cases:1.21%
controls:0.30%
cases:0.36%
controls:0.08%
—
—
cases:0.59%
controls:0.11%
cases:2.09%
controls:0.38%
cases:2.13%
controls:0.62%
33
74
1614
16382
20
50
1627
16406
6
13
1641
16443
—
9
18
1523
16383
29
59
1359
15635
21
74
963
11772
magnesium hydroxide; oral
A02AA04 [21600052]
1.5e+00
1.4e+00
1.5e+00
—
1.7e+00
1.7e+00
1.2e+00
cases:2.00%
controls:0.45%
cases:1.21%
controls:0.30%
cases:0.36%
controls:0.08%
—
—
cases:0.59%
controls:0.11%
cases:2.09%
controls:0.38%
cases:2.13%
controls:0.62%
33
74
1614
16382
20
50
1627
16406
6
13
1641
16443
—
9
18
1523
16383
29
59
1359
15635
21
74
963
11772
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.0e-01
4.3e-01
1.2e+00
3.5e+00
2.0e+00
4.4e-01
2.0e-01
cases:7.16%
controls:5.43%
cases:4.98%
controls:3.30%
cases:1.46%
controls:0.45%
cases:0.97%
controls:0.03%
cases:3.26%
controls:0.44%
cases:5.26%
controls:3.46%
cases:12.70%
controls:10.69%
118
894
1529
15562
82
543
1565
15913
24
74
1623
16382
16
5
1631
16451
50
72
1482
16329
73
543
1315
15151
125
1266
859
10580
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
2.2e+00
2.4e+00
—
—
1.0e+50
—
2.9e+00
cases:0.85%
controls:0.10%
cases:0.49%
controls:0.04%
—
—
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.52%
controls:0.08%
14
16
1633
16440
8
7
1639
16449
—
—
19
0
1513
16401
—
15
10
969
11836
Polyneuropathy, unspecified
G62.9 [45566898]
2.2e+00
—
—
—
—
3.0e+00
2.3e+00
cases:0.73%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.04%
cases:1.02%
controls:0.10%
12
13
1635
16443
—
—
—
—
12
7
1376
15687
10
12
974
11834
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 [2000501573]
2.0e+00
1.6e+00
—
—
—
2.2e+00
1.7e+00
cases:0.79%
controls:0.11%
cases:0.55%
controls:0.11%
—
—
—
—
—
—
cases:0.72%
controls:0.08%
cases:1.63%
controls:0.30%
13
18
1634
16438
9
18
1638
16438
—
—
—
10
13
1378
15681
16
35
968
11811
Functional capacity evaluation
443351003 [40481051]
6.7e-01
8.2e-01
1.3e+00
—
2.1e+00
1.5e+00
9.9e-01
cases:5.04%
controls:2.64%
cases:2.49%
controls:1.11%
cases:1.09%
controls:0.29%
—
—
cases:2.42%
controls:0.29%
cases:5.04%
controls:1.19%
cases:7.62%
controls:2.96%
83
434
1564
16022
41
183
1606
16273
18
48
1629
16408
—
37
48
1495
16353
70
187
1318
15507
75
351
909
11495
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
2.2e+00
2.4e+00
—
—
1.0e+50
—
2.8e+00
cases:0.85%
controls:0.10%
cases:0.49%
controls:0.04%
—
—
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.52%
controls:0.09%
14
16
1633
16440
8
7
1639
16449
—
—
19
0
1513
16401
—
15
11
969
11835
pH of Venous blood
2746-6 [3012544]
8.4e-01
1.1e+00
1.7e+00
—
2.2e+00
9.1e-01
5.6e-01
cases:4.19%
controls:1.85%
cases:3.16%
controls:1.06%
cases:1.28%
controls:0.22%
—
—
cases:1.89%
controls:0.21%
cases:2.81%
controls:1.15%
cases:6.20%
controls:3.65%
69
304
1578
16152
52
174
1595
16282
21
37
1626
16419
—
29
35
1503
16366
39
180
1349
15514
61
432
923
11414
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.3e+00
2.0e+00
—
—
—
2.4e+00
1.8e+00
cases:1.03%
controls:0.30%
cases:0.85%
controls:0.12%
—
—
—
—
—
—
cases:0.86%
controls:0.08%
cases:1.73%
controls:0.29%
17
49
1630
16407
14
20
1633
16436
—
—
—
12
13
1376
15681
17
34
967
11812
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.1e-01
6.3e-01
2.1e+00
—
2.8e+00
8.9e-01
4.9e-01
cases:15.79%
controls:11.02%
cases:7.71%
controls:4.26%
cases:4.31%
controls:0.54%
—
—
cases:7.44%
controls:0.48%
cases:8.43%
controls:3.63%
cases:17.99%
controls:11.87%
260
1814
1387
14642
127
701
1520
15755
71
89
1576
16367
—
114
78
1418
16323
117
569
1271
15125
177
1406
807
10440
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
7.0e-01
8.0e-01
1.6e+00
—
2.5e+00
1.1e+00
6.7e-01
cases:5.22%
controls:2.66%
cases:2.31%
controls:1.05%
cases:0.67%
controls:0.13%
—
—
cases:0.85%
controls:0.07%
cases:2.67%
controls:0.91%
cases:5.49%
controls:2.90%
86
437
1561
16019
38
172
1609
16284
11
22
1636
16434
—
13
12
1519
16389
37
143
1351
15551
54
343
930
11503
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
9.9e-01
2.1e+00
—
—
—
2.5e+00
1.7e+00
cases:1.09%
controls:0.41%
cases:0.79%
controls:0.10%
—
—
—
—
—
—
cases:1.30%
controls:0.11%
cases:2.44%
controls:0.44%
18
67
1629
16389
13
16
1634
16440
—
—
—
18
17
1370
15677
24
52
960
11794
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
1.0e+00
1.3e+00
—
—
3.2e+00
1.7e+00
5.0e-01
cases:2.91%
controls:1.05%
cases:1.76%
controls:0.49%
—
—
—
—
cases:1.24%
controls:0.05%
cases:2.74%
controls:0.50%
cases:2.54%
controls:1.55%
48
172
1599
16284
29
80
1618
16376
—
—
19
8
1513
16393
38
78
1350
15616
25
184
959
11662
Limited function/disability NOS
A28 [2002000162]
8.8e-01
1.0e+00
1.2e+00
5.9e-01
2.0e+00
1.5e+00
8.2e-01
cases:6.80%
controls:2.94%
cases:5.22%
controls:1.94%
cases:2.31%
controls:0.74%
cases:0.43%
controls:0.24%
cases:5.09%
controls:0.74%
cases:8.86%
controls:2.19%
cases:10.47%
controls:4.91%
112
484
1535
15972
86
319
1561
16137
38
122
1609
16334
7
39
1640
16417
78
121
1454
16280
123
343
1265
15351
103
582
881
11264
Weakness/tiredness general
A04 [2002000145]
7.7e-01
1.2e+00
1.6e+00
—
1.6e+00
1.3e+00
8.1e-01
cases:3.76%
controls:1.78%
cases:2.73%
controls:0.84%
cases:0.73%
controls:0.15%
—
—
cases:0.91%
controls:0.18%
cases:2.95%
controls:0.82%
cases:5.59%
controls:2.56%
62
293
1585
16163
45
139
1602
16317
12
25
1635
16431
—
14
29
1518
16372
41
129
1347
15565
55
303
929
11543
Geriatric Psychiatry
27 [38004470]
1.7e+00
2.7e+00
—
—
—
2.9e+00
1.4e+00
cases:0.85%
controls:0.15%
cases:0.79%
controls:0.05%
—
—
—
—
—
—
cases:0.79%
controls:0.04%
cases:0.71%
controls:0.17%
14
25
1633
16431
13
9
1634
16447
—
—
—
11
7
1377
15687
7
20
977
11826
Speech therapy
R4130 [2001310235]
1.1e+00
2.0e+00
—
—
—
2.9e+00
2.3e+00
cases:0.30%
controls:0.10%
cases:0.36%
controls:0.05%
—
—
—
—
—
—
cases:0.94%
controls:0.05%
cases:1.12%
controls:0.11%
5
17
1642
16439
6
8
1641
16448
—
—
—
13
8
1375
15686
11
13
973
11833
Unspecified injury of head
S09.9 [45602140]
2.1e+00
2.6e+00
—
1.0e+50
1.0e+50
2.6e+00
—
cases:0.49%
controls:0.06%
cases:0.49%
controls:0.04%
—
—
cases:0.97%
controls:0.00%
cases:0.33%
controls:0.00%
cases:0.50%
controls:0.04%
—
—
8
10
1639
16446
8
6
1639
16450
—
16
0
1631
16456
5
0
1527
16401
7
6
1381
15688
—
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.0e+00
8.3e-01
—
—
3.1e+00
1.6e+00
7.5e-01
cases:3.34%
controls:1.25%
cases:1.40%
controls:0.61%
—
—
—
—
cases:1.31%
controls:0.06%
cases:2.45%
controls:0.51%
cases:3.46%
controls:1.66%
55
206
1592
16250
23
101
1624
16355
—
—
20
10
1512
16391
34
80
1354
15614
34
197
950
11649
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
2.0e+00
2.4e+00
—
—
1.0e+50
—
2.8e+00
cases:0.79%
controls:0.11%
cases:0.49%
controls:0.04%
—
—
—
—
cases:1.37%
controls:0.00%
—
—
cases:1.63%
controls:0.10%
13
18
1634
16438
8
7
1639
16449
—
—
21
0
1511
16401
—
16
12
968
11834
Pelvis X-ray examination
NE1AA [2001307792]
8.9e-01
6.8e-01
3.2e+00
—
—
2.1e+00
1.0e+00
cases:2.06%
controls:0.86%
cases:0.61%
controls:0.31%
cases:0.91%
controls:0.04%
—
—
—
—
cases:2.16%
controls:0.28%
cases:2.85%
controls:1.04%
34
141
1613
16315
10
51
1637
16405
15
6
1632
16450
—
—
30
44
1358
15650
28
123
956
11723
Bacteria identified in Urine by Culture
630-4 [3026008]
5.8e-01
7.8e-01
1.6e+00
—
2.6e+00
1.1e+00
6.0e-01
cases:11.84%
controls:6.99%
cases:7.71%
controls:3.70%
cases:2.85%
controls:0.60%
—
—
cases:7.25%
controls:0.59%
cases:10.37%
controls:3.78%
cases:17.89%
controls:10.67%
195
1150
1452
15306
127
609
1520
15847
47
99
1600
16357
—
111
96
1421
16305
144
594
1244
15100
176
1264
808
10582
Intravenous general anesthesia
WX404 [2001310807]
4.3e-01
3.3e-01
1.9e+00
1.0e+50
2.4e+00
1.4e+00
1.1e+00
cases:4.49%
controls:2.97%
cases:0.97%
controls:0.70%
cases:0.49%
controls:0.07%
cases:1.94%
controls:0.00%
cases:0.78%
controls:0.07%
cases:1.51%
controls:0.38%
cases:3.66%
controls:1.29%
74
489
1573
15967
16
115
1631
16341
8
12
1639
16444
32
0
1615
16456
12
12
1520
16389
21
59
1367
15635
36
153
948
11693
Neuropsychological investigation
XA800 [2001300412]
3.4e+00
—
—
1.0e+50
1.0e+50
—
3.8e+00
cases:1.03%
controls:0.04%
—
—
—
—
cases:0.49%
controls:0.00%
cases:1.57%
controls:0.00%
—
—
cases:3.66%
controls:0.08%
17
6
1630
16450
—
—
8
0
1639
16456
24
0
1508
16401
—
36
10
948
11836
Base excess in Venous blood by calculation
1927-3 [3002032]
8.6e-01
1.1e+00
1.7e+00
—
2.1e+00
8.8e-01
5.5e-01
cases:4.13%
controls:1.79%
cases:3.04%
controls:1.05%
cases:1.21%
controls:0.23%
—
—
cases:1.63%
controls:0.21%
cases:2.67%
controls:1.12%
cases:6.00%
controls:3.55%
68
295
1579
16161
50
173
1597
16283
20
38
1627
16418
—
25
34
1507
16367
37
176
1351
15518
59
420
925
11426
Bacteria [Presence] in Urine
87829-8 [36304419]
5.4e-01
7.7e-01
1.4e+00
—
2.6e+00
1.1e+00
7.4e-01
cases:11.23%
controls:6.89%
cases:7.23%
controls:3.49%
cases:2.19%
controls:0.53%
—
—
cases:6.40%
controls:0.51%
cases:9.65%
controls:3.55%
cases:17.68%
controls:9.31%
185
1134
1462
15322
119
574
1528
15882
36
88
1611
16368
—
98
84
1434
16317
134
557
1254
15137
174
1103
810
10743
Hand and fingers X-ray examination
ND2AA [2001307607]
7.3e-01
1.1e+00
—
—
2.7e+00
1.4e+00
1.2e+00
cases:2.13%
controls:1.04%
cases:0.91%
controls:0.30%
—
—
—
—
cases:0.46%
controls:0.03%
cases:0.94%
controls:0.24%
cases:2.74%
controls:0.84%
35
171
1612
16285
15
50
1632
16406
—
—
7
5
1525
16396
13
38
1375
15656
27
99
957
11747
Bacteria identified in Isolate by Culture
43409-2 [3042936]
5.7e-01
6.0e-01
1.6e+00
—
3.2e+00
1.2e+00
6.3e-01
cases:5.22%
controls:3.03%
cases:2.06%
controls:1.15%
cases:0.55%
controls:0.12%
—
—
cases:2.81%
controls:0.12%
cases:3.10%
controls:0.97%
cases:6.71%
controls:3.70%
86
499
1561
15957
34
189
1613
16267
9
19
1638
16437
—
43
20
1489
16381
43
152
1345
15542
66
438
918
11408
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
1.8e+00
2.9e+00
—
—
—
2.4e+00
—
cases:0.61%
controls:0.10%
cases:0.55%
controls:0.03%
—
—
—
—
—
—
cases:0.43%
controls:0.04%
—
—
10
17
1637
16439
9
5
1638
16451
—
—
—
6
6
1382
15688
—
General Surgery
2 [38004447]
4.3e-01
7.3e-01
2.1e+00
—
2.4e+00
9.2e-01
5.1e-01
cases:19.79%
controls:13.88%
cases:8.20%
controls:4.14%
cases:4.37%
controls:0.55%
—
—
cases:5.09%
controls:0.50%
cases:9.15%
controls:3.85%
cases:16.36%
controls:10.51%
326
2284
1321
14172
135
681
1512
15775
72
91
1575
16365
—
78
82
1454
16319
127
604
1261
15090
161
1245
823
10601
Fracture of lower end of radius
S52.5 [45573842]
5.4e-01
6.3e-01
2.5e+00
1.0e+50
3.1e+00
1.4e+00
5.9e-01
cases:1.64%
controls:0.97%
cases:0.55%
controls:0.29%
cases:0.36%
controls:0.03%
cases:0.97%
controls:0.00%
cases:0.98%
controls:0.04%
cases:1.15%
controls:0.28%
cases:2.03%
controls:1.14%
27
159
1620
16297
9
48
1638
16408
6
5
1641
16451
16
0
1631
16456
15
7
1517
16394
16
44
1372
15650
20
135
964
11711
Multiple fractures of ribs
S22.4 [45582958]
1.7e+00
1.9e+00
1.0e+50
1.0e+50
—
3.6e+00
1.7e+00
cases:1.09%
controls:0.19%
cases:0.36%
controls:0.05%
cases:0.61%
controls:0.00%
cases:3.10%
controls:0.00%
—
—
cases:2.09%
controls:0.06%
cases:1.63%
controls:0.30%
18
32
1629
16424
6
9
1641
16447
10
0
1637
16456
51
0
1596
16456
—
29
9
1359
15685
16
36
968
11810
escitalopram; oral
N06AB10 [21604718]
1.0e+00
1.1e+00
1.7e+00
—
9.9e-01
1.6e+00
1.5e+00
cases:5.89%
controls:2.19%
cases:3.70%
controls:1.22%
cases:1.58%
controls:0.29%
—
—
cases:0.85%
controls:0.32%
cases:5.98%
controls:1.22%
cases:8.94%
controls:2.11%
97
361
1550
16095
61
200
1586
16256
26
48
1621
16408
—
13
52
1519
16349
83
192
1305
15502
88
250
896
11596
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
7.6e-01
1.3e+00
2.6e+00
—
—
1.3e+00
1.1e+00
cases:2.25%
controls:1.06%
cases:1.76%
controls:0.49%
cases:0.55%
controls:0.04%
—
—
—
—
cases:1.59%
controls:0.46%
cases:4.47%
controls:1.51%
37
175
1610
16281
29
80
1618
16376
9
7
1638
16449
—
—
22
72
1366
15622
44
179
940
11667
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
9.0e-01
9.7e-01
1.3e+00
8.2e-01
1.4e+00
1.5e+00
8.4e-01
cases:5.83%
controls:2.45%
cases:3.04%
controls:1.17%
cases:1.64%
controls:0.44%
cases:0.43%
controls:0.19%
cases:2.02%
controls:0.51%
cases:5.69%
controls:1.28%
cases:6.40%
controls:2.86%
96
403
1551
16053
50
193
1597
16263
27
72
1620
16384
7
31
1640
16425
31
84
1501
16317
79
201
1309
15493
63
339
921
11507
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.5e-01
7.6e-01
1.4e+00
1.0e+50
2.7e+00
1.1e+00
5.1e-01
cases:12.20%
controls:7.45%
cases:6.44%
controls:3.13%
cases:1.82%
controls:0.45%
cases:0.91%
controls:0.00%
cases:6.07%
controls:0.45%
cases:8.79%
controls:3.24%
cases:15.45%
controls:9.89%
201
1226
1446
15230
106
515
1541
15941
30
74
1617
16382
15
0
1632
16456
93
73
1439
16328
122
509
1266
15185
152
1171
832
10675
macrogol; oral
A06AD15 [21600575]
9.5e-01
1.0e+00
—
—
2.0e+00
1.9e+00
1.1e+00
cases:2.91%
controls:1.15%
cases:1.58%
controls:0.59%
—
—
—
—
cases:0.65%
controls:0.09%
cases:4.47%
controls:0.72%
cases:5.49%
controls:1.90%
48
189
1599
16267
26
97
1621
16359
—
—
10
14
1522
16387
62
113
1326
15581
54
225
930
11621
Nursing episode
950 [44777714]
9.0e-01
1.2e+00
1.3e+00
1.4e+00
1.3e+00
1.4e+00
7.7e-01
cases:5.34%
controls:2.24%
cases:4.43%
controls:1.34%
cases:2.00%
controls:0.56%
cases:0.49%
controls:0.12%
cases:2.22%
controls:0.59%
cases:6.05%
controls:1.55%
cases:7.42%
controls:3.58%
88
368
1559
16088
73
221
1574
16235
33
92
1614
16364
8
20
1639
16436
34
96
1498
16305
84
244
1304
15450
73
424
911
11422
Short blood count panel - Blood
55429-5 [40758558]
3.6e-01
4.3e-01
6.6e-01
3.2e+00
1.9e+00
6.0e-01
4.5e-01
cases:9.47%
controls:6.81%
cases:5.65%
controls:3.76%
cases:1.70%
controls:0.89%
cases:1.28%
controls:0.05%
cases:4.77%
controls:0.73%
cases:6.84%
controls:3.86%
cases:13.31%
controls:8.89%
156
1121
1491
15335
93
619
1554
15837
28
146
1619
16310
21
9
1626
16447
73
119
1459
16282
95
606
1293
15088
131
1053
853
10793
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.9e+00
1.6e+00
—
1.0e+50
—
2.1e+00
1.4e+00
cases:0.79%
controls:0.12%
cases:0.67%
controls:0.13%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.65%
controls:0.08%
cases:1.73%
controls:0.45%
13
20
1634
16436
11
22
1636
16434
—
6
0
1641
16456
—
9
13
1379
15681
17
53
967
11793
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
1.7e+00
1.7e+00
—
—
—
2.2e+00
1.4e+00
cases:3.52%
controls:0.65%
cases:1.46%
controls:0.28%
—
—
—
—
—
—
cases:2.74%
controls:0.32%
cases:3.56%
controls:0.92%
58
107
1589
16349
24
46
1623
16410
—
—
—
38
51
1350
15643
35
109
949
11737
risperidone; oral, parenteral
N05AX08 [21604559]
1.2e+00
1.3e+00
1.4e+00
—
1.0e+00
1.5e+00
1.5e+00
cases:2.49%
controls:0.78%
cases:2.25%
controls:0.60%
cases:1.09%
controls:0.28%
—
—
cases:0.72%
controls:0.26%
cases:2.88%
controls:0.63%
cases:4.07%
controls:0.95%
41
129
1606
16327
37
99
1610
16357
18
46
1629
16410
—
11
43
1521
16358
40
99
1348
15595
40
112
944
11734
Limited function/disability (L)
L28 [2002000647]
7.8e-01
1.2e+00
1.1e+00
—
2.4e+00
1.6e+00
8.9e-01
cases:5.83%
controls:2.77%
cases:4.13%
controls:1.30%
cases:0.61%
controls:0.21%
—
—
cases:2.55%
controls:0.23%
cases:6.56%
controls:1.36%
cases:9.86%
controls:4.31%
96
456
1551
16000
68
214
1579
16242
10
34
1637
16422
—
39
38
1493
16363
91
213
1297
15481
97
510
887
11336
Treatment of a patient needing special arrangements
WYA30 [2001310874]
1.2e+00
1.4e+00
—
—
—
2.6e+00
1.7e+00
cases:2.31%
controls:0.68%
cases:0.79%
controls:0.19%
—
—
—
—
—
—
cases:2.02%
controls:0.16%
cases:3.86%
controls:0.73%
38
112
1609
16344
13
32
1634
16424
—
—
—
28
25
1360
15669
38
87
946
11759
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
4.7e-01
8.7e-01
1.8e+00
—
2.4e+00
9.9e-01
8.3e-01
cases:3.58%
controls:2.26%
cases:1.88%
controls:0.80%
cases:0.55%
controls:0.09%
—
—
cases:0.65%
controls:0.06%
cases:1.80%
controls:0.68%
cases:5.18%
controls:2.33%
59
372
1588
16084
31
131
1616
16325
9
15
1638
16441
—
10
10
1522
16391
25
106
1363
15588
51
276
933
11570
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.3e-01
9.3e-01
1.5e+00
—
2.1e+00
1.1e+00
5.9e-01
cases:11.48%
controls:6.45%
cases:6.19%
controls:2.53%
cases:1.46%
controls:0.32%
—
—
cases:2.48%
controls:0.31%
cases:7.20%
controls:2.61%
cases:14.53%
controls:8.59%
189
1062
1458
15394
102
416
1545
16040
24
52
1623
16404
—
38
51
1494
16350
100
409
1288
15285
143
1018
841
10828
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
7.1e-01
8.3e-01
1.1e+00
—
2.3e+00
1.1e+00
9.1e-01
cases:11.72%
controls:6.15%
cases:4.86%
controls:2.17%
cases:0.97%
controls:0.33%
—
—
cases:2.74%
controls:0.29%
cases:5.04%
controls:1.80%
cases:11.89%
controls:5.13%
193
1012
1454
15444
80
357
1567
16099
16
55
1631
16401
—
42
48
1490
16353
70
283
1318
15411
117
608
867
11238
Outpatient Visit
OP [9202]
5.7e-01
3.3e-01
4.5e-01
2.9e+00
1.1e+00
9.2e-01
5.4e-01
cases:84.94%
controls:76.18%
cases:65.03%
controls:57.15%
cases:15.97%
controls:10.80%
cases:9.05%
controls:0.53%
cases:26.96%
controls:10.78%
cases:75.43%
controls:54.96%
cases:88.21%
controls:81.28%
1399
12537
248
3919
1071
9405
576
7051
263
1778
1384
14678
149
88
1498
16368
413
1768
1119
14633
1047
8626
341
7068
868
9629
116
2217
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.3e+00
1.3e+00
—
—
2.2e+00
1.9e+00
1.4e+00
cases:1.15%
controls:0.32%
cases:0.55%
controls:0.15%
—
—
—
—
cases:0.39%
controls:0.04%
cases:1.15%
controls:0.17%
cases:1.52%
controls:0.37%
19
53
1628
16403
9
25
1638
16431
—
—
6
7
1526
16394
16
27
1372
15667
15
44
969
11802
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
7.4e-01
1.3e+00
1.5e+00
—
2.0e+00
9.1e-01
4.6e-01
cases:6.19%
controls:3.05%
cases:5.10%
controls:1.51%
cases:0.97%
controls:0.22%
—
—
cases:1.37%
controls:0.20%
cases:4.54%
controls:1.89%
cases:7.32%
controls:4.76%
102
502
1545
15954
84
248
1563
16208
16
36
1631
16420
—
21
32
1511
16369
63
296
1325
15398
72
564
912
11282
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.7e+00
2.5e+00
—
—
—
2.7e+00
1.3e+00
cases:0.73%
controls:0.13%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.72%
controls:0.05%
cases:0.51%
controls:0.14%
12
22
1635
16434
7
6
1640
16450
—
—
—
10
8
1378
15686
5
16
979
11830
pH of Serum or Plasma
2753-2 [3018418]
8.2e-01
8.1e-01
1.1e+00
—
2.2e+00
1.2e+00
7.1e-01
cases:14.75%
controls:7.09%
cases:8.62%
controls:4.04%
cases:2.19%
controls:0.76%
—
—
cases:5.68%
controls:0.66%
cases:11.82%
controls:3.85%
cases:18.70%
controls:10.14%
243
1167
1404
15289
142
664
1505
15792
36
125
1611
16331
—
87
109
1445
16292
164
605
1224
15089
184
1201
800
10645
Chronic viral hepatitis C
B18.2 [45590846]
1.9e+00
1.8e+00
—
—
—
2.1e+00
2.8e+00
cases:0.43%
controls:0.07%
cases:0.30%
controls:0.05%
—
—
—
—
—
—
cases:0.43%
controls:0.05%
cases:1.12%
controls:0.07%
7
11
1640
16445
5
8
1642
16448
—
—
—
6
8
1382
15686
11
8
973
11838
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
9.1e-01
1.1e+00
1.9e+00
—
2.0e+00
9.2e-01
3.8e-01
cases:3.46%
controls:1.42%
cases:2.37%
controls:0.78%
cases:1.09%
controls:0.17%
—
—
cases:1.24%
controls:0.18%
cases:2.16%
controls:0.87%
cases:4.47%
controls:3.11%
57
233
1590
16223
39
129
1608
16327
18
28
1629
16428
—
19
29
1513
16372
30
137
1358
15557
44
369
940
11477
potassium chloride; oral
A12BA01 [21600877]
8.1e-01
8.9e-01
1.4e+00
—
1.7e+00
1.2e+00
7.9e-01
cases:4.80%
controls:2.19%
cases:2.98%
controls:1.24%
cases:1.15%
controls:0.29%
—
—
cases:1.63%
controls:0.31%
cases:4.68%
controls:1.42%
cases:6.71%
controls:3.16%
79
361
1568
16095
49
204
1598
16252
19
48
1628
16408
—
25
51
1507
16350
65
223
1323
15471
66
374
918
11472
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.1e+00
1.3e+00
1.3e+00
—
1.4e+00
1.5e+00
1.5e+00
cases:4.92%
controls:1.73%
cases:2.73%
controls:0.75%
cases:0.67%
controls:0.19%
—
—
cases:0.98%
controls:0.24%
cases:3.10%
controls:0.71%
cases:5.39%
controls:1.29%
81
285
1566
16171
45
123
1602
16333
11
31
1636
16425
—
15
40
1517
16361
43
111
1345
15583
53
153
931
11693
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.9e+00
2.4e+00
—
—
1.0e+50
—
2.4e+00
cases:0.79%
controls:0.12%
cases:0.49%
controls:0.04%
—
—
—
—
cases:1.04%
controls:0.00%
—
—
cases:1.32%
controls:0.12%
13
20
1634
16436
8
7
1639
16449
—
—
16
0
1516
16401
—
13
14
971
11832
vortioxetine; oral
N06AX26 [44819158]
1.0e+00
1.3e+00
1.6e+00
—
1.5e+00
1.5e+00
1.3e+00
cases:1.40%
controls:0.50%
cases:1.15%
controls:0.33%
cases:0.67%
controls:0.14%
—
—
cases:0.46%
controls:0.10%
cases:1.51%
controls:0.33%
cases:2.54%
controls:0.69%
23
82
1624
16374
19
54
1628
16402
11
23
1636
16433
—
7
16
1525
16385
21
52
1367
15642
25
82
959
11764
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.4e-01
5.9e-01
6.5e-01
2.3e+00
1.6e+00
4.9e-01
5.0e-01
cases:19.19%
controls:12.12%
cases:12.14%
controls:7.09%
cases:2.73%
controls:1.45%
cases:0.49%
controls:0.05%
cases:6.72%
controls:1.43%
cases:11.46%
controls:7.35%
cases:22.97%
controls:15.35%
316
1994
1331
14462
200
1167
1447
15289
45
239
1602
16217
8
8
1639
16448
103
235
1429
16166
159
1153
1229
14541
226
1818
758
10028
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.9e+00
2.4e+00
—
—
1.0e+50
—
2.4e+00
cases:0.85%
controls:0.13%
cases:0.49%
controls:0.04%
—
—
—
—
cases:1.17%
controls:0.00%
—
—
cases:1.42%
controls:0.14%
14
22
1633
16434
8
7
1639
16449
—
—
18
0
1514
16401
—
14
16
970
11830
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
4.9e-01
1.1e+00
1.6e+00
—
2.3e+00
9.4e-01
7.0e-01
cases:2.67%
controls:1.66%
cases:1.82%
controls:0.59%
cases:0.61%
controls:0.13%
—
—
cases:0.85%
controls:0.09%
cases:1.73%
controls:0.68%
cases:3.46%
controls:1.74%
44
273
1603
16183
30
97
1617
16359
10
21
1637
16435
—
13
14
1519
16387
24
107
1364
15587
34
206
950
11640
venlafaxine; oral
N06AX16 [21604745]
1.1e+00
1.5e+00
1.2e+00
—
8.4e-01
1.5e+00
1.5e+00
cases:3.40%
controls:1.22%
cases:3.16%
controls:0.70%
cases:0.85%
controls:0.27%
—
—
cases:0.52%
controls:0.23%
cases:3.10%
controls:0.74%
cases:4.98%
controls:1.21%
56
200
1591
16256
52
116
1595
16340
14
44
1633
16412
—
8
37
1524
16364
43
116
1345
15578
49
143
935
11703
citalopram; oral, parenteral
N06AB04 [21604712]
1.1e+00
1.3e+00
8.9e-01
—
1.5e+00
1.4e+00
1.4e+00
cases:4.86%
controls:1.71%
cases:3.58%
controls:1.03%
cases:0.61%
controls:0.25%
—
—
cases:0.98%
controls:0.22%
cases:3.89%
controls:0.99%
cases:6.10%
controls:1.60%
80
281
1567
16175
59
169
1588
16287
10
41
1637
16415
—
15
36
1517
16365
54
155
1334
15539
60
189
924
11657
gabapentin; oral
N02BF01 [955005]
7.8e-01
9.8e-01
1.2e+00
—
1.4e+00
1.2e+00
1.1e+00
cases:3.46%
controls:1.62%
cases:2.55%
controls:0.97%
cases:0.79%
controls:0.24%
—
—
cases:0.85%
controls:0.22%
cases:3.46%
controls:1.07%
cases:7.52%
controls:2.59%
57
266
1590
16190
42
160
1605
16296
13
39
1634
16417
—
13
36
1519
16365
48
168
1340
15526
74
307
910
11539
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
5.1e-01
6.8e-01
1.3e+00
—
2.5e+00
1.0e+00
6.4e-01
cases:11.35%
controls:7.16%
cases:7.35%
controls:3.86%
cases:2.25%
controls:0.63%
—
—
cases:6.46%
controls:0.55%
cases:9.80%
controls:3.81%
cases:17.99%
controls:10.33%
187
1178
1460
15278
121
635
1526
15821
37
104
1610
16352
—
99
91
1433
16310
136
598
1252
15096
177
1224
807
10622
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.1e+00
2.2e+00
—
—
—
3.0e+00
1.4e+00
cases:0.67%
controls:0.22%
cases:0.49%
controls:0.05%
—
—
—
—
—
—
cases:1.30%
controls:0.06%
cases:1.42%
controls:0.35%
11
37
1636
16419
8
9
1639
16447
—
—
—
18
10
1370
15684
14
41
970
11805
Osmolality of Urine
2695-5 [3026782]
5.4e-01
6.0e-01
1.1e+00
—
2.7e+00
1.0e+00
6.4e-01
cases:9.29%
controls:5.61%
cases:4.31%
controls:2.41%
cases:1.28%
controls:0.44%
—
—
cases:4.70%
controls:0.32%
cases:5.98%
controls:2.19%
cases:10.26%
controls:5.70%
153
923
1494
15533
71
396
1576
16060
21
72
1626
16384
—
72
53
1460
16348
83
343
1305
15351
101
675
883
11171
Unspecified privation
X57 [45756410]
2.2e+00
—
—
1.0e+50
—
2.4e+00
2.0e+00
cases:0.79%
controls:0.09%
—
—
—
—
cases:0.55%
controls:0.00%
—
—
cases:0.36%
controls:0.03%
cases:1.02%
controls:0.14%
13
14
1634
16442
—
—
9
0
1638
16456
—
5
5
1383
15689
10
17
974
11829
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
3.6e+00
—
—
1.0e+50
—
—
3.0e+00
cases:1.70%
controls:0.05%
—
—
—
—
cases:0.30%
controls:0.00%
—
—
—
—
cases:1.22%
controls:0.06%
28
8
1619
16448
—
—
5
0
1642
16456
—
—
12
7
972
11839
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
8.6e-01
1.1e+00
1.7e+00
—
2.0e+00
8.7e-01
4.8e-01
cases:4.13%
controls:1.79%
cases:3.10%
controls:1.03%
cases:1.28%
controls:0.23%
—
—
cases:1.70%
controls:0.23%
cases:2.74%
controls:1.17%
cases:5.79%
controls:3.66%
68
295
1579
16161
51
170
1596
16286
21
38
1626
16418
—
26
37
1506
16364
38
183
1350
15511
57
434
927
11412
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.4e-01
5.7e-01
6.2e-01
2.4e+00
1.6e+00
4.4e-01
4.2e-01
cases:19.19%
controls:12.15%
cases:11.84%
controls:7.09%
cases:2.61%
controls:1.42%
cases:0.49%
controls:0.04%
cases:6.53%
controls:1.45%
cases:11.17%
controls:7.46%
cases:22.36%
controls:15.86%
316
2000
1331
14456
195
1166
1452
15290
43
234
1604
16222
8
7
1639
16449
100
237
1432
16164
155
1171
1233
14523
220
1879
764
9967
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
4.5e-01
1.3e+00
—
1.0e+50
3.0e+00
2.0e+00
1.6e+00
cases:0.61%
controls:0.39%
cases:0.67%
controls:0.19%
—
—
cases:1.64%
controls:0.00%
cases:0.59%
controls:0.03%
cases:0.94%
controls:0.13%
cases:1.83%
controls:0.37%
10
64
1637
16392
11
31
1636
16425
—
27
0
1620
16456
9
5
1523
16396
13
20
1375
15674
18
44
966
11802
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.6e+00
1.6e+00
—
—
—
2.0e+00
1.4e+00
cases:1.52%
controls:0.31%
cases:0.73%
controls:0.15%
—
—
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.52%
controls:0.40%
25
51
1622
16405
12
25
1635
16431
—
—
—
8
12
1380
15682
15
47
969
11799
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.9e-01
6.0e-01
6.6e-01
2.3e+00
1.5e+00
4.9e-01
4.8e-01
cases:19.19%
controls:12.65%
cases:12.81%
controls:7.47%
cases:2.85%
controls:1.49%
cases:0.43%
controls:0.04%
cases:6.46%
controls:1.49%
cases:12.25%
controls:7.85%
cases:24.59%
controls:16.86%
316
2081
1331
14375
211
1229
1436
15227
47
246
1600
16210
7
7
1640
16449
99
245
1433
16156
170
1232
1218
14462
242
1997
742
9849
Basophils [#/volume] in Blood
26444-0 [3006315]
4.9e-01
6.0e-01
6.6e-01
2.3e+00
1.5e+00
4.9e-01
4.7e-01
cases:19.19%
controls:12.71%
cases:12.81%
controls:7.47%
cases:2.85%
controls:1.50%
cases:0.43%
controls:0.04%
cases:6.46%
controls:1.50%
cases:12.25%
controls:7.88%
cases:24.59%
controls:16.91%
316
2091
1331
14365
211
1230
1436
15226
47
247
1600
16209
7
7
1640
16449
99
246
1433
16155
170
1236
1218
14458
242
2003
742
9843
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
5.5e-01
8.6e-01
1.4e+00
—
2.5e+00
8.2e-01
4.6e-01
cases:6.38%
controls:3.80%
cases:5.04%
controls:2.19%
cases:1.40%
controls:0.36%
—
—
cases:4.05%
controls:0.35%
cases:5.04%
controls:2.27%
cases:9.76%
controls:6.40%
105
625
1542
15831
83
361
1564
16095
23
60
1624
16396
—
62
58
1470
16343
70
357
1318
15337
96
758
888
11088
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.3e-01
4.2e-01
6.0e-01
3.2e+00
1.6e+00
4.1e-01
2.2e-01
cases:50.09%
controls:44.40%
cases:42.14%
controls:32.39%
cases:10.20%
controls:5.85%
cases:5.16%
controls:0.21%
cases:22.32%
controls:5.47%
cases:43.66%
controls:33.95%
cases:65.14%
controls:60.05%
825
7307
822
9149
694
5330
953
11126
168
962
1479
15494
85
35
1562
16421
342
897
1190
15504
606
5328
782
10366
641
7114
343
4732
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.8e-01
5.9e-01
7.0e-01
2.3e+00
1.5e+00
4.6e-01
4.6e-01
cases:19.85%
controls:13.24%
cases:13.05%
controls:7.71%
cases:3.10%
controls:1.56%
cases:0.43%
controls:0.04%
cases:6.66%
controls:1.56%
cases:12.25%
controls:8.11%
cases:24.90%
controls:17.35%
327
2178
1320
14278
215
1268
1432
15188
51
257
1596
16199
7
7
1640
16449
102
256
1430
16145
170
1273
1218
14421
245
2055
739
9791
ECG with 12 standard connections
XF400 [2001303368]
1.0e+00
1.2e+00
—
1.0e+50
2.0e+00
1.2e+00
1.1e+00
cases:4.68%
controls:1.70%
cases:1.76%
controls:0.55%
—
—
cases:1.34%
controls:0.00%
cases:0.39%
controls:0.05%
cases:1.30%
controls:0.40%
cases:3.35%
controls:1.12%
77
280
1570
16176
29
90
1618
16366
—
22
0
1625
16456
6
9
1526
16392
18
63
1370
15631
33
133
951
11713
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
5.5e-01
7.2e-01
1.8e+00
1.0e+50
2.7e+00
7.0e-01
4.0e-01
cases:6.98%
controls:4.16%
cases:2.67%
controls:1.32%
cases:0.73%
controls:0.12%
cases:0.43%
controls:0.00%
cases:1.83%
controls:0.13%
cases:2.52%
controls:1.27%
cases:7.42%
controls:5.11%
115
684
1532
15772
44
218
1603
16238
12
19
1635
16437
7
0
1640
16456
28
21
1504
16380
35
199
1353
15495
73
605
911
11241
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
6.6e-01
9.0e-01
1.2e+00
—
2.1e+00
9.8e-01
5.7e-01
cases:10.87%
controls:5.94%
cases:6.50%
controls:2.74%
cases:1.15%
controls:0.34%
—
—
cases:2.81%
controls:0.34%
cases:7.56%
controls:2.98%
cases:13.82%
controls:8.35%
179
978
1468
15478
107
451
1540
16005
19
56
1628
16400
—
43
55
1489
16346
105
467
1283
15227
136
989
848
10857
Cervical spine X-ray examination without contrast
NA1AA [2001306981]
1.7e+00
1.5e+00
—
1.0e+50
1.0e+50
2.8e+00
2.0e+00
cases:0.91%
controls:0.17%
cases:0.43%
controls:0.09%
—
—
cases:1.09%
controls:0.00%
cases:0.65%
controls:0.00%
cases:1.08%
controls:0.06%
cases:0.71%
controls:0.10%
15
28
1632
16428
7
15
1640
16441
—
18
0
1629
16456
10
0
1522
16401
15
10
1373
15684
7
12
977
11834
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.7e-01
7.7e-01
1.2e+00
—
2.5e+00
9.7e-01
5.9e-01
cases:23.13%
controls:15.84%
cases:13.72%
controls:6.84%
cases:2.61%
controls:0.81%
—
—
cases:8.16%
controls:0.74%
cases:16.71%
controls:7.09%
cases:32.42%
controls:21.08%
381
2607
1266
13849
226
1126
1421
15330
43
133
1604
16323
—
125
121
1407
16280
232
1113
1156
14581
319
2497
665
9349
Physical Medicine And Rehabilitation
25 [38004468]
5.7e-01
9.4e-01
—
—
2.2e+00
1.7e+00
1.1e+00
cases:8.14%
controls:4.79%
cases:3.52%
controls:1.41%
—
—
—
—
cases:1.76%
controls:0.20%
cases:6.70%
controls:1.36%
cases:12.09%
controls:4.41%
134
788
1513
15668
58
232
1589
16224
—
—
27
32
1505
16369
93
213
1295
15481
119
522
865
11324
olanzapine; oral, parenteral
N05AH03 [21604543]
1.0e+00
1.3e+00
1.3e+00
—
8.4e-01
1.4e+00
1.4e+00
cases:1.82%
controls:0.66%
cases:1.94%
controls:0.52%
cases:0.79%
controls:0.22%
—
—
cases:0.52%
controls:0.23%
cases:2.38%
controls:0.59%
cases:3.05%
controls:0.79%
30
109
1617
16347
32
85
1615
16371
13
36
1634
16420
—
8
37
1524
16364
33
92
1355
15602
30
93
954
11753
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
7.1e-01
1.1e+00
1.4e+00
—
1.9e+00
8.7e-01
4.5e-01
cases:6.74%
controls:3.42%
cases:5.16%
controls:1.70%
cases:0.91%
controls:0.23%
—
—
cases:1.50%
controls:0.23%
cases:4.83%
controls:2.07%
cases:8.33%
controls:5.47%
111
563
1536
15893
85
279
1562
16177
15
38
1632
16418
—
23
38
1509
16363
67
325
1321
15369
82
648
902
11198
clonazepam; oral, parenteral
N03AE01 [21604415]
1.7e+00
1.8e+00
1.5e+00
—
1.6e+00
1.4e+00
1.5e+00
cases:1.94%
controls:0.35%
cases:1.34%
controls:0.21%
cases:0.30%
controls:0.07%
—
—
cases:0.33%
controls:0.07%
cases:0.79%
controls:0.20%
cases:1.32%
controls:0.31%
32
57
1615
16399
22
35
1625
16421
5
11
1642
16445
—
5
11
1527
16390
11
32
1377
15662
13
37
971
11809
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.5e-01
6.0e-01
6.4e-01
2.1e+00
1.6e+00
4.7e-01
5.0e-01
cases:19.31%
controls:12.15%
cases:12.14%
controls:7.07%
cases:2.73%
controls:1.46%
cases:0.43%
controls:0.05%
cases:6.72%
controls:1.44%
cases:11.31%
controls:7.38%
cases:22.97%
controls:15.36%
318
1999
1329
14457
200
1164
1447
15292
45
240
1602
16216
7
9
1640
16447
103
236
1429
16165
157
1159
1231
14535
226
1820
758
10026
Microorganisms panel - Urine sediment
58435-9 [40761536]
6.2e-01
8.4e-01
1.2e+00
1.0e+50
2.7e+00
1.2e+00
1.0e+00
cases:4.13%
controls:2.26%
cases:2.49%
controls:1.09%
cases:0.49%
controls:0.15%
cases:0.67%
controls:0.00%
cases:2.22%
controls:0.16%
cases:3.46%
controls:1.03%
cases:5.79%
controls:2.11%
68
372
1579
16084
41
180
1606
16276
8
24
1639
16432
11
0
1636
16456
34
26
1498
16375
48
162
1340
15532
57
250
927
11596
Pneumonia, unspecified
J18.9 [45601123]
6.6e-01
5.6e-01
1.5e+00
—
2.3e+00
8.0e-01
5.7e-01
cases:6.56%
controls:3.49%
cases:2.67%
controls:1.55%
cases:1.03%
controls:0.24%
—
—
cases:2.68%
controls:0.26%
cases:3.67%
controls:1.68%
cases:9.04%
controls:5.30%
108
575
1539
15881
44
255
1603
16201
17
40
1630
16416
—
41
43
1491
16358
51
264
1337
15430
89
628
895
11218
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.5e-01
6.0e-01
6.5e-01
2.1e+00
1.6e+00
4.6e-01
4.8e-01
cases:19.19%
controls:12.03%
cases:12.14%
controls:7.07%
cases:2.73%
controls:1.44%
cases:0.43%
controls:0.05%
cases:6.72%
controls:1.44%
cases:11.17%
controls:7.38%
cases:22.87%
controls:15.46%
316
1980
1331
14476
200
1163
1447
15293
45
237
1602
16219
7
9
1640
16447
103
236
1429
16165
155
1159
1233
14535
225
1831
759
10015
Disorientation, unspecified
R41.0 [45558469]
1.7e+00
2.2e+00
—
—
—
2.4e+00
7.9e-01
cases:1.03%
controls:0.18%
cases:0.61%
controls:0.07%
—
—
—
—
—
—
cases:0.86%
controls:0.08%
cases:0.61%
controls:0.28%
17
30
1630
16426
10
11
1637
16445
—
—
—
12
12
1376
15682
6
33
978
11813
Diplopia
H53.2 [45576792]
1.3e+00
2.0e+00
—
—
—
2.4e+00
1.9e+00
cases:0.49%
controls:0.13%
cases:0.36%
controls:0.05%
—
—
—
—
—
—
cases:0.79%
controls:0.07%
cases:0.81%
controls:0.12%
8
22
1639
16434
6
8
1641
16448
—
—
—
11
11
1377
15683
8
14
976
11832
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.7e-01
5.7e-01
6.3e-01
2.3e+00
1.5e+00
4.6e-01
4.4e-01
cases:19.55%
controls:13.24%
cases:12.87%
controls:7.74%
cases:2.85%
controls:1.54%
cases:0.43%
controls:0.04%
cases:6.59%
controls:1.56%
cases:12.32%
controls:8.12%
cases:24.80%
controls:17.57%
322
2178
1325
14278
212
1273
1435
15183
47
253
1600
16203
7
7
1640
16449
101
256
1431
16145
171
1275
1217
14419
244
2081
740
9765
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.1e+00
1.1e+00
—
—
2.4e+00
1.9e+00
1.1e+00
cases:1.34%
controls:0.47%
cases:0.61%
controls:0.19%
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.01%
controls:0.16%
cases:1.42%
controls:0.49%
22
77
1625
16379
10
32
1637
16424
—
—
5
5
1527
16396
14
25
1374
15669
14
58
970
11788
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
7.1e-01
1.1e+00
1.3e+00
—
2.0e+00
8.6e-01
4.4e-01
cases:6.31%
controls:3.21%
cases:4.92%
controls:1.68%
cases:0.85%
controls:0.24%
—
—
cases:1.37%
controls:0.20%
cases:4.61%
controls:2.00%
cases:7.93%
controls:5.28%
104
528
1543
15928
81
276
1566
16180
14
39
1633
16417
—
21
32
1511
16369
64
314
1324
15380
78
625
906
11221
More than one and less than three hours
ZXE10 [2001311401]
5.3e-01
7.8e-01
1.1e+00
—
2.1e+00
1.9e+00
1.1e+00
cases:9.65%
controls:5.93%
cases:2.79%
controls:1.30%
cases:0.43%
controls:0.14%
—
—
cases:1.17%
controls:0.15%
cases:5.40%
controls:0.88%
cases:8.03%
controls:2.73%
159
976
1488
15480
46
214
1601
16242
7
23
1640
16433
—
18
25
1514
16376
75
138
1313
15556
79
323
905
11523
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
4.6e-01
7.3e-01
1.3e+00
—
2.3e+00
9.6e-01
5.8e-01
cases:14.21%
controls:9.49%
cases:9.11%
controls:4.59%
cases:2.67%
controls:0.78%
—
—
cases:7.44%
controls:0.77%
cases:11.38%
controls:4.67%
cases:20.63%
controls:12.73%
234
1561
1413
14895
150
755
1497
15701
44
128
1603
16328
—
114
126
1418
16275
158
733
1230
14961
203
1508
781
10338
In Home Supportive Care Agency
253Z00000X [38004206]
1.0e+00
1.5e+00
1.5e+00
1.2e+00
1.1e+00
1.2e+00
1.1e+00
cases:1.15%
controls:0.41%
cases:1.34%
controls:0.31%
cases:0.79%
controls:0.17%
cases:0.30%
controls:0.09%
cases:0.52%
controls:0.17%
cases:1.22%
controls:0.36%
cases:2.24%
controls:0.79%
19
68
1628
16388
22
51
1625
16405
13
28
1634
16428
5
15
1642
16441
8
28
1524
16373
17
57
1371
15637
22
94
962
11752
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.1e+00
1.5e+00
—
—
—
2.2e+00
1.5e+00
cases:0.85%
controls:0.29%
cases:0.85%
controls:0.19%
—
—
—
—
—
—
cases:2.02%
controls:0.23%
cases:3.76%
controls:0.84%
14
48
1633
16408
14
31
1633
16425
—
—
—
28
36
1360
15658
37
99
947
11747
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
5.4e-01
5.9e-01
1.3e+00
—
2.3e+00
1.0e+00
6.1e-01
cases:8.56%
controls:5.16%
cases:4.13%
controls:2.32%
cases:1.40%
controls:0.40%
—
—
cases:3.46%
controls:0.36%
cases:6.20%
controls:2.35%
cases:11.28%
controls:6.44%
141
849
1506
15607
68
382
1579
16074
23
66
1624
16390
—
53
59
1479
16342
86
369
1302
15325
111
763
873
11083
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.0e-01
7.6e-01
1.3e+00
—
2.5e+00
8.3e-01
4.4e-01
cases:5.89%
controls:3.66%
cases:4.86%
controls:2.33%
cases:1.34%
controls:0.37%
—
—
cases:4.11%
controls:0.36%
cases:5.40%
controls:2.44%
cases:10.67%
controls:7.18%
97
603
1550
15853
80
383
1567
16073
22
61
1625
16395
—
63
59
1469
16342
75
383
1313
15311
105
850
879
10996
Ankle X-ray examination without contrast
NH1AA [2001308235]
1.2e+00
1.6e+00
—
1.0e+50
—
2.3e+00
1.2e+00
cases:1.82%
controls:0.56%
cases:0.73%
controls:0.15%
—
—
cases:0.97%
controls:0.00%
—
—
cases:0.94%
controls:0.10%
cases:2.13%
controls:0.68%
30
92
1617
16364
12
25
1635
16431
—
16
0
1631
16456
—
13
15
1375
15679
21
80
963
11766
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.1e-01
5.9e-01
6.3e-01
2.1e+00
1.5e+00
4.4e-01
4.4e-01
cases:19.31%
controls:12.51%
cases:12.39%
controls:7.26%
cases:2.73%
controls:1.48%
cases:0.43%
controls:0.05%
cases:6.66%
controls:1.49%
cases:11.46%
controls:7.67%
cases:22.97%
controls:16.17%
318
2059
1329
14397
204
1194
1443
15262
45
243
1602
16213
7
9
1640
16447
102
245
1430
16156
159
1204
1229
14490
226
1915
758
9931
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
7.6e-01
1.2e+00
1.1e+00
—
2.1e+00
1.2e+00
9.0e-01
cases:9.41%
controls:4.61%
cases:3.83%
controls:1.14%
cases:0.43%
controls:0.14%
—
—
cases:1.17%
controls:0.15%
cases:3.67%
controls:1.15%
cases:7.72%
controls:3.29%
155
759
1492
15697
63
188
1584
16268
7
23
1640
16433
—
18
24
1514
16377
51
180
1337
15514
76
390
908
11456
pH of Capillary blood
2745-8 [3009343]
7.7e-01
8.7e-01
—
1.0e+50
2.3e+00
1.1e+00
1.1e+00
cases:2.13%
controls:0.99%
cases:1.21%
controls:0.51%
—
—
cases:1.03%
controls:0.00%
cases:0.98%
controls:0.10%
cases:1.59%
controls:0.55%
cases:3.66%
controls:1.22%
35
163
1612
16293
20
84
1627
16372
—
17
0
1630
16456
15
16
1517
16385
22
87
1366
15607
36
145
948
11701
Occupational Medicine Clinic/Center
261QX0100X [38004267]
2.3e+00
2.1e+00
—
—
—
3.8e+00
1.8e+00
cases:0.61%
controls:0.06%
cases:0.30%
controls:0.04%
—
—
—
—
—
—
cases:1.73%
controls:0.04%
cases:0.51%
controls:0.08%
10
10
1637
16446
5
6
1642
16450
—
—
—
24
6
1364
15688
5
10
979
11836
Bloodpressure measurement
XF600 [2001303376]
1.1e+00
1.4e+00
2.6e+00
1.0e+50
—
—
9.9e-01
cases:1.82%
controls:0.63%
cases:0.91%
controls:0.22%
cases:0.43%
controls:0.03%
cases:0.73%
controls:0.00%
—
—
—
—
cases:1.63%
controls:0.61%
30
104
1617
16352
15
37
1632
16419
7
5
1640
16451
12
0
1635
16456
—
—
16
72
968
11774
mirtazapine; oral
N06AX11 [21604740]
1.0e+00
9.9e-01
8.7e-01
—
9.0e-01
1.2e+00
1.1e+00
cases:13.54%
controls:5.25%
cases:8.26%
controls:3.22%
cases:2.37%
controls:1.00%
—
—
cases:2.42%
controls:1.00%
cases:10.52%
controls:3.54%
cases:18.19%
controls:6.62%
223
864
1424
15592
136
530
1511
15926
39
165
1608
16291
—
37
164
1495
16237
146
556
1242
15138
179
784
805
11062
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
6.8e-01
8.0e-01
1.5e+00
—
2.4e+00
1.2e+00
1.0e+00
cases:5.04%
controls:2.62%
cases:2.06%
controls:0.94%
cases:0.36%
controls:0.09%
—
—
cases:1.24%
controls:0.12%
cases:2.95%
controls:0.88%
cases:6.20%
controls:2.36%
83
431
1564
16025
34
155
1613
16301
6
14
1641
16442
—
19
19
1513
16382
41
138
1347
15556
61
280
923
11566
Dizziness and giddiness
R42 [45568132]
9.1e-01
1.4e+00
—
—
1.7e+00
1.3e+00
7.6e-01
cases:7.23%
controls:3.04%
cases:3.40%
controls:0.85%
—
—
—
—
cases:0.65%
controls:0.12%
cases:3.67%
controls:1.01%
cases:6.91%
controls:3.34%
119
500
1528
15956
56
140
1591
16316
—
—
10
20
1522
16381
51
158
1337
15536
68
396
916
11450
Case Management Agency
251B00000X [38004193]
1.9e-01
3.7e-01
7.4e-01
3.7e+00
7.7e-01
4.6e-01
2.0e-01
cases:78.75%
controls:75.47%
cases:75.65%
controls:68.19%
cases:44.26%
controls:27.56%
cases:42.08%
controls:1.68%
cases:44.45%
controls:27.02%
cases:79.18%
controls:70.66%
cases:88.31%
controls:86.09%
1297
12420
350
4036
1246
11221
401
5235
729
4536
918
11920
693
277
954
16179
681
4431
851
11970
1099
11090
289
4604
869
10198
115
1648
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
7.1e-01
1.2e+00
2.0e+00
—
2.2e+00
7.3e-01
4.4e-01
cases:2.06%
controls:1.02%
cases:1.88%
controls:0.56%
cases:0.79%
controls:0.11%
—
—
cases:1.04%
controls:0.12%
cases:1.30%
controls:0.63%
cases:3.76%
controls:2.46%
34
168
1613
16288
31
92
1616
16364
13
18
1634
16438
—
16
20
1516
16381
18
99
1370
15595
37
292
947
11554
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
2.0e+00
—
—
—
—
2.1e+00
2.0e+00
cases:0.91%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.05%
cases:1.02%
controls:0.14%
15
21
1632
16435
—
—
—
—
6
8
1382
15686
10
17
974
11829
Thorax X-ray examination
GD1AA [2001303617]
6.9e-01
8.7e-01
1.0e+00
—
1.9e+00
7.2e-01
7.8e-01
cases:18.70%
controls:10.38%
cases:8.74%
controls:3.88%
cases:1.46%
controls:0.52%
—
—
cases:3.00%
controls:0.45%
cases:7.28%
controls:3.68%
cases:20.02%
controls:10.32%
308
1708
1339
14748
144
638
1503
15818
24
85
1623
16371
—
46
73
1486
16328
101
578
1287
15116
197
1223
787
10623
Heart failure, unspecified
I50.9 [45576879]
7.8e-01
9.9e-01
1.4e+00
—
1.5e+00
7.7e-01
5.6e-01
cases:5.40%
controls:2.56%
cases:3.70%
controls:1.41%
cases:1.34%
controls:0.34%
—
—
cases:1.50%
controls:0.33%
cases:3.96%
controls:1.87%
cases:7.52%
controls:4.43%
89
421
1558
16035
61
232
1586
16224
22
56
1625
16400
—
23
54
1509
16347
55
294
1333
15400
74
525
910
11321
Fracture of other specified cervical vertebra
S12.2 [45568286]
—
2.6e+00
—
—
—
3.4e+00
—
—
—
cases:0.43%
controls:0.03%
—
—
—
—
—
—
cases:1.08%
controls:0.04%
—
—
—
7
5
1640
16451
—
—
—
15
6
1373
15688
—
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.6e-01
6.4e-01
5.7e-01
2.2e+00
1.2e+00
4.8e-01
4.3e-01
cases:30.60%
controls:21.69%
cases:17.61%
controls:10.15%
cases:2.55%
controls:1.45%
cases:0.49%
controls:0.05%
cases:4.77%
controls:1.46%
cases:16.07%
controls:10.55%
cases:34.86%
controls:25.87%
504
3570
1143
12886
290
1671
1357
14785
42
239
1605
16217
8
9
1639
16447
73
240
1459
16161
223
1655
1165
14039
343
3064
641
8782
cyanocobalamin; nasal, oral, parenteral
B03BA01 [21601121]
8.9e-01
1.5e+00
2.1e+00
—
1.3e+00
1.5e+00
3.9e-01
cases:1.09%
controls:0.45%
cases:1.15%
controls:0.25%
cases:0.73%
controls:0.09%
—
—
cases:0.39%
controls:0.10%
cases:1.01%
controls:0.24%
cases:1.02%
controls:0.69%
18
74
1629
16382
19
41
1628
16415
12
15
1635
16441
—
6
17
1526
16384
14
37
1374
15657
10
82
974
11764
colecalciferol; oral
A11CC05 [21600820]
1.2e+00
1.4e+00
1.3e+00
—
8.1e-01
1.2e+00
8.2e-01
cases:1.15%
controls:0.35%
cases:1.52%
controls:0.38%
cases:1.03%
controls:0.28%
—
—
cases:0.65%
controls:0.29%
cases:1.59%
controls:0.48%
cases:2.34%
controls:1.04%
19
58
1628
16398
25
62
1622
16394
17
46
1630
16410
—
10
48
1522
16353
22
75
1366
15619
23
123
961
11723
Feeling depressed
P03 [2002000800]
1.4e+00
1.4e+00
—
—
—
1.8e+00
1.2e+00
cases:2.19%
controls:0.54%
cases:0.97%
controls:0.23%
—
—
—
—
—
—
cases:1.44%
controls:0.23%
cases:2.13%
controls:0.68%
36
89
1611
16367
16
38
1631
16418
—
—
—
20
36
1368
15658
21
80
963
11766

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
878
3016
5.06
236.73
3.1
1.9
408.54
199.84
u/l
1.12
851
2807
133
59
24.42
184.61
2.0
1.2
1.75
1.27
promille
1.29
108
49
505
1579
4.16
142.79
2.0
2.0
29.89
29.95
s
0.07
488
1531
1114
6074
3.54
129.17
21.0
17.0
1.31
1.32
inr
0.19
985
5012
1228
7434
3.51
113.32
9.6
4.6
6.91
6.78
mmol/l
1.43
1192
7052
523
2092
3.19
96.54
3.6
3.3
0.81
0.82
mmol/l
0.79
498
1968
87
63
14.52
95.19
1.7
1.4
3708.53
135.38
e6/l
1.28
55
48
86
62
14.58
94.32
1.6
1.3
25.92
12.55
e6/l
0.45
51
44
1074
6409
2.92
93.48
11.5
7.2
1.20
1.21
mmol/l
5.41
935
5497
186
362
5.66
92.41
2.2
2.3
658.92
438.13
ug/l
0.39
175
347
988
5686
2.83
91.43
11.4
6.3
1.20
1.21
mmol/l
5.26
930
5241
87
69
13.25
90.25
1.6
1.3
—
—
—
0
0
445
1702
3.21
87.62
6.3
5.8
1.00
1.04
mmol/l
2.06
415
1576
738
3739
2.75
86.36
5.2
4.2
—
—
—
0
0
88
80
11.56
83.74
1.5
1.1
626.51
599.40
mg/l
0.06
81
75
659
3213
2.74
82.31
6.3
4.0
81.12
85.75
%
4.54
646
3146
789
4211
2.67
82.13
2.9
2.6
—
—
—
0
0
81
70
12.11
79.61
5.1
6.5
343.50
361.58
umol/l
0.34
69
58
959
5749
2.58
76.70
6.2
5.2
34.04
34.98
g/l
4.98
896
5371
126
206
6.54
74.60
4.3
2.6
33.56
39.79
umol/l
0.71
117
185
396
1545
3.05
74.05
14.2
7.3
5.08
5.06
kpa
0.12
387
1477
396
1545
3.05
74.05
14.1
7.3
12.50
12.25
kpa
0.39
388
1480
833
4729
2.53
73.98
4.9
3.5
37.81
114.32
ng/l
1.18
675
3456
969
5903
2.54
73.87
3.1
2.8
—
—
estimate
—
0
0
393
1548
3.02
72.06
14.3
7.2
7.41
7.41
ph
0.16
214
802
389
1528
3.02
71.65
14.2
7.3
1.12
0.71
mmol/l
1.07
341
1235
76
75
10.57
68.30
1.5
1.1
3.95
3.62
mmol/l
1.43
69
69
329
1219
3.12
66.74
12.9
7.4
1.50
1.35
mmol/l
1.38
323
1193
1177
8103
2.56
65.20
6.4
4.3
601.24
3336.31
e6/l
1.38
17
115
672
3663
2.40
62.51
4.2
3.1
—
—
—
0
0
333
1287
2.99
62.39
15.8
8.0
116.42
119.63
g/l
1.91
328
1250
691
3830
2.38
61.69
5.3
4.3
7.40
7.40
ph
2.18
522
2698
347
1382
2.91
61.49
14.7
7.6
95.84
95.58
%
0.30
338
1329
48
29
17.02
57.51
1.5
1.5
—
—
—
0
0
52
37
14.48
57.21
1.6
1.1
—
—
—
0
0
433
2043
2.52
54.11
2.0
1.7
1158.04
1160.90
nmol/l
0.02
329
1528
315
1271
2.83
53.93
7.1
6.5
9.02
11.24
mmol/l
4.84
294
1210
1009
6815
2.23
53.25
7.8
7.1
12.70
12.75
umol/l
0.04
961
6516
644
3651
2.25
52.52
2.0
1.6
19.20
19.92
nmol/l
0.65
575
2994
507
2623
2.34
51.20
3.4
2.9
523.24
540.81
mosm/kgh2o
1.07
459
2282
720
4370
2.14
48.48
4.3
3.3
36.16
96.18
e6/l
3.16
573
3309
620
3564
2.18
47.87
4.1
3.1
3.48
614.25
estimate
—
6
25
485
2546
2.28
46.65
4.6
3.7
435.55
738.47
ng/l
0.82
417
2152
142
383
3.96
46.57
2.4
1.6
0.40
0.30
mg/l
0.94
85
173
642
3787
2.13
45.96
4.1
3.2
0.35
0.52
e6/l
1.77
500
2746
284
1184
2.69
45.08
14.7
8.5
—
—
—
0
0
859
5712
2.05
43.87
2.5
2.0
92.48
93.71
pmol/l
0.33
503
2962
1294
10058
2.31
43.16
9.8
8.2
84.34
82.23
u/l
0.69
1214
9495
1508
12616
3.16
42.43
27.6
14.9
27.01
28.31
mg/l
0.85
1410
10158
762
4894
2.03
42.43
5.2
3.8
177.57
132.26
e6/l
0.30
589
3460
664
4091
2.04
41.20
4.6
3.2
37.31
39.72
u/l
0.21
626
3855
280
1238
2.52
39.02
2.6
2.3
0.19
0.20
g/l
1.61
258
1165
510
2933
2.07
37.54
3.4
2.6
5.23
5.43
e6/l
0.12
475
2643
301
1419
2.37
36.25
5.3
3.5
7.37
7.38
ph
0.11
169
815
565
3411
2.00
36.04
2.6
2.2
3.11
2.88
mg/l
0.98
487
2921
214
881
2.64
34.34
2.0
2.3
409.73
406.06
nmol/l
0.09
197
819
1063
7989
1.92
34.27
5.0
2.9
69.67
52.52
u/l
3.36
991
7389
171
628
2.92
34.13
3.2
4.0
5.11
5.08
kpa
0.13
163
602
87
211
4.30
32.82
1.4
1.3
74.40
61.01
mmol/l
1.60
80
163
284
1367
2.30
32.32
5.3
3.5
1.67
1.66
mmol/l
0.01
253
1141
344
1792
2.16
32.24
2.4
1.8
—
—
—
0
0
164
610
2.87
31.93
3.2
4.0
7.41
7.42
ph
0.57
147
506
609
3897
1.89
31.80
3.1
2.4
56.74
61.48
u/l
1.35
571
3595
835
5901
1.84
31.69
7.1
6.6
9.28
9.18
%
0.37
783
5520
833
5883
1.84
31.68
7.1
6.5
2.88
2.88
%
0.01
781
5509
288
1406
2.27
31.65
5.4
3.5
5.82
5.76
kpa
0.46
277
1364
649
4253
1.86
31.34
6.8
6.2
—
—
—
0
0
668
4418
1.86
31.32
3.3
3.9
2.35
2.35
mmol/l
0.59
600
3984
831
5894
1.82
30.89
7.2
6.6
0.67
0.67
%
0.01
781
5510
1522
13267
2.79
30.62
35.0
18.0
139.27
139.65
mmol/l
5.83
1501
12936
1522
13300
2.76
29.83
35.2
18.3
3.97
4.00
mmol/l
5.14
1498
12941
895
6539
1.80
29.69
7.2
6.5
0.19
0.20
e9/l
0.83
781
5587
871
6336
1.79
29.10
7.0
6.2
0.04
0.04
e9/l
0.65
746
5337
838
6038
1.78
28.83
7.2
6.5
25.97
26.58
%
0.80
792
5712
867
6319
1.78
28.59
7.0
6.2
0.62
0.61
e9/l
0.50
738
5326
60
120
5.15
28.58
10.9
6.7
7.70
7.37
mmol/l
0.30
50
104
823
5911
1.78
28.51
7.1
6.4
57.93
58.10
%
0.14
783
5631
880
6469
1.77
27.91
7.2
6.3
1.81
1.84
e9/l
0.15
772
5608
243
1162
2.28
27.84
4.9
2.9
4.65
4.44
kpa
0.51
231
1125
769
5454
1.76
27.50
3.6
2.9
168.15
161.43
ug/l
0.15
690
5068
385
2223
1.95
26.68
3.8
3.1
2.53
1.86
e6/l
0.68
195
1127
106
340
3.26
26.62
1.9
1.8
21.21
21.87
s
0.46
97
305
961
7310
1.75
26.43
10.5
10.4
4.27
4.20
e9/l
0.34
815
6247
356
2020
1.97
25.87
3.0
2.5
21.94
22.64
%
0.31
323
1898
1346
11385
1.97
25.32
5.6
4.5
2.05
2.03
mu/l
0.08
1211
10240
54
111
4.99
24.94
2.9
3.4
—
—
—
0
0
1494
13161
2.37
24.84
23.9
13.3
—
—
—
0
0
370
2156
1.92
24.74
2.9
2.5
2.24
2.25
g/l
0.06
341
2009
386
2288
1.90
24.47
3.0
2.5
12.40
12.63
umol/l
0.16
357
2156
245
1237
2.15
24.37
2.7
2.4
33.14
39.82
u/l
0.76
206
1053
274
1445
2.07
24.31
3.7
2.8
10.00
10.12
umol/l
0.03
233
1280
868
6517
1.70
24.11
4.6
3.6
0.00
0.00
estimate
-0.00
216
1391
266
1394
2.08
23.98
2.1
1.6
—
—
—
0
0
795
5845
1.69
23.78
15.4
11.2
0.00
0.00
e9/l
0.10
649
4721
394
2372
1.87
23.70
3.6
3.0
0.96
1.11
e6/l
0.40
206
1280
747
5409
1.69
23.61
2.6
2.3
75.24
78.63
nmol/l
2.32
658
4821
88
271
3.37
23.58
1.9
2.2
131.28
124.93
g/l
1.03
70
203
871
6607
1.67
22.76
4.7
3.6
23.70
2.85
estimate
0.86
224
1425
876
6661
1.67
22.62
4.7
3.6
0.03
0.00
estimate
0.68
209
1337
98
331
3.08
22.56
6.0
2.6
61.68
61.62
%
0.01
90
321
1117
9079
1.71
22.10
4.4
3.7
14.96
14.96
pmol/l
0.00
982
8169
418
2621
1.80
21.78
3.2
3.3
2.47
2.47
mmol/l
0.03
368
2333
99
344
3.00
21.70
3.7
3.3
2.35
2.14
index
0.10
49
168
403
2503
1.81
21.67
1.9
1.7
470.04
28823093.75
pmol/l
1.97
330
2047
77
234
3.40
21.08
3.9
4.7
2.67
2.64
mmol/l
0.02
51
158
77
236
3.37
20.80
2.3
3.4
89.43
89.20
%
0.10
71
231
141
607
2.45
20.33
11.5
4.3
1.68
1.57
%
0.54
135
567
1258
10662
1.75
20.31
34.8
19.2
13.95
13.73
%
5.88
1242
10472
132
555
2.50
20.02
12.1
4.4
0.95
0.87
%
0.81
126
517
50
116
4.41
19.99
1.7
1.3
278.24
276.02
mosm/kgh2o
0.21
41
87
704
5176
1.63
19.90
3.8
3.2
6.25
6.22
ph
0.30
387
2923
78
248
3.25
19.87
15.8
5.5
105.68
105.30
mmol/l
0.25
71
215
78
248
3.25
19.87
15.8
5.5
11.20
11.60
mmol/l
0.44
71
215
130
554
2.46
19.15
2.6
1.9
3.25
2.13
ug/l
0.46
101
497
1529
13882
2.30
18.94
34.3
20.2
81.30
82.85
umol/l
0.69
1516
13668
213
1119
2.04
18.84
2.9
2.7
265.68
244.78
ng/l
0.25
190
1018
206
1071
2.05
18.75
2.3
2.3
7.94
8.04
ug/l
0.02
176
963
555
3890
1.64
18.74
7.1
6.6
—
—
—
0
0
221
1181
2.01
18.63
2.1
1.6
—
—
—
0
0
395
2535
1.73
18.60
1.7
1.6
1.85
1.53
mg/l
0.63
306
1965
96
361
2.76
18.22
14.1
4.7
1.42
1.38
mmol/l
0.09
86
319
1110
9238
1.61
17.76
5.0
4.0
—
14715.82
—
0
28
76
257
3.05
17.48
3.4
4.0
—
—
—
0
0
170
844
2.13
17.45
5.4
3.0
124.97
127.25
g/l
0.60
165
824
195
1020
2.03
17.41
4.0
4.1
1.22
1.23
mmol/l
0.43
168
867
65
203
3.29
17.07
4.4
2.6
—
—
—
0
0
70
241
2.99
15.63
3.1
2.2
—
—
—
0
0
1536
14170
2.14
14.98
40.0
22.9
236.53
241.85
e9/l
2.43
1506
13764
1536
14175
2.14
14.89
39.9
22.8
91.94
91.37
fl
4.42
1519
13948
99
418
2.46
14.88
3.8
4.1
—
—
—
0
0
1536
14176
2.14
14.87
39.8
22.8
30.59
30.43
pg
2.69
1519
13950
1536
14177
2.13
14.85
41.8
23.3
39.07
41.00
%
4.38
1519
13943
1536
14177
2.13
14.85
39.9
22.8
4.32
4.50
e12/l
28.73
1503
13710
1536
14182
2.13
14.75
40.2
23.0
130.55
135.78
g/l
29.81
1519
13966
1536
14182
2.13
14.75
39.9
22.9
7.09
6.72
e9/l
7.17
1504
13710
576
4276
1.53
14.33
3.7
3.1
2393.62
1764.93
ng/l
1.12
501
3765
194
1099
1.87
13.61
2.4
2.9
66.25
66.03
g/l
0.14
171
1014
267
1664
1.72
13.58
2.6
2.6
1.86
1.76
%
0.85
232
1500
1497
13765
1.90
13.53
15.4
11.3
26.79
26.09
u/l
0.74
1454
13259
318
2080
1.65
13.48
1.5
1.6
2.88
2.70
g/l
0.67
182
1290
78
311
2.58
13.23
3.9
4.1
24.73
24.73
mmol/l
0.00
78
281
1383
12469
1.66
12.95
5.2
5.0
6.12
5.97
mmol/l
3.26
1239
11221
266
1677
1.70
12.93
2.2
1.7
—
—
—
0
0
176
984
1.88
12.84
5.1
3.5
—
—
—
0
0
339
2287
1.61
12.61
1.4
1.2
1.66
1.68
u/ml
0.01
84
602
75
302
2.55
12.48
3.1
2.2
—
—
—
0
0
17
7
24.50
12.47
1.1
1.3
—
—
mmol/l
—
0
0
17
7
24.50
12.47
1.1
1.3
—
—
mmol/l
—
0
0
21
35
6.06
12.14
1.2
1.2
59.38
63.15
umol/l
—
8
20
499
3720
1.49
11.66
1.4
1.3
—
—
—
0
0
142
765
1.94
11.58
1.2
1.2
—
—
—
0
0
229
1437
1.69
11.25
1.9
1.5
—
—
—
0
0
73
306
2.45
11.19
1.1
1.3
88.89
108.39
titre
—
9
31
489
3656
1.48
11.18
4.8
3.6
0.00
0.00
estimate
0.01
204
1249
461
3421
1.48
10.89
3.5
2.9
0.08
0.03
0.28
12
110
1349
12238
1.55
10.67
7.1
6.1
40.16
39.32
mmol/mol
2.45
1232
11290
106
530
2.07
10.67
2.4
2.5
4.08
4.13
g/l
0.25
90
493
18
14
12.98
10.65
1.8
1.2
46.50
—
%
—
6
0
406
2960
1.49
10.40
3.8
3.4
0.13
1.26
—
8
42
105
530
2.05
10.30
2.4
2.5
3.91
3.79
g/l
0.23
89
491
76
337
2.32
10.30
3.1
2.1
—
—
—
0
0
95
463
2.12
10.23
2.5
2.5
10.20
10.64
g/l
0.35
80
421
242
1584
1.62
10.03
1.3
1.3
—
—
—
0
0
467
3523
1.45
10.00
4.6
3.2
0.00
0.01
estimate
1.08
184
1049
147
841
1.82
9.95
2.3
3.1
11.09
10.94
g/l
0.15
135
780
46
164
2.86
9.74
2.0
2.7
—
—
—
0
0
459
3473
1.44
9.61
3.0
2.9
359.03
360.55
umol/l
0.09
387
3065
75
341
2.26
9.61
3.1
2.1
—
—
—
0
0
621
4962
1.40
9.56
4.9
3.5
0.02
0.05
estimate
0.65
184
1135
30
83
3.66
9.56
1.2
1.1
35.68
34.73
mmol/l
0.07
24
73
214
1377
1.64
9.49
1.4
1.3
733.68
495.45
titre
0.61
38
303
75
343
2.24
9.48
3.2
2.1
—
—
—
0
0
22
32
6.95
9.32
2.4
2.3
—
—
—
0
0
202
1293
1.64
9.13
2.6
2.6
70.05
68.99
e9/l
0.14
147
960
21
31
6.85
8.84
1.1
1.0
762.46
778.90
ng/l
0.04
13
21
21
31
6.85
8.84
1.1
1.0
357.88
230.52
ng/l
0.94
16
21
215
1409
1.60
8.83
1.5
1.4
—
—
—
0
0
67
305
2.25
8.59
1.2
1.2
—
1680.00
—
0
5
122
695
1.82
8.39
1.8
1.7
1.44
1.54
g/l
0.58
100
599
121
689
1.82
8.33
1.8
2.1
1.41
1.34
g/l
0.08
110
623
71
338
2.15
8.17
3.2
2.1
—
—
—
0
0
150
935
1.66
7.52
4.8
3.7
114.11
95.17
ng/l
1.13
123
799
104
584
1.83
7.51
6.4
3.8
36.90
36.89
°c
0.04
99
579
138
843
1.69
7.46
1.9
1.5
—
—
—
0
0
567
4615
1.35
7.30
4.3
3.6
—
0.65
—
0
17
35
127
2.79
7.24
3.7
4.0
15.89
11.19
index
1.08
19
69
97
548
1.82
6.89
2.4
2.4
15.56
20.19
au/ml
—
5
57
568
4666
1.33
6.75
3.5
3.3
7.50
7.52
mmol/l
0.03
465
3910
24
74
3.28
6.56
1.0
1.0
—
—
—
0
0
65
329
2.02
6.43
1.4
1.4
227.13
248.72
ug/g
0.32
35
200
89
501
1.82
6.41
1.3
1.3
74.00
53.69
au/ml
—
5
48
175
1181
1.54
6.31
4.0
4.2
7.39
7.36
ph
1.21
127
831
44
192
2.33
6.30
1.1
1.1
—
—
—
0
0
21
61
3.47
6.29
1.0
1.0
—
—
—
0
0
365
2834
1.37
6.22
4.8
3.6
1.02
1.02
kg/l
0.28
275
1885
1308
12144
1.37
6.14
4.3
4.0
1.35
1.26
mmol/l
4.33
1179
10967
52
249
2.12
5.97
1.4
1.2
—
—
—
0
0
43
191
2.28
5.93
1.7
1.4
148.21
161.80
au/ml
0.38
19
56
32
124
2.61
5.90
1.1
1.3
281.66
267.47
pmol/l
0.12
27
105
45
209
2.19
5.60
1.7
1.4
—
—
—
0
0
76
426
1.82
5.59
1.1
1.3
—
—
—
0
0
164
1121
1.51
5.58
3.1
2.5
0.51
0.50
e6/l
0.01
164
1083
31
122
2.57
5.55
1.5
1.4
0.19
0.21
nmol/l
0.36
24
99
23
77
3.01
5.54
1.4
1.1
—
—
—
0
0
54
275
2.00
5.30
1.2
1.1
—
—
—
0
0
177
1245
1.47
5.24
2.2
2.6
183.03
154.09
ug/g
0.42
145
1001
103
643
1.64
5.19
1.8
1.7
—
—
—
0
0
12
19
6.35
5.08
1.5
1.2
171.83
145.95
nmol/l
0.57
12
19
76
441
1.76
5.01
3.5
4.2
1.52
7.71
ratio
1.78
46
264
33
144
2.32
4.79
1.5
1.4
0.27
0.17
nmol/l
—
6
12
58
1019
0.55
4.78
1.3
1.4
—
—
—
0
0
15
42
3.59
4.77
1.9
1.6
—
—
—
0
0
41
197
2.11
4.73
1.1
1.1
—
—
—
0
0
32
141
2.29
4.56
1.1
1.5
143.59
47.00
mu/l
0.59
27
122
27
112
2.43
4.40
1.4
1.5
—
—
nmol/l
—
0
0
88
552
1.63
4.39
1.3
1.3
—
—
—
0
0
30
131
2.31
4.37
1.1
1.6
34.88
36.52
ng/l
0.05
30
131
16
435
0.36
4.32
1.1
1.1
1.33
1.51
g/l
1.93
16
435
51
275
1.88
4.30
1.5
1.6
0.25
0.24
g/l
0.46
46
263
80
494
1.65
4.25
3.5
4.4
57.99
50.89
mg/l
0.12
67
425
26
108
2.43
4.23
1.1
1.1
2.00
4.06
u/ml
1.07
13
51
196
1465
1.38
4.17
3.5
3.5
4.22
4.70
e9/l
0.61
162
1258
535
4586
1.25
4.11
4.3
4.0
9.01
7.98
mg/mmol
0.24
346
2864
54
304
1.80
4.00
1.2
1.2
—
—
—
0
0
79
495
1.63
3.99
3.6
4.3
48.77
177.35
mg/l
0.62
67
423
1376
13085
1.30
3.96
5.8
5.5
2.48
2.69
mmol/l
15.01
1258
11988
41
213
1.95
3.89
3.7
3.8
4.60
4.22
e9/l
0.49
41
213
186
1398
1.37
3.83
1.5
1.4
—
—
—
0
0
7
8
8.78
3.77
5.9
1.0
16.41
19.55
umol/l
—
7
8
25
109
2.31
3.69
1.0
1.1
—
—
—
0
0
518
4472
1.23
3.65
3.5
3.4
51.92
45.77
mg/l
0.28
349
2867
50
284
1.78
3.63
1.5
1.6
1.25
1.17
g/l
0.95
43
271
1351
12860
1.27
3.56
5.1
4.8
4.35
4.58
mmol/l
13.38
1230
11820
57
339
1.71
3.54
1.2
1.3
—
9.90
—
0
8
23
101
2.30
3.36
1.0
1.2
—
—
—
0
0
6
7
8.60
3.26
1.2
1.6
66.67
76.00
ug/l
—
6
7
43
242
1.80
3.24
1.4
1.4
9.10
8.20
u/l
0.28
35
195
61
379
1.63
3.24
1.6
1.6
19.34
19.04
u/ml
0.01
13
88
23
103
2.25
3.23
2.1
2.4
21.52
34.30
iu/ml
—
5
11
1339
12774
1.25
3.20
5.0
4.7
1.39
1.44
mmol/l
4.89
1217
11659
23
104
2.23
3.16
2.1
1.9
—
—
—
0
0
89
607
1.49
3.16
2.8
3.2
—
—
—
0
0
49
292
1.70
3.06
1.6
1.8
—
—
—
0
0
155
1176
1.35
3.04
2.3
2.0
0.00
0.01
estimate
0.50
36
234
327
2735
1.24
3.04
5.0
4.8
—
—
—
0
0
37
205
1.82
2.96
1.2
1.2
206.08
265.97
u/ml
1.29
25
123
580
5149
1.19
2.95
2.4
2.2
—
—
—
0
0
91
1277
0.70
2.88
1.7
2.0
3.46
3.55
ratio
0.29
65
1022
15
58
2.60
2.87
2.5
1.2
9.99
27.88
umol/l
3.73
15
51
87
604
1.46
2.85
2.9
3.4
4.30
4.49
pmol/l
0.94
77
538
13
47
2.78
2.82
1.7
1.2
11.74
13.04
g/l
—
8
40
14
53
2.66
2.79
2.1
1.9
286.00
514.73
e6/l
—
8
41
1141
10765
1.19
2.78
36.6
19.8
332.04
332.40
g/l
0.64
1136
10688
422
4817
0.83
2.66
3.6
3.2
—
—
—
0
0
32
176
1.83
2.65
1.7
1.6
—
—
—
0
0
53
337
1.59
2.62
2.6
3.5
0.80
0.82
nmol/l
0.12
45
269
48
300
1.62
2.55
1.1
1.1
—
—
—
0
0
15
62
2.43
2.54
4.7
3.1
637.33
1564.23
u/ml
1.33
15
62
23
115
2.01
2.51
1.3
1.1
—
—
—
0
0
25
130
1.94
2.46
3.8
2.7
—
—
—
0
0
30
167
1.81
2.41
1.2
1.4
—
—
—
0
0
30
167
1.81
2.41
1.2
1.4
—
—
—
0
0
30
167
1.81
2.41
1.2
1.4
—
—
—
0
0
30
167
1.81
2.41
1.2
1.4
—
—
—
0
0
6
12
5.01
2.40
1.0
1.1
—
—
—
0
0
21
104
2.03
2.36
1.9
1.5
62.92
62.66
%
0.01
12
62
12
46
2.62
2.36
2.2
1.4
2243.00
42926.71
e6/l
—
5
28
42
260
1.63
2.34
3.9
3.7
60.71
59.46
%
0.30
42
260
20
98
2.05
2.32
3.9
2.3
36.34
37.82
%
0.19
20
98
65
928
0.69
2.31
1.3
1.8
3.27
3.51
mmol/l
0.93
40
661
9
28
3.23
2.30
5.4
5.3
—
—
—
0
0
19
92
2.08
2.27
1.2
1.1
—
—
—
0
0
63
433
1.47
2.23
4.4
3.4
317.87
494.21
mg/l
0.48
39
213
47
303
1.57
2.23
1.2
1.1
—
—
—
0
0
145
1144
1.29
2.22
4.6
4.9
0.18
0.13
%
0.13
34
327
654
5974
1.16
2.20
5.4
5.7
5.62
3.77
ug/l
0.25
581
5411
12
48
2.51
2.18
1.7
1.4
2.40
3.91
%
—
5
11
21
108
1.96
2.15
1.2
1.2
—
—
—
0
0
10
36
2.79
2.14
1.0
1.3
—
—
—
0
0
80
582
1.39
2.11
2.2
2.1
0.00
0.01
estimate
0.50
29
179
152
1216
1.28
2.10
3.9
4.6
1.00
0.91
%
0.20
45
407
38
237
1.62
2.08
1.5
2.2
1.09
0.88
%
0.89
28
163
5
10
5.01
2.07
1.2
1.2
—
—
—
0
0
10
37
2.71
2.07
4.5
3.0
0.62
0.62
mmol/l
—
10
37
10
38
2.64
2.00
1.3
1.0
—
—
—
0
0
86
640
1.36
1.99
1.2
1.3
233.88
231.94
u/ml
0.01
73
588
144
1153
1.27
1.99
4.1
4.6
0.80
0.76
%
0.08
44
388
84
624
1.36
1.97
1.2
1.2
72.63
149.42
u/ml
1.45
24
215
46
306
1.52
1.94
2.3
2.3
163.35
74.03
ug/min
0.34
25
174
17
85
2.01
1.90
1.4
2.7
15.70
16.15
%
0.20
17
85
18
92
1.97
1.90
1.4
2.4
10.09
8.21
mmol/l
0.73
18
92
144
1162
1.26
1.88
4.0
4.6
0.03
0.11
%
1.92
37
351
119
943
1.28
1.80
3.7
3.0
—
—
—
0
0
11
47
2.35
1.78
3.5
2.9
—
—
—
0
0
7
24
2.92
1.72
2.6
2.4
—
—
—
0
0
0
46
0.00
1.71
0.0
1.1
—
—
—
0
0
85
649
1.33
1.70
2.5
2.4
—
—
—
0
0
17
89
1.92
1.70
2.2
2.7
39.71
34.50
%
—
8
45
10
40
2.51
1.66
1.0
1.3
169.80
177.40
mmol/24h
—
10
40
8
31
2.59
1.66
2.1
1.4
1.64
1.84
umol/l
—
8
24
16
84
1.91
1.60
1.3
1.3
0.19
1.82
u/ml
—
6
48
8
32
2.51
1.59
2.1
1.4
24.50
27.44
umol/l
—
8
27
8
32
2.51
1.59
1.0
1.0
—
—
—
0
0
6
20
3.01
1.58
1.2
1.4
—
—
—
0
0
7
26
2.70
1.58
1.0
1.5
50.86
326.00
nmol/24h
—
7
26
120
970
1.26
1.58
3.5
2.7
6.05
5.99
ph
0.28
82
675
80
616
1.31
1.54
3.1
3.7
2768.88
5075.38
u/ml
0.37
71
533
8
33
2.43
1.54
1.1
1.1
—
—
—
0
0
54
391
1.39
1.53
1.7
1.7
4.37
6.86
iu/ml
—
10
79
29
185
1.58
1.52
1.8
1.5
—
—
—
0
0
220
1899
1.18
1.51
1.4
1.4
—
—
—
0
0
42
292
1.45
1.49
7.5
2.9
36.59
29.37
mg/l
0.45
28
198
7
28
2.51
1.45
4.6
7.7
4.93
4.90
kpa
—
7
28
23
140
1.65
1.45
3.2
2.3
2500.47
1955.35
u/l
—
8
59
41
287
1.44
1.42
1.7
1.5
16903.19
13557.41
e6/l
0.19
26
199
75
580
1.31
1.42
1.3
1.3
—
—
—
0
0
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
47
339
1.40
1.39
3.5
4.5
—
—
—
0
0
29
190
1.54
1.37
2.4
2.7
—
—
—
0
0
5
17
2.95
1.36
20.4
12.1
4.14
5.55
mmol/l
—
5
17
29
191
1.53
1.35
1.7
1.4
25354.06
61451.57
e6/l
0.84
17
102
9
42
2.15
1.33
1.0
1.4
17.40
6.57
u/l
—
9
35
19
113
1.69
1.32
3.3
2.1
1.23
1.15
u/field
0.04
13
61
73
570
1.29
1.30
2.0
1.8
—
—
—
0
0
9
43
2.10
1.30
1.0
1.1
176.21
162.23
iu/ml
—
9
43
16
91
1.77
1.29
1.3
1.3
—
—
—
0
0
26
169
1.55
1.29
1.3
1.4
—
—
—
0
0
15
84
1.79
1.27
2.3
2.3
—
—
—
0
0
213
1869
1.16
1.22
1.3
1.3
34.38
37.50
iu/ml
0.14
63
579
19
116
1.65
1.21
1.4
1.3
1.31
1.52
nmol/l
0.25
19
104
8
37
2.17
1.21
1.0
1.2
1.11
1.08
ratio
—
8
28
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
565
5278
1.11
1.18
2.0
1.8
1.39
1.31
mmol/l
1.22
447
4385
24
357
0.67
1.17
1.4
1.6
—
—
—
0
0
5
20
2.50
1.15
1.4
2.2
—
—
—
0
0
31
216
1.44
1.14
1.6
1.4
863.63
1880.77
e6/l
1.64
19
146
195
1711
1.16
1.13
1.3
1.2
31.29
18.79
u/ml
0.68
56
654
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
18
111
1.63
1.12
1.1
1.1
—
—
—
0
0
5
21
2.38
1.09
1.8
1.2
—
—
—
0
0
15
90
1.67
1.04
2.7
1.5
—
—
—
0
0
7
34
2.06
1.03
1.0
1.0
1914.43
1574.65
miu/ml
—
7
34
187
1657
1.14
0.97
4.4
5.0
5.52
27.10
ug/l
3.18
145
1393
13
77
1.69
0.95
1.3
1.2
—
—
—
0
0
28
383
0.73
0.91
24.0
10.3
—
—
—
0
0
16
102
1.57
0.90
2.0
1.3
30.21
30.40
%
—
8
61
25
177
1.42
0.88
1.0
1.1
—
—
—
0
0
25
177
1.42
0.88
1.0
1.1
—
—
—
0
0
79
943
0.83
0.88
1.5
1.3
—
—
—
0
0
14
217
0.64
0.87
1.5
1.9
18.83
28.36
ug/l
0.73
14
212
156
1379
1.14
0.86
2.2
2.0
13.79
13.93
nmol/l
0.07
144
1256
25
179
1.40
0.84
1.2
1.4
0.85
0.76
g/l
0.22
20
140
25
180
1.39
0.82
1.7
1.4
—
—
—
0
0
6
32
1.88
0.82
1.2
1.9
—
—
—
0
0
32
420
0.76
0.81
1.8
1.7
—
—
—
0
0
24
172
1.40
0.81
1.3
1.2
—
—
—
0
0
33
251
1.32
0.78
1.2
1.4
0.86
0.77
nmol/l
0.21
22
216
19
133
1.43
0.73
1.1
1.2
—
—
—
0
0
7
38
1.85
0.73
2.1
1.6
—
2148.57
—
0
7
24
176
1.37
0.72
2.1
2.7
0.81
1.20
g/24h
0.62
16
109
17
240
0.71
0.70
1.2
1.4
—
—
—
0
0
7
41
1.71
0.70
1.7
2.0
39.44
39.08
g/l
—
7
41
0
22
0.00
0.59
0.0
2.5
—
0.64
—
0
22
11
72
1.53
0.59
2.1
1.6
108.28
107.87
ng/l
0.00
11
72
6
37
1.62
0.55
2.7
1.5
—
—
—
0
0
14
99
1.42
0.54
2.4
1.6
—
—
—
0
0
39
466
0.83
0.50
1.2
1.2
—
—
—
0
0
26
207
1.26
0.49
1.6
1.9
4.16
4.87
mmol/24h
0.43
20
178
7
46
1.52
0.48
2.4
4.3
—
—
—
0
0
7
46
1.52
0.48
1.3
1.8
0.00
0.00
estimate
—
7
46
7
49
1.43
0.46
2.4
4.2
—
—
—
0
0
5
81
0.62
0.46
1.4
1.6
—
—
—
0
0
5
82
0.61
0.45
1.4
1.7
—
—
—
0
0
17
129
1.32
0.45
1.4
1.1
—
—
—
0
0
10
69
1.45
0.44
1.7
2.1
—
—
—
0
0
7
51
1.37
0.44
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
76.52
—
0
11
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
35
411
0.85
0.40
4.8
3.9
—
—
—
0
0
15
116
1.30
0.37
1.9
2.4
—
—
—
0
0
16
125
1.28
0.37
1.0
1.0
1.48
1.64
eliau/ml
—
5
48
6
44
1.36
0.34
2.2
2.2
27.83
31.93
%
—
6
44
6
46
1.31
0.33
1.8
1.4
2.38
100.99
ug/l
—
6
25
10
74
1.35
0.32
1.3
1.8
—
—
—
0
0
21
174
1.21
0.31
1.1
1.1
1.18
2.40
u/ml
—
10
89
32
279
1.15
0.28
1.5
1.7
7.58
4.06
iu/l
—
6
103
15
121
1.24
0.28
1.1
1.1
—
—
—
0
0
11
85
1.30
0.28
4.0
4.3
78.82
406.28
nmol/l
0.72
11
85
9
117
0.77
0.27
1.7
2.1
—
—
—
0
0
18
151
1.19
0.25
2.8
2.5
—
—
—
0
0
11
87
1.27
0.24
1.5
1.1
110.18
105.51
pmol/l
0.24
11
87
79
736
1.08
0.23
3.5
3.3
1.02
1.02
ratio
0.05
69
670
0
12
0.00
0.21
0.0
1.3
—
4.92
—
0
5
0
14
0.00
0.20
0.0
3.3
—
36.57
—
0
7
359
3676
0.97
0.19
3.1
3.3
0.70
0.82
ug/l
2.39
253
2436
15
128
1.17
0.18
1.1
1.1
6.46
2.08
u/ml
—
7
60
7
63
1.11
0.17
1.1
1.5
—
—
—
0
0
14
120
1.17
0.16
1.1
1.1
7.71
3.25
u/ml
—
6
52
16
139
1.15
0.16
1.1
1.1
1.33
1.51
u/ml
—
6
67
11
92
1.20
0.16
1.1
1.4
7.43
7.41
ph
—
6
57
8
72
1.11
0.16
1.1
1.2
—
—
—
0
0
38
351
1.08
0.15
4.2
3.9
76.65
1625.11
u/ml
1.25
33
322
14
121
1.16
0.15
1.2
1.3
—
—
—
0
0
9
81
1.11
0.15
1.6
1.4
71.44
85.22
umol/l
—
9
81
14
122
1.15
0.13
2.4
2.6
871.50
857.83
mg
0.01
14
122
80
767
1.05
0.12
1.2
1.3
—
—
—
0
0
121
1248
0.97
0.11
1.5
1.4
—
—
—
0
0
13
147
0.88
0.11
1.1
1.1
—
—
—
0
0
17
153
1.11
0.11
1.1
1.0
5.41
5.47
u/ml
—
7
79
16
145
1.10
0.09
1.1
1.0
1.23
1.67
u/ml
—
7
58
30
317
0.95
0.07
1.1
1.1
—
—
—
0
0
8
76
1.05
0.07
1.1
1.2
—
—
—
0
0
112
1104
1.02
0.04
1.6
1.5
—
—
—
0
0
14
133
1.05
0.01
1.0
1.1
—
—
—
0
0
10
102
0.98
0.00
2.8
2.3
11.40
37.99
mg/l
—
5
75
10
98
1.02
0.00
1.0
1.1
—
—
—
0
0
11
107
1.03
0.00
1.2
1.4
191.00
188.64
pmol/l
0.03
11
107
0
7
0.00
-0.00
0.0
9.7
—
99.29
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
70.57
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.15
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.50
—
0
6
0
8
0.00
-0.00
0.0
4.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TRAUMAT_SUBAR_HAEMORRHAGE – Traumatic subarachnoid haemorrhage

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).